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Colorectal cancer is a relentless disease plaguing over one million people just in the 
United States. Survival rates are highly dependent on the stage of malignancy, with a low 
survival rate once the cancer has metastasized. Therefore, it is crucial to understand the 
molecular changes that occur during the progression of colorectal cancer tumorigenesis to 
determine effective treatments. Colorectal cancer risk in the United States is highly tied to 
lifestyle aspects: diet, body weight, and activity. Determining dietary changes to assist in 
preventing or slowing progression to metastasis could increase survival rates. 
Anthocyanins, a subcategory of flavonoids, are natural red, purple, and blue pigments in 
a variety of plants consumed in a healthy diet. Many colorful fruits, vegetables, cereals, and 
legumes are rich in anthocyanins. The reported health benefits of anthocyanins and foods 
containing them include anti-carcinogenic, anti-diabetic, and anti-obesity effects. It is our long-
term goal to understand the mechanisms of action that anthocyanins and anthocyanin-rich 
extracts can exert to inhibit colorectal tumorigenesis and progression towards metastasis. We 
hypothesize that anthocyanins and anthocyanin-rich extracts can hinder colorectal cancer 
progression by induction of apoptosis, suppression of angiogenesis, and stimulation of immune 
response. To test this hypothesis, we utilized several in vitro and in silico models to demonstrate 
potential mechanisms of action of the anthocyanins and extracts to inhibit colorectal cancer 
progression. Utilizing the knowledge we gained on anthocyanins and anthocyanin-rich extracts 
through these studies, we tested an anthocyanin-enriched and black lentil extract in an in vivo 
carcinogenesis model in the final aim.  
We tested a variety of anthocyanin-rich extracts in vitro: red and purple corns, black 
lentil, red and purple grapes, sorghum, black rice, black and purple beans, purple sweet potato, 




HCT 116 and HT-29, which have different phenotypic and genotypic characteristics to give a 
more thorough analysis of the anthocyanins and anthocyanin-rich extract effects. The first aim 
utilized colored corn extracts and showed anti-proliferative effects on HCT 116 and HT-29 
human colorectal cancer cells. The concentration of 50% inhibition (IC50) ranged from 1.1 to 6.3 
mg/mL; the red corn had the highest potential to inhibit the cancer cell viability. All purple corn 
extracts increased apoptotic cells (19-53%) and impacted markers of apoptosis (BAX, BCL-2, 
and cytochrome C). Angiogenesis markers were also affected; colored corn extracts induced a 
decrease of the expression of vascular endothelial growth factor. In aim two, eleven phenolic-
rich cereal, legume, vegetable, and fruit extracts were tested on HCT 116 and HT-29 cells to dig 
deeper into the effects of chemical composition on inhibition potential. Inhibition of HCT 116 
and HT-29 cells significantly and strongly correlated with total phenolics (r = 0.87 and 0.77, 
respectively, p < 0.05) and delphinidin-3-O-glucoside (D3G) concentration correlated with HT-
29 inhibition (r = 0.69, p < 0.05). Black lentil had the lowest IC50 for both cell lines (HCT 116: 
0.9 mg/mL, HT-29: 1.4 mg/mL). Plant extracts induced apoptosis and arrested cells in G1. 
Anthocyanins exhibited tyrosine kinase inhibitory potential in silico and biochemically; 
cyanidin-3-O-glucoside (C3G) had one of the highest binding affinities with all of the tested pro-
angiogenic kinases. Aim three utilized insight on chemical composition discovered in aim two to 
focus on the impact of pure phenolics on human colorectal cancer cells and determine the effects 
on immune-suppressing checkpoints, programmed cell death protein 1 (PD-1) and programmed 
death-ligand 1 (PD-L1). D3G and its metabolites, delphinidin and gallic acid, had IC50 values 
ranging from 81-600 µg/mL. C3G, D3G, and delphinidin decreased PD-L1 fluorescence 
intensity by 39%, 30%, and 27%, respectively. C3G reduced PD-L1 expression in HCT 116 cells 




monoculture by 41% and 55%, and co-culture with HCT-116 and HT-29 cells by 39% and 26% 
(C3G) and 50% and 51% (D3G), respectively. In the final aim, a mouse model was used to 
determine the effect of a black lentil water extract and D3G-enriched extract on azoxymethane 
(AOM) and dextran sodium sulfate (DSS) induced colitis-associated carcinogenesis. The black 
lentil group had a lower disease activity index throughout and at the end of 2.4 compared to 6.3 
of the AOM/DSS control (p<0.05). Mice in the black lentil group had an average of 7.8 ± 1.0 
neoplasms while the AOM/DSS control had 12.8 ± 0.9 (p<0.05). Interleukin-6 protein expression 
was downregulated in colon mucosa (-44.5%), plasma (-72.6%) and gene expression was 
reduced in colon polyp tissue (fold change: -4.0) in the black lentil group compared to the 
AOM/DSS control. Although the D3G group did not have significant macroscopic changes 
compared to the AOM/DSS control, gene expression in the non-polyp tissue compared to the 
healthy control tissue was very similar with only four genes significantly modified (Secreted 
phosphoprotein 1 and CXCL2, CXCL5, and CXCL10). Black lentil and D3G-enriched extracts 
impacted interleukin-17 signaling, cytokine-cytokine receptor interaction, and intestinal immune 
network pathways. Black lentil treatment showed both anti-carcinogenic and anti-inflammatory 
properties while the D3G treatment demonstrated a decrease in the expression of pro-
inflammatory genes.    
Overall, anthocyanin-rich extracts showed potential to inhibit colorectal cancer 
progression. In successful completion of this project, we have contributed to the understanding 
of the anti-proliferative, pro-apoptotic, anti-angiogenic, and stimulatory immune response effects 
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CHAPTER 1: INTRODUCTION 
1.1 Overview 
In 2018, colorectal cancer was the third most common type of cancer in men and second 
in women worldwide, with an estimated 880,800 deaths (American Cancer Society, 2018). In the 
United States, this disease is the fourth most common type of cancer diagnosed and second 
leading cause of cancer death, with an overall 64.5% five-year survival rate (National Institutes 
of Health, 2019). Five-year survival rates are highly dependent on the stage of malignancy, with 
89.8% survival at a localized stage but only 13.8% if the cancer has metastasized; with 21% of 
colorectal cancer cases found at the distant stage and only 39% at the local stage, better detection 
technology and preventative strategies are necessary (National Institutes of Health, 2019). The 
most common sites of metastasis are the liver (13.8%), the lungs (3.7%), bone (0.8%), and the 
brain (0.2%) (Qiu, Hu, Yang, Cosgrove, & Xu, 2015). It is crucial to find effective treatments 
that target the molecular changes that occur during the progression of colorectal cancer 
tumorigenesis. The American Institute for Cancer Research (2018) determined that nearly half of 
colorectal cancer cases in the United States could be prevented through diet and lifestyle aspects: 
healthy diet and staying lean and active. Determining dietary changes to assist in preventing or 
slowing progression to metastasis could increase survival rates. 
Eating whole grains and foods high in fiber have been shown to decrease the risk of 
colorectal cancer, while evidence points toward increased risk with a low intake of non-starchy 
vegetables and fruits (AICR, 2018). Foods that fall into these categories are plant foods, which 
typically contain non-nutritive constituents such as polyphenols. Flavonoids are a polyphenol 
category. Anthocyanins are a subcategory of flavonoids, which provide many plant foods with a 




which include anti-carcinogenic, anti-diabetic, and anti-obesity effects, have been discussed in 
the recent scientific literature (Khoo, Azlan, Tang, & Lim, 2017). In vitro and animal studies 
have provided a preclinical basis for inhibition of colorectal cancer by anthocyanin-rich foods, 
but the mechanisms of action of anthocyanins and anthocyanin-rich foods is not fully 
understood. The bioavailability of anthocyanins is also a factor that impacts their potential to 
exert anti-carcinogenic effects. It is known that a low amount of parent anthocyanins remain in 
plasma but a fairly high percentage, around 45-70% of anthocyanins reach the colon; the extent 
of transformation of the anthocyanins that reach the colon plays an important role in their health 
effects with metabolites like phenolic acids also exerting anti-tumorigenic effects (Kay, Pereira-
Caro, Ludwig, Clifford, & Crozier, 2017; Lila, Burton-Freeman, Grace, & Kalt, 2016). 
Understanding the metabolism of anthocyanins and the effects of their metabolites assists in 
translating results seen in in vitro and animal models to human clinical and epidemiological 
studies.  
1.2 Project overview 
It is our long-term goal to understand the mechanisms of action that anthocyanins and 
anthocyanin-rich extracts can exert to inhibit colorectal tumorigenesis and progression towards 
metastasis. We hypothesized that anthocyanins and anthocyanin-rich extracts could hinder 
colorectal tumorigenesis and progression towards metastasis by induction of apoptosis, 
suppression of angiogenesis, and stimulation of immune response. In order to analyze this 
hypothesis, we utilized several in vitro and in silico models in the first three aims to demonstrate 
potential mechanisms of action of the anthocyanins and anthocyanin-rich extracts on colorectal 
cancer inhibition, culminating with an in vivo investigation in the fourth aim. Looking at the 




clinical trials gave us direction for pathway and molecular target analysis with the anthocyanins 
and anthocyanin-rich extracts. Throughout the aims, we focused on four of the ten hallmarks of 
cancer: resisting cell death, inducing angiogenesis, avoiding immune destruction, and tumor-
promoting inflammation (Hanahan & Weinberg, 2011).  
1.3 Specific aims 
The first aim focused on the in vitro colorectal cancer inhibitory potential of anthocyanin-
rich extracts from one food source, colored corn. The objective was to discover the effect of 
water-soluble anthocyanin-rich purple and red corn extracts on proliferation in human colon 
cancer cells, HCT 116 and HT-29, and then to analyze their potential to promote apoptosis and 
suppress markers of angiogenesis in vitro. We tested four anthocyanin-rich extracts, one red corn 
extract and three purple corn extracts with three different extraction methods and discovered that 
the anthocyanin-rich colored corn extracts were able to inhibit the viability of both cell lines; the 
red corn had the highest viability inhibition potential. Purple corn extracts increased apoptotic 
cells, decreased expression of anti-apoptotic markers, and increased pro-apoptotic markers. Corn 
extracts decreased angiogenesis markers like vascular endothelial growth factor. Also, 
computational docking showed high affinity for corn anthocyanins, especially cyanidin-3-O-
glucoside (C3G), and tyrosine kinases involved in angiogenesis, suggesting a potential anti-
angiogenic effect.   
The second aim looked at a larger variety of anthocyanin-rich extract sources, looking 
deeper into the effects of chemical composition on the inhibition of colorectal cancer 
progression. The objective was to determine the chemical composition of eleven anthocyanin-
rich plant extracts and compare their inhibitory effect on HCT 116 and HT-29 human colon 




biochemical assays. We utilized the various chemical composition findings to determine 
correlations with bioactivity to understand predictors of anti-carcinogenic potential. Total 
phenolic concentration and delphinidin-3-O-glucoside (D3G) concentration had strong 
correlations with inhibition of colorectal cancer cells. We also determined that black lentil, 
sorghum, and red grape were the top three inhibitors of HCT 116 and HT-29 viability. The plant 
extracts were able to induce apoptosis and decrease anti-apoptotic markers, in addition to 
arresting cells in the G1 phase.  
Aim three analyzed immune response effects of pure anthocyanins and other phenolics 
identified in the extracts used in aim two. The objective was to compare the anti-progression and 
stimulatory immune response effects by anthocyanins and their metabolites in silico and on 
human colorectal cancer cells, HCT-116 and HT-29. D3G and its metabolites, delphinidin and 
gallic acid, inhibited HCT 116 and HT-29 cell viability and induced apoptosis. C3G, D3G, 
delphinidin, gallic acid, and red grape and black lentil extracts reduced programmed death ligand 
1 (PD-L1) expression. C3G showed the highest binding affinities for immune related proteins. 
C3G and D3G decreased programmed death protein 1 (PD-1) expression in peripheral blood 
mononuclear cells in a monoculture and co-culture model with HCT 116 and HT-29 cells. 
Finally, the fourth aim advances to an in vivo mouse model to understand the translation 
of anthocyanin and anthocyanin-rich extract effects seen in vitro. The most potent extract and 
anthocyanin discovered in the first three aims were black lentil and D3G, respectively. A 
delphinidin-3-O-glycoside is the major anthocyanin in black lentil. The objective was to compare 
the efficacy of a black lentil water extract and a D3G-enriched lentil extract to prevent tumor 
development and activation of inflammatory processes and to impact immune response in an 




lentil extract was able to reduce the disease activity index, the number of neoplasms, and the pro-
inflammatory markers, especially interleukin-6, in the colon mucosa and plasma compared to the 
disease control group. The D3G-enriched treated group only had a lower disease activity index at 
the last measurement with no other macroscopic beneficial effects but did elicit anti-
inflammatory effects as shown by the gene expression modulation in the colon tissue. The black 
lentil extract was more effective than the D3G-enriched extract at reducing carcinogenesis.  
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FIGURES AND TABLES 
Table 1.1 Research aims summary 
Aim Chapter Types of Analysis Publication 
Aim 1: To discover the effect 
of anthocyanin-rich purple and 
red corn extracts on colon 
cancer proliferation in human 
colon cancer cells, HCT 116 
and HT-29, and then to 
analyze their potential to 
promote apoptosis and 
suppress markers of 
angiogenesis in vitro. 
4 -Characterization of 
colored corn extracts 
-In silico analysis of corn 
anthocyanins and 
angiogenesis markers 
-In vitro proliferation, 
apoptosis, and 
angiogenesis analysis with 
colon cancer cells 
Mazewski, C., Liang, K., & 
Gonzalez de Mejia, E. (2017). 
Inhibitory potential of 
anthocyanin-rich purple and 
red corn extracts on human 
colorectal cancer cell 
proliferation in vitro. J. Funct. 
Foods, 34, 254-265. 
Aim 2: To determine the 
chemical composition of 
eleven anthocyanin-rich plant 
extracts and compare their 
inhibitory effect on HCT 116 
and HT-29 human colon 
cancer cell viability and to 
analyze their mechanism of 
action in vitro, in silico, and 
through biochemical assays. 
5 -Characterization of 
eleven plant extracts 
-In silico analysis of 
anthocyanins and 
angiogenesis markers 
-In vitro proliferation, 
apoptosis, and cell cycle 




composition and colon 
cancer cell inhibition 
potential 
Mazewski, C., Liang, K., & 
Gonzalez de Mejia, E. (2018). 
Comparison of the effect of 
chemical composition of 
anthocyanin-rich plant extracts 
on colon cancer cell 
proliferation and their potential 
mechanism of action using in 
vitro, in silico, and 
biochemical assays. Food 
Chem., 242, 378-388. 
Aim 3: To compare the anti-
progression and stimulatory 
immune effects by 
anthocyanins and their 
metabolites on human 
colorectal cancer cell lines, 
HCT-116 and HT-29, in vitro 
and in silico. 
6 -In silico analysis of 
anthocyanins and immune 
response markers 
-In vitro proliferation, 
apoptosis, and immune 
response analysis with 
colon cancer cells 
- In vitro co-culture 
analysis with peripheral 
blood mononuclear cells 
Mazewski, C., Kim, S., & 
Gonzalez de Mejia, E. (2019). 
Anthocyanins, delphinidin-3-
O-glucoside and cyandidin-3-
O-glucoside, inhibit immune 
checkpoints in human 
colorectal cancer cells in vitro 
and in silico. Submitted to 
Scientific Reports #SREP-19-
11915. 
Aim 4: To determine and 
compare the efficacy of a black 
lentil water extract and a D3G-
enriched lentil extract to 
prevent tumor development 
and inflammatory processes 
and impact the immune 
response in a colitis-associated 
carcinogenesis mouse model. 
7 -Characterization of black 
lentil aqueous extract and 
D3G-enriched extract 
-In vivo C57BL/6 colitis-
associated carcinogenesis 
mouse model  
-Gene expression, 
histology, plasma, and 
mucosa analysis pertaining 
to inflammation and 
immune response   
Mazewski, C., Luna, D., 
Berhow, M., & de Mejia, E.G. 




modulation of cytokines 
mediating the communication 
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Figure 1.4 Overview of the methods performed in Aim 3. Cell pictures from American Type Culture Collection. Lactate 
dehydrogenase (LDH); MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; 










Figure 1.5 Overview of the methods performed in Aim 4. Ad libitum food throughout, regular water when not given DSS. AOM, 









CHAPTER 2: LITERATURE REVIEW – IMPACT OF ANTHOCYANINS ON 
COLORECTAL CANCER 
2.1 Abstract 
Anthocyanins, a subcategory of flavonoids, are red, blue, and purple natural pigments found in a 
variety of plants. Berries are the most well-known sources, but many other colorful fruits, as well 
as some vegetables, cereals, and legumes are rich in anthocyanins. There are reports in the 
scientific literature on the potential health benefits of anthocyanins, such as anti-diabetes, anti-
obesity, and anti-cancer effects. In vitro and animal studies have provided a preclinical basis for 
inhibition of colorectal cancer by anthocyanin-rich foods. Although some positive results have 
been reported with anthocyanins and colorectal cancer in clinical and epidemiological studies, 
still existing inconsistencies need to be investigated. The purpose of this chapter is to review in 
vitro, animal, clinical, and epidemiological studies on anthocyanins and anthocyanin-rich foods 
and colorectal cancer and to discuss the gap in knowledge to encourage new research that could 
result in promising clinical outcomes. 
  
Reprinted (adapted) with permission from (Mazewski, C. & de Mejia, E.G. (2018). ‘Impact 
of anthocyanins on colorectal cancer.’ Advances in Plant Phenolics: From Chemistry to 
Human Health. American Chemical Society Symposium Series #1286, Chapter 19, 339-





The identification that nearly half of colorectal cancer cases in the United States could be 
prevented through healthy diet and staying lean and active has highlighted the need to understand 
how diet components affect colorectal cancer (American Institute for Cancer Research, 2017). 
Anthocyanins are bioactive compounds in plants that can interact with biological markers 
involved in the processes that lead to tumor growth and can potentially hinder progression 
(Khoo, Azlan, Tang, & Lim, 2017). The levels of anthocyanins are high in many colorful fruits, 
vegetables, cereals, and legumes, as they are natural pigments. The health benefits of 
anthocyanins and foods containing them have attracted attention and have been studied mainly 
with the use of in vitro and in vivo animal models (Li, Wang, Luo, Zhoa, & Chen, 2017). These 
forms of analysis are pertinent to further understanding the impact of phenolics on colorectal 
cancer, especially on their mechanisms of action. However, additionally, clinical and 
epidemiological studies are needed to validate results. The absorption and bioavailability of 
anthocyanins in humans are not fully understood. It is known that a low amount of anthocyanins 
remain in plasma and are excreted in urine, but it is believed that enterohepatic circulation and 
transformation of the anthocyanins that reach the colon play an important role in their health 
effects (Kay, Pereira-Caro, Ludwig, Clifford, & Crozier, 2017; Lila, Burton-Freeman, Grace, & 
Kalt, 2016). This is essential to understand in order to translate results with anthocyanins seen 
in in vitro and animal models to human clinical and epidemiological studies. This chapter 
identifies and evaluates recent studies that have assessed the effect of anthocyanins and 
anthocyanin-rich foods on colorectal cancer. 




In 2012, colorectal cancer was the third most common type of cancer in men and second in 
women worldwide, with an estimated 693,900 deaths (American Cancer Society, 2015). In the 
United States, this disease is the fourth most common type of cancer diagnosed, with an overall 
64.9% five-year survival rate (National Institutes of Health, 2016). Survival rates are highly 
dependent on the stage of malignancy, with 89.9% survival at a localized stage but only 13.9% if 
the cancer has metastasized (National Institutes of Health, 2016). Therefore, it is crucial to 
understand the molecular changes that occur during progression of colorectal tumorigenesis to 
determine effective treatments. A majority of colorectal cancers progress in a way similar to the 
following. First, an adenomatous polyposis coli (APC) gene mutation transforms normal 
epithelium to a dysplastic crypt and an early adenoma forms (Frank, 2007). APC normally 
represses β-catenin, but if mutated, β-catenin alters cell adhesion processes and stimulates 
cellular division (Frank, 2007). Next, a mutation in the Kirsten rat sarcoma (KRAS) gene leads 
to an intermediate adenoma (Frank, 2007). KRAS is involved in pro-proliferative intracellular 
signaling, and when mutated, it is constitutively active, leading to proliferation and cell growth 
(Tan & Du, 2012). A late adenoma is the result of an additional mutation of the DCC, SMAD4, 
or SMAD2 genes which are related to tumor suppression and cell adhesion (Frank, 2007). The 
adenomas, or benign polyps, in the colon or rectum lining can be discovered through 
colonoscopies and removed at the early stages of development. However, a p53 mutation, after 
these beginning mutations, leads to a carcinoma. As a tumor suppressor gene, p53 helps invoke 
cell cycle arrest and induce apoptosis when typical distress to the cells occur (Frank, 2007). 
Without that regulation, a main control over cell proliferation is lost. Additional mutations, 
proliferation, and promotion of pathways like angiogenesis will then lead to metastasis. Tumor 




aberrations, is in about 85% of colorectal tumors and 15% have microsatellite instability, 
mismatch repair mutations (Frank, 2007). Colorectal tumors may undergo alternative changes to 
pathways and sequences of events, but overall, progression occurs with the accumulation of 
mutations related to tumor suppression and cell survival pathways and with chromosomal or 
microsatellite instability. The mutations and instability characteristics of cancer cells found in 
this review are shown in Table 2.1 (American Type Culture Collection, 2014; Ahmed et al., 
2013; Mathieu et al., 2016). The estimated staging, where known, is also included in the table. 
Staging is based on the tumor, node, and metastasis (TNM) system where T indicates primary 
tumor characteristics, N pertains to the degree to which regional lymph node metastasis has 
occurred, and M representing distant metastasis measures to other organs (Compton et al., 2012). 
The numbers associated with each letter indicate the overall stage number ranging from 0-4, 
which is more commonly recognized (Compton et al., 2012). 
2.4 Anthocyanin Structure 
Anthocyanins belong to the flavonoid class of phenolic compounds. In nature, they exist as 
glycosides (Li, Wang, Luo, Zhoa, & Chen, 2017). The aglycone forms of anthocyanins, without 
sugar, are anthocyanidins; the six main anthocyanidins found in food are cyanidin, delphinidin, 
peonidin, pelargonidin, malvidin, and petunidin (Li, Wang, Luo, Zhoa, & Chen, 2017). The 
anthocyanin structure varies but consists of a flavylium cation, methoxyl, and hydroxyl groups, 
and typically, an attached sugar, most commonly glucose (Burton-Freeman, Sandhu, & 
Edirisinghe, 2016). The color, red, blue, or purple, is dependent on structure and pH, among 
other factors. The structure of anthocyanins can affect their health benefit potential. For example, 
anthocyanidins and acylated anthocyanins have been shown to have higher antioxidant activity 




hydroxyl group on the B ring of the anthocyanin structure increases antioxidant activity (Ali & 
Ali, 2017). The hydroxyl and methoxyl groups, as well as the presence of a sugar, can modify 
the structure-function relationship of the anthocyanin with molecular targets of carcinogenesis. 
The glycoside structures of the six main anthocyanidins are shown in Figure 2.1. 
2.5 Food Sources of Anthocyanins 
Anthocyanins are abundant in many types of commonly eaten plant foods: fruits, vegetables, 
cereals, nuts, and legumes. Beverages derived from fruits, wines and juices, may also contain 
high amounts of anthocyanins. Intake of anthocyanins in the United States is estimated at 12.5 
mg/day, with a majority coming from fruits (Burton-Freeman, Sandhu, & Edirisinghe, 2016). 
Fruits have the greatest amount of anthocyanin sources compared to the other categories. 
Although fruit sources are not limited to berries, berries make up a large portion, and most 
berries listed in the USDA database of flavonoid content in foods contain anthocyanins 
(Bhagwat, Haytowitz, & Holden, 2013). Some examples include açaí, blackberry, blueberry, 
chokeberry, cranberry, raspberry, and strawberry (Bhagwat, Haytowitz, & Holden, 2013). 
Vegetable sources high in anthocyanins include red cabbage, eggplant, Tasmanian peppers, 
radicchio, radishes, and purple sweet potatoes (Bhagwat, Haytowitz, & Holden, 2013). Nuts and 
seeds have a lower concentration compared to fruits and vegetables, but there are anthocyanins, 
mainly cyanidin, in almonds, hazelnuts, pecans (also contain delphinidin), pistachios, and 
walnuts (Bhagwat, Haytowitz, & Holden, 2013). The only cereal with anthocyanins listed in the 
USDA database is purple wheat; however, sources used in articles found in this review include 
purple and black rice and purple and red corn (Bhagwat, Haytowitz, & Holden, 2013). In the 
legume category, beans with anthocyanins include black and red kidney, and the black seed 




Holden, 2013). Cyanidin is the most distributed anthocyanidin in fruits and vegetables at 50%, 
followed by delphinidin, peonidin, and pelargonidin all at 12%, and malvidin and petunidin at 
7% (Khoo, Azlan, Tang, & Lim, 2017). The concentration of cyanidin is also much higher in 
food sources than the other five anthocyanidins. Tasmanian peppers and black raspberries have 
the highest concentration of cyanidin, 752.68 and 669.01 mg/100 g, respectively, whereas the 
highest concentration of delphinidin in a raw source is 97.59 mg/100 g in bilberries (Bhagwat, 
Haytowitz, & Holden, 2013). Figure 2.1 shows typical sources and the concentration of the six 
anthocyanidins found in that food source. 
2.6 Anthocyanin Bioavailability 
The specifics on the bioavailability of anthocyanins are still unclear, although it is accepted that 
their presence in plasma and urinary concentrations are low. This has led to the belief that 
bioavailability is also low. However, studies have found anthocyanins and their metabolites 
accumulated in most tissues, such as the bladder, prostate, eye, and adipose tissue; the 
accumulation indicates chronic exposure to tissues, providing some insight on potential means to 
which anthocyanins exert their health benefits (Fernandes, Faria, Calhau, de Freitas, & Mateus, 
2014). Absorption occurs in the stomach through bilitranslocase, which has more affinity for 
anthocyanins than anthocyanidins (Lila, Burton-Freeman, Grace, & Kalt, 2016). In the small 
intestine, anthocyanins can be hydrolyzed to their aglycone form mainly in two ways: by lactase 
phlorizin hydrolase on the brush border of the epithelial cells or by β-glucosidase within 
epithelial cells (Kay, Pereira-Caro, Ludwig, Clifford, & Crozier, 2017). In the small intestine, the 
hydrophobic anthocyanidins can be absorbed through passive diffusion, but the anthocyanins are 
likely to utilize a glucose transporter (Lila, Burton-Freeman, Grace, & Kalt, 2016). Although 




of a sugar, a majority of absorption has been predicted to occur in the stomach and jejunum 
(Lila, Burton-Freeman, Grace, & Kalt, 2016). After entering circulation, anthocyanins will go to 
the liver and be metabolized, but some anthocyanins and their metabolites reach the colon. High 
amounts of phenolic acids are seen in the colon; the colonic microbiota can induce ring fission of 
the basic flavonoid C6- C3-C6 to produce phenolic acids (Lila, Burton-Freeman, Grace, & Kalt, 
2016). Clinical metabolism studies are helping to elucidate the pharmacokinetics of anthocyanins 
in humans. A recent study analyzed the bioavailability of wild blueberry anthocyanins in human 
subjects for 24 h (Zhong, Sandhu, Edirisinghe, Burton-Freeman, 2017). No anthocyanins were 
detected in plasma after 24 h, and most had a peak plasma concentration at 2 h post ingestion 
(Zhong, Sandhu, Edirisinghe, Burton-Freeman, 2017). Glucuronide metabolites had a biphasic 
response with peaks at around 2 and 8 h which could be explained by enterohepatic circulation 
(Zhong, Sandhu, Edirisinghe, Burton-Freeman, 2017). Enterohepatic circulation has been noted 
as a mechanism that increases the bioavailability of anthocyanins by increasing residence time in 
the body and increasing the variety of conjugates seen by the gastrointestinal tract (Lila, Burton-
Freeman, Grace, & Kalt, 2016). The bioavailability of anthocyanins was around 1%, but many 
metabolites like phenolic acids were found in significantly higher concentrations in those who 
ingested the wild blueberry beverage compared to the placebo (Zhong, Sandhu, Edirisinghe, 
Burton-Freeman, 2017). Kalt et al. conducted two human studies on blueberry juice anthocyanin 
bioavailability (Kalt, McDonald, Liu, & Filmore, 2017; Kalt, McDonald, Vinqvist-Tymchuk, 
Liu, & Filmore, 2017). In one of these studies, they found a majority of urinary anthocyanins 
were aglycone or aglycone glucuronides (Kalt, McDonald, Liu, & Filmore, 2017). The high 
amount of glucuronide conjugates confirms what was seen in the previously mentioned wild 




found an indication of slow anthocyanin release (Kalt, McDonald, Vinqvist-Tymchuk, Liu, & 
Filmore, 2017). Also, they discovered a difference in anthocyanin retention based on dosing 
either once daily or three times a day, with one-time dosing retaining parent anthocyanins better 
(Kalt, McDonald, Vinqvist-Tymchuk, Liu, & Filmore, 2017). These results are relevant for 
clinical studies to design dosages for better treatment responses. The most recent studies 
highlight that it is not just the parent compounds and anthocyanin presence in plasma that 
determine the health effects of anthocyanins. In the colon, anthocyanin parent compounds are not 
absorbed, but the high concentration of metabolites produced by colonic bacteria exist (Lila, 
Burton-Freeman, Grace, & Kalt, 2016). The metabolite production and presence could be greater 
elucidated to provide further understanding of anthocyanin colon health benefits. 
2.7 In Vitro Studies 
A variety of anthocyanin-rich foods have been tested in vitro on colorectal cancer cells. The 
majority of studies have examined extracts from fruits, such as grapes, açaí berry, and bilberry, 
but vegetables, cereals, and legumes have also been studied. There is also a variety of types of 
cells utilized: Caco-2, HCT-116, colon cancer stem cells, HT-29, COLO 320DM, SW-480, 
RKO, and SW620. Data from several cell lines gives a representation of varying stages of colon 
tumorigenesis. For example, HCT-116 cells are considered to be at an early stage, while HT-29 
cells are classified as advanced colon cancer cells (Charepalli et al., 2016). HT-29 cells were 
used in nine of the fifteen studies; the common usage of these cells could be due to the mutations 
and phenotype characteristics being representative of most colorectal cancers as described in the 
“colorectal cancer” section of this review. Further cell line detail is outlined in Table 2.1. 
In vitro studies are outlined in Table 2.2 (fruit sources) and Table 2.3 (vegetables, legumes, 




angiogenesis, among others. Cleaved caspase-3, an essential protein in the promotion of 
apoptosis, was tested in most of the in vitro studies. Anthocyanin-rich extracts and pure 
anthocyanins increased cleaved caspase-3 expression or demonstrated activation inducing 
capabilities. Pertaining to cell cycle, pure anthocyanins from bilberry and black currant and red 
wine de-alcoholized extract increased p21 expression (Anwar et al., 2016, Signorelli et al., 
2015). For cell cycle analysis using flow cytometry, extracts arrested HT-29 cells, but the stage 
differed among extracts. Illawarra plum arrested HT-29 cells in S phase, while purple tea extract 
arrested in G0/G1, and black lentil, sorghum, and red grape arrested in G1 phase (Symonds, 
Konczak, & Fenech, 2013; Hsu, Shih, Lin, Chiu, & Lin, 2012; Mazewski, Liang, & Gonzalez de 
Mejia, 2018). Analysis of inflammation showed açaí, cocoplum, and pomegranate juice extract 
reduced expression of inflammation markers like NFκB (Dias et al., 2014; Venancio et al., 2017; 
Banerjee, Kim, Talcott, & Mertens-Talcott, 2013). Also, in angiogenesis analysis, vascular 
endothelial growth factor expression was reduced by açaí, pomegranate juice, and purple and red 
corn extracts (Dias et al., 2014, Banerjee; Kim, Talcott, & Mertens-Talcott, 2013; Mazewski, 
Liang, & Gonzalez de Mejia, 2017). Glycosides of all six most common anthocyanidins in foods 
are represented, either identified in extracts or tested as pure anthocyanins. Pure anthocyanins 
were tested in a few studies like those derived from eggplant and from bilberry and black currant 
but a majority of studies used anthocyanin-rich extracts (Anwar et al., 2016; Jing et al., 2015). 
Because anthocyanins are known to undergo metabolic transformations by the gut microbiome, 
recent studies have used metabolites of anthocyanins as part or as the focus of the research. 
Determining metabolites to test has been done through literature identification, simulated 
gastrointestinal digestion, and fermenting extracts with human feces. In the study where past 




gallic acid and 3-O-methylgallic acid decreased Caco-2 cell viability where malvidin-3-O-
glucoside did not affect up to 100 μM (Forester, Choy, Waterhouse, & Oteiza, 2014). The 
simulated human model study used purple potatoes and a five-step digestion model (Kubow et 
al., 2017). The cultivar that had higher concentrations of anthocyanins in the colonic vessels of 
the simulated model had higher potency on Caco-2 cell inhibition (Kubow et al., 2017). Finally, 
the study that fermented with human feces used grape and strawberry extracts (López de las 
Hazas, Mosele, Macià, Ludwig, & Motilva, 2017). The extracts and some of the metabolites, like 
hydroxyphenylacetic acid, reduced cell viability and promoted caspase-3 activation in HT-29 
cells (López de las Hazas, Mosele, Macià, Ludwig, & Motilva, 2017). Analyzing metabolite 
effects provides realistic dimension to testing extracts in vitro and can help progress in 
vivo testing. 
2.8 Animal Studies 
Animal model studies are outlined in Table 2.4. As in the in vitro studies, there is an abundance 
of animal model studies that have tested anthocyanin-rich foods on colorectal cancer. All studies 
utilized either a mouse or rat model. Typically, the higher dosage used (0.5-10%) in each animal 
study was required to see the most significant effects, although some saw responses at the lower 
dosage (0.2%-5%). Tumor incidence, apoptosis, and inflammation were commonly tested 
utilizing various assays. Generally, anthocyanin-rich extracts reduced tumor count. Apoptosis 
results showed increase in caspase-3 with purple rice and açaí extract treatment (Wongjaikam, 
Summart, & Chewonarin, 2014; Choi et al., 2017). Purple fleshed potato extract increased 
TUNEL staining and grape extract showed a decrease in BCL-2 but also in BAX expression 
(Charepalli et al., 2015; Oshima et al., 2015). Many studies analyzed inflammation and found 




decreased inflammatory markers like cytokines (TNF-α, IL-1β, and IL-6) and NF-κB (Banerjee, 
Kim, Talcott, & Mertens-Talcott, 2013; Choi et al., 2017; Shi et al., 2015). Bilberry extract 
protected from colonic length reduction, a result of inflammation, and mulberry extract 
decreased mucosa damage and lymphocyte infiltration (Lippert et al., 2017; Qian et al., 2015). 
Fruit sources were the dominant group represented in the animal models studied as was seen in 
vitro. Some other sources included purple potato, black soybean seed, and purple rice 
(Wongjaikam, Summart, & Chewonarin, 2014; Charepalli et al., 2015; Park, Kim, Kim, Choung, 
& Sung, 2015). Common sources used in in vitro studies are also seen in animal studies: açaí 
berry, bilberry, grapes, pomegranate, purple rice, purple potatoes, and strawberries. This enables 
comparisons between the types of models used. Beneficial effects were seen in both in 
vitro and in vivo applications for these sources. In both models, açaí berry and pomegranate 
showed capabilities of decreasing proliferation and inhibiting inflammation (Dias et al., 
2014; Banerjee, Kim, Talcott, & Mertens-Talcott, 2013; Choi et al., 2017; Romualdo et al., 
2015), while purple potatoes and rice decreased proliferation and increased apoptosis in vitro and 
in mice and rat models (Wongjaikam, Summart, & Chewonarin, 2014; Charepalli et al., 2015). 
Showing effectiveness in both models strengthens the potential for clinical studies. 
2.9 Clinical Studies 
Clinical studies specific to anthocyanins and colorectal cancer are outlined in Table 2.5. 
Although limited, there are clinical trials evaluating the effect of anthocyanin-containing foods 
on colorectal cancer. Three studies utilized black raspberries which are high in a variety of 
phenolics including anthocyanins. One study analyzed whether black raspberries could regress 
rectal polyps in patients with familial adenomatous polyposis (Li-Shu et al., 2014). Patients with 




they were used for the study (Li-Shu et al., 2014). The burden of rectal polyps was significantly 
reduced with black raspberry suppositories, but there was no effect as a result of added oral 
supplementation (Li-Shu et al., 2014). Black raspberries were also used in two studies by one 
research group on colorectal cancer patients; in one part, markers of apoptosis, angiogenesis, and 
proliferation were evaluated while the other examined metabolites in plasma and urine to 
understand the metabolism of the black raspberries (Wang et al., 2011; Pan, Skaer, Stirdivant, 
Young, Stoner, Lechner, Huang, & Wang, 2015). In the first part, the black raspberry treatment 
had beneficial effects, decreasing markers of proliferation and angiogenesis and increasing 
markers of apoptosis (Wang et al., 2011). Also, there were beneficial effects of the high dose 
treatment on Wnt pathway markers which are commonly studied in cancer treatment effects 
(Wang et al., 2011; Zhan, Rindtorff, & Boutros, 2017). The second part discovered the black 
raspberry ingestion changed metabolite profiles, with many changes seen in urinary metabolites 
(Pan, Skaer, Stirdivant, Young, Stoner, Lechner, Huang, & Wang, 2015). These alterations could 
be connected to some of the anti-carcinogenic effects found in the first part of the study. These 
results confirm benefits seen in a mouse model study that also utilized black raspberries and 
found decreased polyp size and amounts and reversed 23 metabolites related to the APC gene 
mutation (Pan, Skaer, Wang, Stirdivant, Young, Oshima, Stoner, Lechner, Huang, & Wang, 
2015). Positive results were not seen when a vegetable and fruit supplement was tested clinically 
(Blázovicsa et al., 2016). Antioxidant activities and reducing power were lowered in both healthy 
and post-colectomysed patients attributed to a rebound effect with very high levels of 
antioxidants (Blázovicsa et al., 2016). There were no significant changes in tumor markers and 
contradicting results with inflammation markers (Blázovicsa et al., 2016). This could be due to 




extract supplementation, which typically contains anthocyanins, in 35 colorectal cancer patients 
although this study was focusing on the impact of ellagitannins (Nuñez-Sánchez et al., 2017). 
Gene expression was analyzed in colon tissues after colonoscopies of the colorectal cancer 
patients, before their initial surgery (Nuñez-Sánchez et al., 2017). The results did not reflect the 
changes reported in cultured colon cells exposed to either mixed or single ellagitannin 
metabolites but part of the issue was considerable inter-individual variability, and it was noted 
that there was a high influence on expression from experimental procedures (Nuñez-Sánchez et 
al., 2017). The authors also noted that larger sample sizes would result in more significant data 
and better reflect in vitro results (Nuñez-Sánchez et al., 2017). The beneficial results seen with 
the black raspberry studies are promising reasons to pursue further clinical studies with 
anthocyanin-rich foods; however, there are also studies showing no significant effects indicating 
that a further understanding of ANC mechanism of actions needs to be elucidated. 
The results from a randomized, phase II, double-blind trial combining anthocyanins and 
curcumin, another flavonoid, in patients with colorectal adenoma, which started in 2014 with 
estimated completion in 2019, will add to the clinical discussion of anthocyanins (National 
Library of Medicine, 2017). The primary outcome will be immunohistochemical expression of β-
catenin in normal and adenomatous tissue, which was a marker that was modulated in one of the 
previously mentioned black raspberry studies (Wang et al., 2011; National Library of Medicine, 
2017). 
2.10 Epidemiological Studies 
Epidemiological studies specific to anthocyanins and colorectal cancer are outlined in Table 2.6. 
Three epidemiological studies were found on the potential relationship between dietary 




2016); two additional studies were meta-analyses of case-control or cohort studies and colorectal 
or stomach cancer risk (Woo & Kim, 2013; He & Sun, 2016). The epidemiological studies taking 
place in the U.S. and Europe did not find an overall inverse relationship between anthocyanin 
intake and colorectal cancer risk once all multivariable adjustments were made (Zamora-Ros et 
al., 2017; Nimptsch et al., 2016), but there was an inverse relationship seen in a Chinese cohort 
(Xu et al., 2016). Also, the study with the Health Professionals Follow-Up Study men’s cohort 
did find a relationship between anthocyanin intake and decreased risk for colorectal cancer but 
once multivariable adjustment was applied the association was not significant (Nimptsch et al., 
2016). For the European prospective investigation into cancer and nutrition (EPIC) study, the 
only association seen with anthocyanins was a lower risk of colorectal cancer with former 
smokers (Zamora-Ros et al., 2017). However, limitations were noted. The main limitation of the 
EPIC study was that the food frequency questionnaire used was not specific for flavonoid 
measurement and so could have had foods missing that contain flavonoids and therefore with a 
less accurate representation of flavonoid intake (Zamora-Ros et al., 2017). One meta-analysis did 
find an inverse relationship between flavonoid intake and colorectal cancer risk but mentioned 
there could be a bias in the selection of studies, and therefore, the results are not conclusive 
(Woo & Kim, 2013). A second meta-analysis reported that there was not a relationship found 
between total flavonoids and colorectal cancer incidence but did find a reduced risk with 
anthocyanins in case-control studies for males and reported no publication bias (He & Sun, 
2016). A study that evaluated the relationship between flavonoid groups and inflammation 
markers in a U.S. cohort found that anthocyanins had an inverse relationship with all 
inflammation markers subgroups (Cassidy et al., 2015). Tumor-promoting inflammation is a 




this study provides some evidence that anthocyanins can reduce colorectal cancer risk. The 
epidemiological studies do not strongly confirm positive in vitro and animal model study results 
with anthocyanin-rich foods, but some beneficial outcomes are identified. Studies better 
designed to evaluate flavonoid intake could show statistically stronger correlations by having a 
food frequency questionnaire that better captures flavonoid intake. 
2.11 Conclusions 
The plethora of studies using human colorectal cancer cell lines in vitro and mice and rat 
models in vivo shows potential for anthocyanin-rich foods to inhibit colorectal cancer growth and 
development. The effect of anthocyanins has been tested on a wide range of molecular pathways 
including apoptosis, angiogenesis, inflammation, cell cycle, survival, oxidative effect, DNA 
damage, and migration. Although the mechanism of action has not been fully described, 
beneficial effects through anthocyanin-rich foods have been demonstrated on all of these 
pathways. The positive results of black raspberries in clinical studies have shown potential for 
anthocyanins to help hinder colorectal cancer progression in humans. Negative effects using 
supplements could be due to too high doses in the supplement form versus use of a whole food 
approach. Lack of significant epidemiological evidence raises questions about anthocyanin 
impact on colorectal cancer; therefore, using questionnaires more specific for flavonoid 
measurement are needed to ensure more accurate results. Further understanding about the 
presence of anthocyanin metabolites in the colon and the biological activity of metabolites in 
humans could lead to more successes in clinical settings. In addition, more double blind, cross-
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FIGURES AND TABLES 
Table 2.1 Phenotypic and genotypic characteristics of human cancer cell lines. 
 
Cell line Histology Estimated 
Malignancy Stage* 
Mutations Oncogenes Genomic 
Instability 
References 
Caco-2 Adenocarcinoma Unknown TP53 Unknown Chromosomal ATCC, 2014; Ahmed et 
















ATCC, 2014; Ahmed et 
al., 2013 




TGF beta 1+, 
TGF beta 2+ 
Microsatellite ATCC, 2014; Ahmed et 
al., 2013; Mathieu et al., 
2016 




myc +; myb +; ras 
+; fos+; sis +; p53 
+; abl -; ros -; src - 
Chromosomal ATCC, 2014; Ahmed et 
al., 2013; Mathieu et al., 
2016 











myc +; myb + ; ras 
+; fos+; sis +; p53 




ATCC, 2014; Ahmed et 
al., 2013; Mathieu et al., 
2016 
SW620 Adenocarcinoma Stage 3 APCHM, KRASHM, 
SMAD4HM, 
TP53HM 
myc +; myb + ; ras 
+; fos+; sis +; p53 
+; abl -; ros -; src - 
Chromosomal ATCC, 2014; Ahmed et 
al., 2013; Mathieu et al., 
2016 
Superscripts: HT: heterozygous mutation, HM: homozygous mutation (if known). CDKN2A: cyclin-dependent kinase inhibitor 2A; CTNNB1: catenin (cadherin-associated 
protein) beta 1; PIK3CA: phosphatidylinositol-4, 5-bisphosphate 3- kinase, catalytic subunit alpha; KRAS: Kirsten rat sarcoma; TGF: transforming growth factor; APC: 
adenomatous polyposis coli; BRAF: B-RAF (rapidly accelerated fibrosarcoma); SMAD4: mothers against DPP homolog 4. *Stages translated from Duke’s stage to TNM system 





Figure 2.1 The glycoside structure of the six most abundant anthocyanidins in foods and an 




























colon cancer stem 
cells (CCSC) 
Proliferation: MTT assay 
Survival: colony formation 
assay 
Apoptosis: Caspase Glo 3/7 and 
TUNEL assays 
Java plum extract suppressed 
HCT-116 proliferation and 
CCSC colony formation and 
















Caco-2 Proliferation: trypan blue dye 
exclusion assay 
Survival: clonogenic assay 
Antioxidant activity: discoloration 
of ABTS•+ radical 
Intracellular ROS: DCFH-DA 
assay Apoptosis: caspase-3 
western blot Cell cycle: p21 
western blot 
Berry ANC-rich supplement 
inhibited Caco-2 proliferation 
and colony formation, increased 
intracellular ROS accumulation, 
and induced caspase-3 









Not determined HCT-116 Proliferation: sulforhodamine 
B proliferation assay 
Migration: wound-healing assay 
Antioxidant activity: ferric 
reducing antioxidant power test, 2-
deoxyribose degradation assay, 
Nrf2 expression Intracellular ROS: 
d-ROMs test kit Cell cycle: p53, 
p21 western blots, sphingolipid 
LC-MS analysis 
EMT: E-cadherin, CD44, CD133 western 
blot or mRNA expression  
Red wine extract decreased 
proliferation, increased cell 
cycle regulators: p53, p21, 
sphingolipid mediators, 
increased antioxidant activity 
possibly through activation 
of Nrf2, and positive impacts 
on EMT: increased E-
cadherin and decreased 














HT-29 Proliferation: MTT 
assay Cell cycle: flow 
cytometry 
DNA damage: CBMN cytome assay, 
quantitative real-time PCR to measure 
telomere length, HDAC activity assay 
and telomerase, sirtuin 1, and p53 mRNA 
expression 
Illawarra plum extract reduced 
cell viability, induced cell 
cycle arrest in S phase, 
increased HDAC activity, and 
shortened telomere length 
while decreasing telomerase 







Table 2.2 (cont.) 












Proliferation: electronic cell 
count Intracellular ROS: 
DCFH-DA assay Gene 
expression or western blots: 
Inflammation: NF-кB, ICAM-1, 
VCAM-1  
Apoptosis: Sp transcription factors, 
BCL-2, cleaved caspase-3, 
cytochrome C, PARP- 1, survivin 
Angiogenesis: VEGF 
Açaí extract inhibited net 
growth in HT-29 and SW-480, 
impacted inflammatory 
(decrease NF-kB, ICAM-1, and 
VCAM-1), apoptosis (decrease 
BCL-2 and survivin, increase 
cytochrome C and cleaved 
caspase -3) and angiogenesis 
(decrease VEGF) genes and 
proteins in SW-480 





petunidin and peonidin 
glycosides 
HT-29 Proliferation: resazurin-based in vitro 
toxicology assay kit 
Intracellular ROS: DCFH-DA assay 
Inflammation: NF-κB, TNF-α, IL-
1β, IL-6 RT-qPCR mRNA 
expression 
Cocoplum extract decreased cell 
viability, increased intracellular 
ROS generation, and decreased 
markers of inflammation at the 










HT-29 Proliferation: electronic cell counter 
Apoptosis: RT-qPCR of cleaved 
caspase-3 and PARP 
Inflammation: RT-qPCR of 
COX-2, NFκB, VCAM-1, 
ICAM-1 
Survival: RT-qPCR of pAKT, 
PI3K, and miR-126 
Angiogenesis: RT-qPCR of VEGF 
Pomegranate juice extract 
reduced viability, increased 
cleaved caspase-3 and PARP 
expression, reduced NFκB, 
VCAM-1, ICAM-1, COX-2, 
pAKT, and VEGF 
expression and increased 















acid (grape), tyrosol 
(strawberry) 
HT-29 Metabolite generation: 8 h 
anaerobic in vitro incubation with 
human feces Metabolites, mixture 
of metabolites, and extracts tested: 
Proliferation: MTT assay 
Apoptosis: flow cytometry and 
caspase-3 assay 
No significant effect on cell 
viability but metabolite, 
hydroxyphenylacetic acid and 
grape and strawberry extracts 
induced apoptosis, only the grape 
metabolite mixture promoted 




ANC: anthocyanin(s); ABTS•+: 2,2-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid); ROS: reactive oxygen species; DCFH-DA: dichloro-dihydro-fluorescein diacetate; CCSC: colon cancer stem 
cells; MTT: (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide); TUNEL: terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling; NF-κB: nuclear factor kappa B; ICAM-
1: intercellular adhesion molecule 1; VCAM-1: vascular cell adhesion molecule 1; Sp: specificity protein; BCL-2: B-cell lymphoma 2; PARP-1: poly [ADP-ribose] polymerase 1; VEGF: vascular 
endothelial growth factor; EMT: epithelial to mesenchymal transition; TNF-α: tumor necrosis factor alpha; IL-1β: interleukin-1 beta; IL-6: interleukin 6; RT-qPCR: reverse transcription quantitative 




Table 2.3 In vitro colorectal cancer cells treated with vegetable, pulse, cereal, and tea extracts containing anthocyanins. 














Apoptosis: flow cytometry, 
BAX, BCL-2, procaspase-3, 
PARP western blots 
Cell cycle: flow cytometry, 
cyclin D1, E, A, and B, 
p21, p27 western blots 
Purple tea extract inhibited the proliferation 
of both cell lines, arrested cells at the 
G0/G1 phase, induced apoptosis, increased 
BAX/BCL- 2 ratio, activated PARP and 
caspase-3. 
Purple tea extract reduced expression of 
cyclin E and D1 in COLO 320DM, and 
in HT-29 increased p21 and p27 
expression 













HCT-116 and HT- 
29 
Proliferation: MTS assay 
Apoptosis: flow 
cytometry, apoptosis 
protein array Cell cycle: 
flow cytometry 
Angiogenesis: in silico 
analysis of six ANC and 
tyrosine kinases, EGFR kinase 
binding assay 
Black lentil, sorghum, and red grape were 
the most potent inhibitors of proliferation 
on both cell lines, they induced apoptosis 
and arrested cells in G1 phase, there was a 
strong correlation with phenolic 
concentration and cell inhibition potential, 
cyanidin-3-O- glucoside had the highest 














HCT-116 and HT- 
29 
Proliferation: MTS assay 
Apoptosis: flow cytometry, 
BAX, BCL-2, cytochrome C 
western blots, apoptosis 
protein array 
Angiogenesis: VEGF, Abl-2 
western blots, angiogenesis 
protein array, in silico 
analysis of tyrosine kinases 
and colored corn ANC 
All four corn extracts inhibited 
proliferation in both cell lines with the red 
corn having the highest potency, purple 
corn extracts increased apoptotic cells and 
increased expression of BAX and 
cytochrome C, all corn extracts decreased 
VEGF expression, pure ANC had favorable 










HCT-116 and HT- 
29 
Intracellular ROS: DCF 
assay, γ-GCLC, GSR, NQO1 
western blots 
DNA damage: comet assay 
Delphinidin derivatives reduced ROS 
levels in both cell lines, greatest decrease 
with delphinidin-3-glucoside, 3-
sambubioside, and 3-rutinoside, additional 
sugars at the C5 position decreased 
scavenging capabilities, GSR expression 
increased in HT-29 





Table 2.3 (cont.) 
















Caco-2 Simulated digestion: human 
GI model – 5 reactors 
Antioxidant activity: 
ferric reducing 
antioxidant power assay 
Proliferation: MTT assay 
The Leona cultivar, that had higher ANC 
concentration in the simulated colonic 
vessels, had higher potency on Caco-2 cells 
and no cytotoxicity on normal colon cells, 
increased antioxidant capacity with 








RKO and SW620 Proliferation: MTT assay 
Apoptosis: flow 
cytometry DNA damage: 
DNA fragmentation 
assay 
Crude ethanol sub-fraction, hexane soluble 
fraction extract, was the most potent on 
both cell lines on proliferation suppression, 
it induced apoptosis and produced DNA 
ladders where the whole crude ethanol 
extract was less potent 
Wongjaika













Proliferation: BrdU assay, 
sphere formation assay 
Apoptosis: TUNEL assay, 
BAX, BCL-2, cytochrome C, 
β-catenin, c-Myc, cyclin D1 
western blots 
Suppressed proliferation and elevated 
apoptosis, an increased BAX/BCL-2 ratio 
and cytochrome C expression, as well as 
suppressed β-catenin and its target 
proteins in both functioning and 
attenuated p53 cells 
Charepalli 
et al., 2015 
ANC: anthocyanin(s); ROS: reactive oxygen species; DCF: dichlorofluorescin; γ-GCLC: gamma glutamate-cysteine ligase catalytic subunit; GSR: glutathione 
reductase; NQO1: NAD(P)H quinone dehydrogenase 1; CCSC: colon cancer stem cells; BrdU: (5-bromo-2′-deoxyuridine); TUNEL: terminal deoxynucleotidyl 
transferase dUTP nick end-labeling; BCL-2: B-cell lymphoma 2; BAX: BCL-2-associated X; GI: gastrointestinal; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide; MTS: 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenil)-2-(4-sulphophenil)-2H-tetrazolium; VEGF: vascular  endothelial growth factor; 





Table 2.4 Animal models of colorectal cancer studies with foods containing anthocyanins. 
 
Food source Major ANC 
identified 








Dawley rats 2 
groups: n= 10 
per group 
Tumor induction: AOM injected at week 2 and 3 
after start of diet 
Experimental diet: pomegranate juice instead of 
water for 10 weeks 
Analysis post sacrifice: 
Proliferation: ACF total number, 
Ki-67 immunohistochemistry 
Inflammation: Quantitative reverse transcription–
PCR of COX-2, iNOS, NFκB, VCAM-1, IGF, and 
IGFR and VCAM-1, COX-2 western blots 
Survival: Quantitative reverse transcription–
PCR of PI3K, AKT, mTOR, miR-126 
Pomegranate juice 
suppressed the number of 
ACF and lowered 
proliferative index, 
decreased expression of 
COX-2, iNOS, NFκB, and 
VCAM-1 while  
suppressing PI3K/AKT and 
mTOR expression and 








rats 5 groups: 
n = 6 per 
group 
Tumor induction: subcutaneously injected with 
DMH weekly for 2 weeks 
Experimental diet: orally administered ethanol 
extract at 100 (low) and 1000 (high) mg/kg body 
weight for 4 weeks 
Analysis post sacrifice: 
Proliferation: ACF total 
number 
Apoptosis: caspase-3 ELISA analysis on colonic 
mucosa cells 
Highest dose of purple rice 
extract decreased numbers 
of ACF and AC per focus 
and increased caspase-3 
activity in colonic 
epithelium cells 
Wongjaika
m et al., 
2014 







groups: n = 
8 per groups 
1 and 5, n = 
13 per 
groups 2-4 
Tumor induction: AOM injection at week 0 
Colitis induction: 2.5% DSS in drinking water for 7 
days at week 1 
Experimental diet: 14 weeks of açaí fruit pulp 
powder 2.5 or 5% 
Analysis post sacrifice: 
Proliferation: adenoma and cancer incidence 
and multiplicity, size of tumor, PCNA 
western blot Inflammation: ELISA analysis 
MPO and cytokines (TNF-α, IL-1β, IL-6), 
COX-2 western blot 
Apoptosis: BCL-2, Bad, cleaved caspase-3 
western blots 
5% açaí pulp powder 
reduced adenoma and 
cancer incidence, 
decreased expression of 
MPO, TNF-α, IL-1β, and 
IL-6, PCNA and BCL-2 
and increased Bad and 
cleaved caspase-3 
expression 





















groups: n = 
13 per group 
Tumor induction: AOM injections weekly for six 
weeks Experimental diet: supplemented 20% w/w 
baked purple- fleshed for 4 weeks (5 mice per group 
sacrificed for analysis after 1 week) 
Analysis  post  sacrifice: Proliferation: tumors > 2mm 
counted 
Apoptosis: β-Catenin and TUNEL staining 
Treatment with purple potatoes 
reduced tumor incidence, 
increased apoptosis as seen 
through increased TUNEL- 
positive cells, decreased 
number of crypts with nuclear 












groups: n = 
5 per group 
Tumor induction: AOM injected twice weekly 
Experimental diet: 1 or 2% grape juice concentrate for 
14 weeks 
Analysis post sacrifice: Apoptosis: BCL-2 and BAX 
immunostaining Oxidative stress: 8-OHdG 
immunostaining 
2% grape juice concentrate 
decreased BCL-2 expression 
but also decreased BAX 
expression. No statistical 




















Tumor induction: AOM one time injection at week 0 
Colitis induction: 2% (w/v) DSS in drinking water for 
7 days at week 1 
Experimental diet: 2.5%, 5.0% or 10.0% lyophilized 
strawberries week 4 to 20 
Analysis post sacrifice: Proliferation: tumor incidence 
and multiplicity, Disease Activity Index 
Inflammation: real-time PCR of TNF-α, IL-1β, IL-
6, COX-2 and iNOS, PI3K/AKT, ERK, and NF-κB 
non- phosphorylated and phosphorylated western 
blots, prostaglandin E2 measurement, nitrate/nitrite 
colorimetric assay;  
Nitrosative stress: immunoreactivity of 
nitrotyrosine 
Lyophilized strawberries 
reduced tumor incidence and 
nitrosative stress, and decreased 
expression of 
proinflammatory mediators as 
well as phosphorylation of PI3K, 
AKT, ERK, and NF-κB 
Shi et al., 
2015 
Bilberry Not determined Female 
Balb/c mice, 
3 groups: n = 
50 
Tumor induction: AOM injection at week 2 
Colitis induction: 3 or 5% DSS in drinking water 
for 7 days at week 3 and 5 
Experimental diet: 10 or 1% anthocyanin-rich 
bilberry extract for 10 weeks Colonoscopy: biopsy 
at week 4 and 9 Analysis post sacrifice: 
Proliferation: number, size, and location of tumors 
Inflammation: length of colon 
10% ANC-rich bilberry extract 
reduced number of tumors, 









Table 2.4 (cont.) 
Food source Major ANC 
identified 
Model Method Main Results Reference 
Mulberry Cyanidin-3- 
glucoside 
BALB/c mice 4 
groups: n = 6-8 per 
group MUC2−/− 
mice 
3 groups: n = 10 
per group 
Colitis induction (BALB/c): 3% DSS in 
drinking water for 9 days after 10 days of 
experimental diet Experimental diet: 5% or 
10% mulberry fruit powder MUC2−/− for 3 
months, BALB/c for 10 days 
Analysis post sacrifice: Inflammation (BALB/c): 
body and spleen weight and colon length. 
Proliferation (MUC2-/-): tumor incidence, 
frequency and histopathology. Inflammation 
(MUC2-/-): degree of intestinal mucosa damage 
and lymphocyte infiltration 
Mulberry fruit extract 
decreased tumor and 
inflammation incidence in 
MUC2−/− mice and reduced 
pathological symptoms of 
acute colitis in BALB/c 
mice. (Also showed anti-
inflammatory effects in 
macrophages) 
Qian et 











3 groups: n = 10 per 
group 
Experimental diet: 0.2% or 0.5% black 
soybean extract for 7 weeks 
Analysis post sacrifice: 
Proliferation: number of 
tumors 
Oxidative stress & Inflammation: COX-2 
and cPLA2 semi-quantitative reverse 
transcription- -catenin western blot, 
and cPLA2 assay, PGE2 ELISA 
0.5% black soybean extract 
lowered intestinal tumors 
and decreased expression of 
COX-2 and cPLA2. Both .2 









Male Swiss mice 
4 groups: n= 15 
per 
groups 1-3, n= 5 for 
group 4 
Tumor induction: AOM injections at weeks 3 
and 4 Experimental diet: first 4 weeks – low 
fat diet and açaí fruit pulp powder 2.5 or 5%  
Week 10-14: high fat diet Analysis post 
sacrifice: 
Proliferation: number of AC/colon, ACF/colon, 
and AC in each ACF, Ki-67 staining  
Apoptosis: cleaved caspase-3 staining 
DNA damage: peripheral blood cell : tail 
intensity and tail moment 
Antioxidant activity: hepatic glutathione kinetic 
assay 
Açaí pulp powder 
suppressed DNA damage 
in peripheral blood cells 
after AOM injection, diet 
intervention at 5% açaí 
powder increased hepatic 
glutathione levels and 







Table 2.4 (cont.) 
Food source Major ANC 
identified 






2 groups: n 
=19 and n = 
24, wild-type 
mice  n = 20 
Experimental diet: 5% freeze dried black 
raspberries for 8 weeks Analysis post sacrifice: 
Proliferation: colonic and intestinal polyps 
size and number 
Metabolism analysis: liver, colonic mucosa 
and fecal sample metabolomics, quantitative 
real-time PCR with fecal samples, 
immunohistochemistry and computer- 
assisted image analysis of ornithine 
decarboxylase 
Black raspberry extract 
reduced size and number of 
polyps in APCMin/+ mice, 
suppressed ornithine 
decarboxylase, and 
reversed 13 colonic 
mucosa, 8 liver, and 2 fecal 
metabolites related to the 
APC gene mutation. 8 
metabolites correlated with 
the reduced size and 
number of polyps 
Pan et 
al., 2015 
AOM: azoxymethane; AC: aberrant crypt; ACF: aberrant crypt foci; APC: adenomatous polyposis coli; DSS: dextran sulfate sodium; ELISA: enzyme-linked 
immunosorbent assay; MPO: myeloperoxidase; TNF-α: tumor necrosis factor α; IL-1β: interleukin 1 beta; IL-6: interleukin 6; COX-2: cyclooxygenase 2; cPLA2: cytosolic 
phospholipase A2; PGE2: prostaglandin E2; PCNA: proliferating cell nuclear antigen; BCL-2: B-cell lymphoma 2; Bad: BCL-2-associated death promoter (Bad); 8-OHdG: 
8- hydroxy20 -deoxyguanosine; COX-2: cyclooxygenase-2; iNOS: inducible nitric oxide synthase; NF-κB: nuclear factor kappa B; IGF: insulin-like growth factor; IGFR: 
insulin-like growth factor receptor; PI3K: phosphoinositide 3-kinase; AKT: protein kinase B; mTOR: mechanistic target of rapamycin; TUNEL: terminal deoxynucleotidyl 






Table 2.5 Clinical colorectal cancer studies with foods containing anthocyanins. 
 
Food source Major ANC 
identified 












Delivery: 7 patients - orally administered 20 
g 3 times per day in water and 2 x 720 mg 
suppositories of black raspberry powder at 
night, 7 patients - oral placebo version and 
the same suppositories for 9 months 
Proliferation: flexible sigmoidoscopy for 
rectal polyp amounts and sizes collected at 
the beginning and end, Ki-67 staining 
Apoptosis: TUNEL staining 
Wnt pathway/DNA methylation: p16, c-Myc, 
DNMT1, DNMT3b staining, MassARRAY, 
PyroMark LINE-1 Kit pyrosequencing, 
MBDCap-seq, mapping, and normalization 
Black raspberry treatment 
decreased the burden of polyps but 
the number reduction was not 
significant and 3 patients had 
more adenomas at the end. Oral 
delivery did not have a benefit. 
Treatment decreased Ki-67 
staining, DNMT1 expression, and 












Delivery: orally administered freeze-dried 
berry powder mixed with water 20 grams 3 
times per day for 1 to 9 weeks Proliferation: 
Ki-67 staining 
Apoptosis: TUNEL staining 
Angiogenesis: CD105 staining 
Wnt pathway/DNA methylation: E-cadherin, 
p16, β-catenin, c-Myc, DNMT1 staining, 
high-throughput MassARRAY of p16, 
PAX6a, SFRP2, SFRP5, and WIF1, LINE-1 
repetitive element bisulfite/pyrosequencing 
assay 
Black raspberry treatment 
decreased expression of Ki-67, 
and CD105 and increased 
expression of TUNEL and p16 in 
tumor tissues overall and 
comparing high to low dose, high 
dose treatment (~4 weeks) 
modulated the Wnt pathway by 
demethylating tumor suppressor 
genes and modulating expression 















Delivery: orally administered freeze-dried 
berry powder mixed with water 20 grams 3 
times per day for 1 to 9 weeks 
Metabolism analysis: metabolomic profiling 
on plasma and urine samples collected at 
baseline and after treatment 
 
Freeze-dried black raspberries 
modified 34 urinary and 6 plasma 
metabolites, and increased amino 
acid metabolism and benzoate 
metabolites and a TCA cycle 
intermediate 
 





Table 2.5 (cont.) 








cyanidin 3-O- sambubioside, 
delphinidin 3-O- (6”-
coumaroyl)-5- O-diglucoside, 
petunidin 3- O- (6”-
caffeoyl)- glucoside (100 g 
supplement: 330 mg ANC, 
20 ANC identified)  
25 colectomy 
patients (within 




Delivery: oral supplement doses 
3 g twice daily with main meals 
for 3 months Proliferation: tumor 
markers CEA, CA 19-9, AFP by 
LIA-mAT chemiluminescent 
methods on blood samples 
Inflammation: CRP levels in 
erythrocytes Antioxidant activity: 
SOD and GSHPx activities with 
Randox kits, Oyaizu's method for 
reducing power of plasma, total 
scavenger activity through 
chemiluminescence assay 
Supplement treatment did 
not change tumor 
markers, lowered CRP 
levels in colectomysed 
patients but increased 
rheumatoid factor in both 
groups. Rebound effect 
seen in both groups with 
higher plasma 
chemiluminescence and 




ANC: anthocyanin(s); TUNEL: terminal deoxynucleotidyl transferase dUTP nick end-labeling; DNMT1: DNA methyltransferase 1; PAX6a: paired box 6a; SRFP: secreted 
frizzled related protein; WIF1: Wnt inhibitory factor 1; LINE-1: Long Interspersed Element-1; TCA: tricarboxylic acid; MBDCap-seq: methyl- binding-domain–capture 
sequencing; SOD: superoxide dismutase; GSHPx: glutathione peroxidase enzyme; CEA: carcinoembryonic antigen; CA: carbohydrate antigen; AFP: alpha-fetoprotein; LIA: 





Table 2.6 Epidemiological studies on colorectal cancer with dietary flavonoids. 
 
Cohort/Study type Final number of 
participants (or 
studies) 
Method Main Results Reference 
EPIC 477,312 
(~70% Women) 
Food-frequency questionnaire (varied 
based on country). Follow up an average 
of 11 years. 
Analyzed in quintiles of flavonoid 
subclasses 
Overall, no association with flavonoid subclass 
intake and CRC incidence. 
Anthocyanins, flavan-3-ol monomers, theaflavins, 
and flavonols were inversely associated with CRC 
risk in former smokers 
Zamora-









Food-frequency questionnaire every four 
years for 26 years, reported how often 
they ate food items over the past year. 
Analyzed in quintiles of flavonoid 
subclasses 
Anthocyanin intake was statistically associated 
with decreased risk of CRC for men, but with 
multivariable adjustment the association was not 
significant. No other subclass had a significant 
association with CRC risk 
Nimptsch et 
al., 2016 




cancer cases and 
1632 frequency- 
  matched controls  
Food frequency questionnaire given 
twice 1 year apart, multivariate logistical 
regression models used for associations 
Anthocyanidins from total diet and all flavonoid 
subclasses from fruits and vegetables had an 
inverse relationship with colorectal cancer risk 
Xu et al., 
2016 
Meta-analysis of case- 
control or cohort 
studies 
23 studies (out of 
209): 13 case- 
control, 10 cohort 
PubMed search of original English- 
written articles with case-control or 
cohort design up to June 30, 2012, search 
terms related to stomach and CRC risk 
and dietary flavonoids 
Anthocyanidin intake in case-control but not 
cohort studies was associated with lower CRC 
risk, as well as for other subclasses, but not total 
flavonoids. Noted that bias due to design could 
impact inverse relationship in case-control studies 
Woo et al., 
2013 
Meta-analysis 18 studies (out of 
1,358) 9 case- 
control, 9 cohort 
PubMed, Web of Science, and the 
Cochrane Library search for articles up to 
December, 2015, random-effect model 
for associations 
No relationship found with total flavonoids and 
colorectal cancer incidence. A reduced risk was 
seen with anthocyanins but only for case-control 
studies and only for males. No publication bias 
was reported 
He et al., 
2016 




CHAPTER 3: HYPOTHESIS AND OBJECTIVES 
3.1 Long term goal 
To understand the mechanisms of action that anthocyanins and anthocyanin-rich extracts can 
exert to inhibit colorectal tumorigenesis and progression towards metastasis. 
3.2 Central hypothesis 
Anthocyanins and anthocyanin-rich extracts can hinder colorectal tumorigenesis and progression 
towards metastasis by induction of apoptosis, suppression of angiogenesis, and stimulation of 
immune response. 
3.3 Overall objective 
To analyze the effect of anthocyanin-rich extracts, pure anthocyanins, and other phenolic 
compounds on colorectal tumorigenesis and progression towards metastasis and their 
mechanisms of action. 
3.4 Specific aims 
To test the hypothesis, we completed four aims. In the first three, we utilized biochemical, in 
vitro, and in silico models to demonstrate potential mechanisms of action of anthocyanin-rich 
extracts and pure phenolics. We analyzed the chemical composition of over fifteen extracts and 
discovered the main phenolic compounds contributing to those that were efficacious at inhibiting 
colon cancer cell growth. As black lentil was discovered as the most potent inhibitor and 
delphinidin-3-O-glucoside was its main anthocyanin, in the last aim, we used a mouse model to 
determine the anti-inflammatory and anti-carcinogenic effects of these extracts in vivo. 
Aim 1: To discover the effect of anthocyanin-rich purple and red corn extracts on colon cancer 
proliferation in human colon cancer cells, HCT 116 and HT-29, and then to analyze their 




Hypothesis: Anthocyanin-rich corn extracts will inhibit human colon cancer cell proliferation, 
induce apoptosis, and suppress angiogenesis. 
Aim 2: To determine the chemical composition of eleven anthocyanin-rich plant extracts and 
compare their inhibitory effect on HCT 116 and HT-29 human colon cancer cell viability and to 
analyze their mechanism of action in vitro, in silico, and through biochemical assays. 
Hypothesis: Anthocyanin-rich plant extracts will inhibit human colon cancer cell viability and 
promote apoptosis and higher anthocyanin and phenolic concentration will correlate with greater 
colon cancer cell inhibition. 
Aim 3: To compare the anti-progression and stimulatory immune effects by anthocyanins and 
their metabolites on human colorectal cancer cell lines, HCT-116 and HT-29, in vitro and in 
silico. 
Hypothesis: Delphinidin-3-O-glucoside will be the most potent of the phenolics tested on cell 
inhibition and on immune response promotion through inhibition of immune checkpoints and 
that its metabolites would also have anti-progression effects. 
Aim 4: To determine and compare the efficacy of a black lentil water extract and a D3G-
enriched lentil extract to prevent tumor development and inflammatory processes and impact the 
immune response in an azoxymethane/dextran sodium sulfate colitis-associated carcinogenesis 
mouse model. 
Hypothesis: Black lentil extract will be the most effective at inhibiting tumor growth and having 





CHAPTER 4: INHIBITORY POTENTIAL OF ANTHOCYANIN-RICH PURPLE AND 
RED CORN EXTRACTS ON HUMAN COLORECTAL CANCER CELL 
PROLIFERATION IN VITRO 
4.1 Abstract 
Anthocyanin-rich foods have shown potential health benefits. The objective was to evaluate the 
anti-proliferative and anti-apoptotic effect of anthocyanin-rich purple and red corn on HCT-116 
and HT-29 human colorectal cancer cells. Concentrations of 50% viability inhibition ranged 
from 1.1 to 6.3 mg/mL, suggesting the corn extracts exhibited anti-proliferative effects on colon 
cancer cells; the red corn had the highest potential. All extracts increased apoptotic cells and 
impacted markers of apoptosis (BAX, BCL-2, cytochrome C, TRAILR2/D5). Angiogenesis 
markers were also affected; a decreased expression of VEGF resulted with all corn extracts. Red 
corn significantly reduced other important markers of angiogenesis like Tie-2. Free binding 
energy of anthocyanins to tyrosine kinases was estimated at 7.86 and 7.76 kcal/mol for cyanidin-
3-glucoside with a non-receptor tyrosine kinase and peonidin with a receptor tyrosine kinase, 
respectively. The results indicate that anthocyanin-rich purple and red corn can potentially 




This chapter is part of the publication: Mazewski, C., de Mejia, E.G. & Liang, K. (2017). 
Inhibitory potential of anthocyanin-rich purple and red corn extracts on colorectal cancer 
cell proliferation in in vitro models. Journal of Functional Foods, 34, 254-265. 





Colorectal cancer (CRC) is the third most common type of cancer in men and women in the 
United States and was estimated to cause 49,190 deaths in 2016 (National Institutes of Health, 
2016). The survival rate of CRC decreases dramatically if not caught before the cancer has 
metastasized to other organs. The 5-year survival rate for the localized stage is 90.1%, while for 
the distant stage is 13.5% (National Institutes of Health, 2016). Once colon cancer has become 
metastatic, it becomes difficult to treat with surgery; often a combination of chemotherapy, 
radiation, and targeted therapies are utilized (American Cancer Society: Cancer Facts, 2016). 
Oxaliplatin is a cytotoxic drug used in treating advanced colon cancer, mainly through induction 
of apoptosis caused by inter- and intra-strand crosslinks with DNA (Alcindor & Beauger, 2011). 
It has been used with other chemotherapy drugs, as well as with monoclonal antibody targeted 
therapies. Oxaliplatin induces apoptosis in colon cancer cells through the intrinsic pathway 
involving caspase 3, BAX, and cytochrome C (Cyt C) (Alcindor & Beauger, 2011). BAX is a 
pro-apoptotic protein that has been shown to be an integral part of death receptor-mediated 
apoptosis induced by DNA damage in colon cancer cells by modifying the mitochondrial 
membrane permeability (Zhu et al., 2012). Cyt C is also a pro-apoptotic protein; it is released 
from the mitochondria into the cytosol and then subsequently activates caspases (Martins et al., 
2014). When Cyt C initiates the caspase activation cascade, caspase-3 works as an executioner 
caspase which cleaves substrates, leading to apoptosis (Wang et al., 2015). Together, these 
proteins are important factors in DNA damage-induced apoptosis.  
There has been research linking poor diet that is high in red or processed meat and low in fruit 
and vegetable intake to an increased risk of getting colorectal cancer; foods associated with 




Society, 2016). This has partially been attributed to their bioactive compounds, namely 
functional carbohydrates, short chain fatty acids, peptides and polyphenols, which include 
anthocyanins (Watson & Preedy, 2010). Anthocyanins (ANC), pigments in the flavonoid family, 
have shown potential to provide various health benefits, including prevention and suppression of 
colon cancer (Afrin et al., 2016). They are found in a variety of fruits, vegetables, cereals, and 
legumes, providing their red, blue, or purple pigments (Harakotr, Suriharn, Scott, & Lertrat, 
2015). The pH and chemical structure influence the ANC color. In pigmented corn, the most 
prevalent ANC are cyanidin-3-O-glucoside (C3G), peonidin-3-O-glucoside (P3G), and 
pelargonidin-3-O-glucoside (Pr3G) (Harakotr et al., 2015).  
There is a potential for ANC to inhibit cancer cell proliferation and promote apoptosis in cancer 
cells (Bao, Li, & Wang, 2011; Bishayee et al., 2011; Charepalli et al., 2015; Sharma, McClees, 
& Afaq, 2017). A rat feeding study on black currant extract, which is high in cyanidin and 
delphinidin, found an increased BAX/BCL-2 ratio in hepatocellular cancer compared to the 
control (Bishayee et al., 2011). Increased BAX/BCL-2 ratio is an indicator that apoptosis is 
being induced as there are more pro-apoptotic (BAX) and less anti-apoptotic (BCL-2) proteins. 
Purple-fleshed potato extract, also high in ANC, prompted an increase in BAX/BCL-2 ratio, as 
well as increased Cyt C expression, in colon cancer stem cells (Charepalli et al., 2015). Other 
polyphenols have also elicited pro-apoptotic properties in cancer cells; quercetin, a flavonol, 
increased expression of pro-apoptotic proteins, such as BAX and Cyt C, while reducing 
expression of anti-apoptotic proteins, like BCL-2 and AKT (Forbes-Hernández et al., 2014). 
In addition to ANC having anti-proliferative effects, there is also potential for anti-angiogenic 
effects. Angiogenesis is a major step leading to the metastasis of a tumor. Tyrosine kinases and 




signaling takes part in directing blood vessel growth to tumors so inhibition of VEGF can 
deregulate the maintenance of tumor blood vessels and help reduce angiogenesis 
(Hanahan & Weinberg, 2011). ANC-rich mixtures from bilberries and grapes were shown to 
inhibit receptor tyrosine kinases and growth factors (Teller et al., 2009). There is also research 
supporting the capability of ANC to inhibit VEGF. Black raspberry extracts, which have high 
amounts of C3G derivatives, exhibited inhibition of VEGF-mediated migration, proliferation, 
and tube formation in human esophageal and intestinal microvascular endothelial cells 
(Medda et al., 2015). In addition, a review on potential health benefits of blueberry bioactive 
compounds found evidence indicating potential reduction in IL-1b, as well as other pro-
inflammatory markers related to angiogenesis, by bilberry or blueberry consumption in vivo or 
application in vitro on HepG2 cells (Shi, Loftus, McAinch, & Su, 2017).  
The hypothesis of this study was that ANC-rich corn extracts would inhibit human colorectal 
cancer cell proliferation through inducing apoptosis and suppressing angiogenesis. The objective 
was to determine the effect of ANC-rich purple and red corn extracts on colon cancer 
proliferation and to evaluate the possible pathways on human colon cancer cells, HCT-116 and 
HT-29, and then to analyze their potential to suppress markers of angiogenesis in vitro. 
4.3 Materials and methods 
4.3.1 Materials 
Commercially-available purple corn cultivar was purchased from Angelina’s Gourmet (Swanson, 
CT). Red corn was obtained from Siskiyou Seeds (Williams, OR). Hard endosperm yellow dent 
corn flour (P1602) was obtained from Dr. Vijay Singh’s laboratory at the University of Illinois, 
Urbana-Champaign. Human normal colon cells, CCD-33Co, and human colon cancer cells, HT-




ANC were acquired from ChromaDex (Irvine, CA). Primary antibodies cytC (sc-13156), BAX 
(sc-20067), BCL-2 (sc-56018), and GAPDH (sc-25778) as well as the radioimmunoprecipitation 
(RIPA) buffer were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Secondary 
antibodies, anti-mouse IgG and anti-rabbit IgG horseradish peroxidase conjugated, were obtained 
from GE Healthcare (Buckinghamshire, UK). Primary antibodies Abl2 (1H1B11), human 
VEGF165 (AF-293-NA), secondary antibody anti-goat IGG, and Human Apoptosis Array 
(Ary009) from R&D Systems (Minneapolis, MN). VEGF receptor 2 (cat-2472) primary antibody 
was purchased from Cell Signaling Technology (Danvers, MA). The CellTiter 96
®
 AQueous 
One Solution Cell Proliferation Assay was purchased from Promega Corporation (Madison, WI). 
Nintedanib, a triple angiokinase inhibitor which inhibits three growth factor receptor pathways, 
was purchased from Fischer Scientific (Hampton, NH) (Boehringer Ingelheim, 2016). All other 
chemicals used in this study were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise stated.  
4.3.2 Chemical composition of the ANC extracts 
4.3.2.1 Extraction and semi-purification of ANC from corn 
4.3.2.1.1 Purple corn pericarp water extract (PW). The purple corn pericarp flour was diluted at 
a 1:10 ratio (g flour to mL distilled water). It was stirred at 4 ˚C for 24 h in the dark. Then, the 
mixture was centrifuged for 10 min and filtered through grade 2 filter paper. Amberlite resin 
FPX66 (Dow Chemical, Midland, MI) was used mixing with distilled water in a 1:1 (w/v) ratio; 
it was stirred and the supernatant was taken off twice. Then 25 mL of corn extract was added and 
stirred for 2 h, and the supernatant was taken off. After, 25 mL of ethanol was added and stirred 




approximately 20 min. Next, 1 mL of distilled water was added and this was freeze-dried and 
then kept at -20 ˚C until use. 
4.3.2.1.2 Purple corn resin-purified acidified water extract (PAW). The PAW extract was 
obtained by extracting 1 kg of whole corn kernels with 2 L of 2% v/v aqueous formic acid at 4 
°C for 20–24 h in the dark. The extract was filtered through grade 2 filter paper followed by 0.45 
mm nylon membrane filters. The clarified extract was passed through a column containing 
Amberlite FPX66 (Dow Chemical, Midland, MI) resin (~1:1 ratio of extract and resin volumes) 
previously washed with water. The resin column was then washed with water until readings 
taken with a conductivity meter equipped with a flow cell (Traceable
®
, ThermoScientific, 
Waltham, MA) suggesting that no significant amounts of unretained compounds were present. 
Absolute ethanol (USP grade) was introduced onto the column to remove ANC as well as other 
adsorbed phenolic compounds. Collection was started when color elution was observed and 
terminated when the eluate was colorless. Ethanol and water were removed under water aspirator 
vacuum using a rotary evaporator at bath temperatures of less than 4 °C in the dark. The 
remaining water extract was freeze-dried and the dried extract was stored at -20 °C.  
4.3.2.1.3 Red corn resin-purified acidified water extract (RAW). Whole red corn kernels were 
used for RAW extraction. The same procedure was followed as described in Section 4.3.2.1.2. 
After one year of storage at -20 °C, some water absorption occurred and further freeze-drying 
was needed. 
4.3.2.1.4 Purple corn PAW extract with additional ethyl acetate purification (PAWE). PAW (3 
mg/mL) was dissolved in water and extracted 5 times with an equal volume of ethyl acetate (v:v) 




was placed on a rotary evaporator with water aspirator vacuum and bath temperature of 40 °C 
until all traces of residual ethyl acetate were removed. The aqueous layer was then freeze-dried. 
4.3.2.1.5 Yellow corn water extract (YW). Yellow corn flour was obtained through hammer 
milling yellow dent corn with a 0.5 mm screen. The YW extract was extracted in the same way 
as in Section 4.3.2.1.1. 
4.3.2.2 Measurement of total monomeric ANC concentration 
All the colored corn extracts were analyzed for total monomeric ANC concentration by the pH 
differential method (Lee, Durst, & Wrolstad, 2005) as previously reported using a microplate 
reader method in three independent replicates. Samples were diluted using two buffers (pH 1.0, 
0.25 M KCl buffer, and pH 4.5, 0.40 M sodium acetate buffer). Two hundred mL of diluted 
solutions at each pH were transferred to a 96-well plate and the absorbance read at 520 nm and 
700 nm using a Synergy 2 multiwell plate reader (Biotek, Winooski, VT). The total monomeric 
ANC concentration was calculated as C3G equivalents per L as described in the equations: 
Total monomeric ANC (mg/L) = (A * MW * D * 1000)/(ε * PL) 0.45 (1) 
A = (A520 – A700) at pH1.0 – (A520 – A700) at pH4.5 (2) 
Where A = Absorbance at the indicated wavelength; MW = 449.2 g/mol for C3G; D = dilution 
factor; PL = constant path length 1 cm; ε = 26900 L/mol-cm which is the molar extinction 
coefficient for C3G, 1000 conversion factor from g to mg and 0.45 as the conversion factor from 
the established plate reader method. Final results were expressed as mg C3G equivalents per g of 
dry extract. 
4.3.2.3 HPLC analysis of ANC in purple and red corn extracts 
HPLC analysis of samples for ANC profile was performed in triplicate using a Hitachi HPLC 




wavelength detector, L-7100 pump, following a previously reported protocol (West & Mauer, 
2013) with some modifications. The injection volume was 20 mL, and the flow rate was one 
mL/min. The gradient used was from A. 2% formic acid in water and B. 0% acetonitrile 
to 40% acetonitrile in a linear fashion using a Grace Prevail C18 (5 mm, 250 x 4.6 mm, 
Columbia, MD) for 30 min. Peaks were identified at 520 nm based on the same retention time as 
available standards, or literature (West & Mauer, 2013). The concentration of each ANC was 
determined using a calibration curve with 5 points in the range of 50–2000 ng/ml of C3G 
standard; P3G, Pr3G, cyanidin-3-O-(600-malonyl-glucoside) (C3G-mal), peonidin- 
3-O-(600-malonyl-glucoside) (P3G-mal), and pelargonidin-3-O-(600-malonyl-glucoside) (Pr3G-
mal) standards were also utilized. The calibration curve was obtained by plotting the area of C3G 
peak versus its concentration (r
2
 > 0.99). 
4.3.3 In vitro studies 
4.3.3.1 Cell culture 
All three cell lines, HT-29, HCT-116, and CCD-33Co, were cultured in Minimum Essential 
Medium Eagle with 10% FBS, 1% penicillin/ streptomycin and 1% sodium pyruvate at 37 °C in 
5% CO2 and 95% air. HCT-116 cells exhibit microsatellite instability characteristics of early 
stage colon cancer cells, whereas HT-29 cells are microsatellite stable cells that have been 
associated with advanced stage (Charepalli et al., 2016). 
4.3.3.2 HT-29, HCT-116, and CCD-33Co cell proliferation 
The CellTiter 96
®
 AQueous One Solution Cell Proliferation Assay was used to determine IC50 
values for corn extracts on the HT-29 and HCT-116 cells and to determine cytotoxicity of the 
extracts on the CCD-33Co cells. The assay consists of 3-(4,5-dimethylthiazol-2-yl)-5-(3-




coupling reagent (phenazine ethosulfate). For each cell line tested, wells of a 96 well plate 
seeded with 1 x 10
4
 cells per well and the volume of each well was adjusted to 200 mL with 
added medium. After 24 h, the corn extracts were added in various concentrations (0.25–10 
mg/mL), as well as oxaliplatin (5–50 mM) and the plates were incubated for 24 h. The wells 
were washed one time with 100 mL of PBS to get rid of any remaining color (purple or red) from 
the extracts. Then 100 mL of media was added to each well followed by 20 mL of the CellTiter 
solution. After one h of incubation, the plate absorbance was read at 515 nm using an ELX808IU 
Ultra Microplate Reader (BioTek, Winooski, VT). Using the absorbance readings, the percent of 
cells inhibited was calculated by comparing untreated cells to treated cells. Prism 6 software 
(GraphPad Software, La Jolla, CA) was used to calculate IC50 values for the HT-29 and HCT-
116 cells. 
4.3.3.3 Flow cytometry to measure apoptosis 
HT-29 cells were seeded at 3 x 10
5
 cells per well in a six-well plate and grown at 37 °C in 5% 
CO2 95% air for 24 h. They were treated with the red and purple corn extracts and oxaliplatin for 
24 h at the IC50 determined values. The media was taken and put in a separate 15 mL tube for 
each well. Each well was then washed with 1 mL of PBS and then washed twice with 0.5 mL of 
trypsin. The plate was incubated for 5 min at 37 °C. Cells were collected in 1 mL of PBS and 
added to the media of the designated 15 mL tubes. Cells were counted to determine volume of 
binding buffer to resuspend for a density of 1 x 10
6
 cells/mL. Tubes were centrifuged at 
500g for 3 min and then the media and PBS were aspirated carefully to not disturb the pellet. 
Cells were then resuspended in the binding buffer, and this cell suspension was added to the top 




strained through the mesh. Annexin V-FITC was added at suggested ratio of 5 mL per 500 mL 
suspension and propidium iodide at 10 mL per 500 mL. After 10 min, a BD LSR II Flow 
Cytometry Analyzer (BD Biosciences, San Jose, CA) was used to evaluate the state of 10,000 
cells. Duplicate readings of each well were taken and two independent experiments were 
analyzed. 
4.3.3.4 Western blot analyses 
Western blots were run using a protocol based on that used in Dia and Gonzalez de Mejia (2011). 
Either HCT-116 or HT-29 cells were seeded in a six-well plate at 2 x 10
5
 cells per well for 24 h 
at 37 °C in 5% CO2 and 95% air. Then cells were either left untreated or treated with the corn 
extracts or with oxaliplatin at their IC50 values determined from the cell viability tests. After 
another 24 h, cell lysates were obtained. The supernatant post-centrifugation was collected, and a 
DC™ protein assay was used to calculate the volume needed for each sample per well. SDS-
PAGE electrophoresis was used to separate the proteins and then the proteins were transferred to 
PVDF membranes. Primary antibody was added at a dilution of 1:500 and was incubated 
overnight on a shaker at 4 °C. The next day membranes were washed; the secondary antibody 
was added at a dilution of 1:2500 and incubated for 1–3 h at room temperature. A GelLogic 4000 
Pro Imaging System (Carestream Health, Inc., Rochester, NY) was used to visualize the protein 
on each membrane. Three apoptotic markers were tested: BCL-2, BAX, and Cyt C. BCL-2 is an 
anti-apoptotic protein, while BAX and Cyt C are pro-apoptotic. Two angiogenic markers were 
tested through western blots: Abl2 and VEGF. Abl2 is a non-receptor tyrosine kinase, while 
VEGF is a growth factor. 




R&D System’s (Minneapolis, MN) Human Apoptosis Array was used to analyze the effect of the 
corn extracts on markers of apoptosis. HCT-116 cells at a 1 x 10
6
 seeding density in a 25 cm
2
 
flask were incubated for 24 h at 37 °C and 5% CO2/95% air. Then, they were treated with the 
IC50 concentrations for the red and purple corn acidified water extracts (1.1 and 2.5 mg/ml, 
respectively) and oxaliplatin (8.8 mg/mL), and one was left untreated. After 24 h, cells were 
harvested. A Gel Logic 4000 Pro imaging system was used to detect protein expression on the 
membranes. 
4.3.3.6 Angiogenesis protein array 
Abcam’s (Cambridge, UK) Human Angiogenesis Antibody Array was used to analyze the effect 
of the corn extracts on angiogenesis markers. HCT-116 cells at a 1 x 10
6
 seeding density in a 25 
cm
2
 flask were incubated for 24 h at 37 °C and 5% CO2/95% air. Then, they were treated with 
the IC50 concentrations for the red and purple corn acidified water extracts (1.1 and 2.5 mg/ml, 
respectively) and oxaliplatin (8.8 mg/mL), and one was left untreated. After 24 h, cells were 
harvested. A Gel Logic 4000 Pro imaging system was used to detect protein expression on the 
membranes. 
4.3.4 In silico studies 
DockingServer was utilized for molecular modelling of the corn ANC with tyrosine kinases 
(Bikadi & Hazai, 2009). The MMFF94 force field and Gasteiger partial charges were used in the 
modelling. Non-polar hydrogen atoms were merged and rotatable bonds defined. Docking 
calculations were carried out on receptor tyrosine kinase (3VHE) and non-receptor tyrosine 




Bank (Rutgers, The State University of New Jersey, and the University of California, San 
Diego). Ligands of C3G, Pr3G, P3G, cyanidin, pelargonidin, peonidin, and nintedanib were used 
and structures were imported from the PubChem Compound database (National 
Center for Biotechnology Information, Bethesda, MD). Essential hydrogen atoms, Kollman 
united atom type charges, and solvation parameters were added with the aid of AutoDock tools 
(Morris et al., 1998). AutoDock parameter set- and distance-dependent dielectric functions were 
used in the calculation of the van der Waals and the electrostatic terms, respectively. Initial 
position, orientation, and torsions of the ligand molecules were set randomly. Docking results 
were derived from 100 different runs that were set to terminate after a maximum of 250,000 
energy evaluations. The population size was set up to 150. During the search, a translational step 
of 0.2 Å, and quaternion and torsion steps of 5 were applied. 
4.3.5 Statistical analysis 
Statistical analyses were conducted using one-way ANOVA to compare experimental to control 
values with JMP version 8.0. Comparisons between groups were performed using Tukey- 
Kramer test, and differences were considered significant at p < 0.05. Comparisons between 
untreated control and extracts or drug were performed using Student’s t-test, and differences 
were considered significant at p < 0.05. At least 2 independent experiments run in at least 
duplicate were performed for every study. 
4.4 Results and discussion 
4.4.1 Total ANC concentration and HPLC profiles of colored corn extracts 
The total ANC concentrations of all four extracts are shown in Table 4.1. PAWE contained the 
highest concentration of ANC at 217.5 mg C3G equivalent/g extract where RAW had the lowest 




PAWE, and PW are shown in Figure 4.1, as well as the concentrations of each ANC. The three 
purple corn extracts have similar HPLC profiles, although their peak intensities differ; they are 
high in condensed forms, C3G, and C3G-mal. Similar peaks and intensities were seen in a study 
by Pedreschi and Cisneros-Zevallos (2005) in Andean purple corn. PAWE has the greatest 
concentration of the condensed forms, C3G, and C3G-mal (25.9, 63.4, and 25.0 mg C3G 
equivalent/g extract, respectively). C3G makes up nearly 50% of the ANC concentration for 
PAW and PAWE (48%, 47%, respectively) and a large portion of PW (36%). The 
ANC that makes up the greatest concentration of RAW is C3G-mal (14.5 mg C3G equivalent/g 
extract, 40%). P3G-mal is the only ANC that RAW has a statistically higher concentration than 
PAW or PAWE (RAW: 8.9, PAW: 7.1, PAWE: 7.1, PW: 8.6 mg C3G equivalent/ g extract), and 
it accounts for a more significant percentage of its ANC make up (RAW: 24%, PAW: 6%, 
PAWE: 5%, PW: 9%).  
4.4.2 HT-29 and HCT-116 cell proliferation inhibition by ANC-rich corn extracts  
The IC50 values for RAW, PAW, PAWE, PW, and oxaliplatin for the HT-29 and HCT-116 
human cells are shown in Table 4.1. RAW had the lowest IC50 for both cell lines (HT-29: 2.5 
mg/mL, HCT-116: 1.1 mg/mL). RAW IC50 was statistically lower than PAWE and PW but not 
PAW in HT-29 cells. For the HCT-116 cells, RAW IC50 was statistically lower than the other 
extracts, and PAWE and PAW were statistically lower than PW (p < 0.05). For all extracts and 
oxaliplatin, the IC50s for HCT-116 cells were lower than HT-29 cells because the HT-29 cells 
represent a more advanced stage of colon cancer, so a greater concentration of extract or drug 
was required to inhibit 50% of cell proliferation. A study comparing IC50 values of various CRC 




HT-29 cell line (Richard & Martinez Marignac, 2015). RAW appeared to have the highest 
potential to inhibit both cell lines, which could be due to its ANC profile. Probably the high 
P3G-mal could be playing a larger part in effectively inhibiting the growth of the cancer cells. 
Ho et al. (2010) discovered that P3G had a slight inhibitory effect on lung cancer cell viability 
and significant reduction in cell migration and in proteins promoting invasion indicating its 
potential anti-metastatic capabilities. The percentages of inhibition at 10 mg/mL of PW for HT-
29, HCT-116, and CCD-33Co cells were 93.0%, 86.8%, and 23.4%, respectively; the 
percentages of inhibition at the same concentration of PAWE for HT-29, HCT-116, and CCD-
33Co cells were 88.2%, 88.2%, and 31.9%, respectively. Cell proliferation inhibition of HT- 
29 and HCT-116 were statistically different from the CCD-33Co cells in both cases. The 
percentages of inhibition at 5 mg/mL of PAW for HT-29, HCT-116, and CCD-33Co cells were 
92.1%, 92.6%, and 20.0%, respectively; the percentages of inhibition at 5 mg/mL of RAW for 
HT-29, HCT-116, and CCD-33Co cells were 59.7%, 66.3%, and 25.5%, respectively. Cell 
proliferation inhibition of HT-29 and HCT-116 were again statistically different from the CCD- 
33Co cells in both cases. A study on strawberry anthocyanins also did not show a cytotoxic 
effect on non-cancerous cells and had a protective effect against apoptosis in human dermal 
fibroblasts (Giampieri et al., 2014). These tests confirmed that there is no toxicity to normal cells 
at concentrations that had high inhibition of both colon cancer cell lines. Pure P3G, C3G, and 
Pr3G were also tested on both cancer cell lines. No inhibition was seen with pure Pr3G. A dose-
dependent response was seen with C3G and P3G, but percentages of inhibition were low and 
never surpassed 50% even at concentrations up to 500 μM (data not shown). Previous studies 
have demonstrated that inhibition of cancer cell proliferation may be due to synergistic effects 




breast cancer cells (Wang, Zhu, & Marcone, 2015). This could explain why the pure ANCs did 
not show a significant inhibitory effect.  
A yellow dent corn was also tested on both cell lines to compare to the pigmented corn. The 
yellow corn also exhibited increased inhibition with increasing concentrations. However, the 
predicted IC50 for the yellow corn was higher than all the purple and red corns at 6.6 mg/mL for 
HT-29 cells and 5.9 mg/mL for HCT-116 cells based on linear regression with R
2
 values of 0.99 
and 0.97, respectively. This indicates that the pigmented corn still has a greater potential to 
inhibit the colon cancer cells, but it demonstrated that there might be some components within 
the corn, that are not ANC, that could contribute to the inhibitory effects since there was a dose-
dependent response with the yellow corn. The PAWE extract was the most purified extract, and 
it did not demonstrate the highest potential for inhibiting colon cancer cell proliferation. 
This further shows that there may be small phenolic compounds (i.e. chlorogenic acid, catechins, 
among others) that are playing a role in suppressing the colon cancer cell growth. An in vivo 
study that looked at the effect of blue, white, yellow, and red corn tortillas on rat colon 
adenocarcinoma incidence found that blue corn tortilla had the highest potential for reducing 
tumor incidence and burden compared to the control, followed by white, red, and yellow 
(Reynoso-Camacho et al., 2015). The blue corn had the highest amount of ANC which could 
explain its high potential, but other components such as fiber and free or bound phenolics were 
noted that could account for the ability of the other tortilla types to reduce incidence and burden. 
Recently, an in vivo study on blue maize demonstrated its health benefits related to the metabolic 
syndrome, such as decreasing triacylglycerol levels and abdominal fat in rats (Guzmán-




of anthocyanin-rich foods can provide health benefits such as oligosaccharide-enriched fractions 
purified from cranberries having antioxidant capabilities (Sun et al., 2016). 
4.4.3 Effect of ANC-rich corn extracts on apoptosis by flow cytometry 
HT-29 cells that were treated with purple corn extracts and oxaliplatin had a statistically 
significant increase in the percentage of apoptotic cells compared to the untreated cells 
(Untreated: 12.4%, PAW: 31.4%, PAWE: 51.6%, PW: 65.6%, and OX: 51.2%) when they were 
treated for 24 h (Figure 4.2). This shows that the reduction in cell viability from the colored corn 
extracts was at least partially due to apoptosis in HT-29 cells. A study looking at sugar beet 
molasses, which is high in polyphenols, found that increasing concentrations of C3G increased 
the number of apoptotic cells in Caco-2 cells (Chen, Zhao, & Yu, 2016). After PAWE and PW 
treatment, more cells were in late apoptosis (36.6 ± 11.1%, 43.1 ± 10.7%, respectively) than 
early apoptosis (15.0 ± 2.8%, 22.5 ± 6.8%, respectively). PAW and oxaliplatin had a greater 
amount of cells in early (17.3 ± 2.8%, 29.3 ± 0.8%, respectively) than in late apoptosis (14.1 ± 
3.5%, 21.9 ± 6.2%, respectively). RAW had an almost equal amount of cells in early and late 
apoptosis (7.6 ± 1.7%, 7.4 ± 0.9%). In a study on lowbush blueberries, an increase in early 
apoptotic cells was seen when THP-1 cells were treated with the blueberry proanthocyanidins, 
which are also part of the flavonoid class (Minker et al., 2015). PAW, PAWE, and PW 
demonstrated a capability to induce apoptosis in HT-29 cells. 
4.4.4 Effect of ANC-rich corn extracts on protein expression of markers of apoptosis and 
angiogenesis by western blots 
Figure 4.3 shows the protein expressions, compared to the control, from the extracts for both 
cancer cell lines using western blots. The BCL-2 protein expression was down-regulated for all 




expression was decreased compared to the untreated cells for oxaliplatin, RAW, and PAW. A 
study by Dias et al. (2014) demonstrated reduced protein expression of BCL-2 induced in 
SW480 human colon cancer cells by açai extract, which is rich in C3G and cyanidin-rutinoside. 
BAX protein was not significantly overexpressed for all extracts compared to the control in 
HCT-116 cells. For the HT-29 cells, BAX was overexpressed for PAW, PAWE, and oxaliplatin. 
A study on proanthocyanins found in cranberry, on esophageal adenocarcinoma cells showed 
downregulation of the anti-apoptotic pathway of PI3K/AKT/mTOR, which is responsible for 
blocking BAX (Weh, Aiyer, Howell, & Kresty, 2016). Cyt C was overexpressed for all but 
PAWE in the HCT-116 cells and for PAW, PAWE, and PW in HT-29 cells. The study by Dias 
(2014) also showed that açai extract increased protein expression of Cyt C with increasing 
concentration. ANC-rich corn extracts may have pro-apoptotic effects in colon cancer cells, with 
more of a significant effect shown in the HT-29 cells, in particular with the PAW extract. Abl2 
was not statistically different compared to the control with any extracts in the HCT-116 cells. In 
the HT-29 cells, PAW, PAWE, and oxaliplatin decreased expression of Abl2 compared to the 
control. 
Increased Abl2 expression has been identified as an indicator of poor prognosis in certain 
cancers, such as hepatocellular, as it is a non-receptor tyrosine kinase (Xing, Qu, & Wang, 
2014). The results do not suggest a strong inhibitory effect of the extracts on this protein. VEGF 
was down-regulated by PAWE, PW, and nintedanib in HCT-116 cells, and all extracts and 
nintedanib in HT-29 cells compared to the control. Kang, Lim, Lee, Yeo, and Kang (2013) 
discovered that purple corn extract decreased VEGF expression by using a diabetic in vitro 
model. Purple rice bran extract, which is rich in C3G, P3G and cyanidin 3-O-gentiobioside has 




endothelial cells (Tanaka et al., 2012). The decreased expression of VEGF, especially with 
PAWE and PW significantly reducing expression in both cell lines, indicates potential for the 
ANC-rich extracts to impact the angiogenesis pathway. 
4.4.5 Effect of ANC-rich corn extracts on markers of apoptosis and angiogenesis using arrays 
Figure 4.4A shows the pixel quantities of some of the apoptosis markers for the control and corn 
extracts RAW and PAW and oxaliplatin in HCT-116 cells. Cleaved caspase-3, TRAIL r1/dr4, 
and FADD expressions for each extract and drug, compared to the untreated control, were not 
statistically different (p > 0.05). TRAIL r2/dr5 expression significantly increased for PAW and 
oxaliplatin (Untreated: 974.4, RAW: 1341.7, PAW: 1838.3, OX: 1673.3 pixels). In a study 
involving purple potatoes, TRAIL pathways were induced by the ANC-rich extracts (Bontempo 
et al., 2015). FAS/TNFRSF6/CD95 expression increased significantly for RAW and oxaliplatin 
compared to the untreated control (Untreated: 748.3, RAW: 1356.7, PAW: 895.6, OX: 2887.5 
pixels). Survivin expression decreased significantly for PAW and oxaliplatin compared to the 
control (Untreated: 2825.1, RAW: 2395.7, PAW: 1221.1, OX: 1232.5 pixels). Jaboticaba seed 
extract, which is high in C3G and delphinidin, showed apoptosis inducing effects possibly due to 
a decreased expression of survivin (Wang et al., 2014). The apoptosis protein array results 
suggest there could be an interaction between the purple and red corn ANCs and the death 
receptor apoptotic pathway. Table 4.2 describes the function for some of the apoptosis proteins, 
as well as the percent changes compared to the control of protein expression for RAW, PAW, 
and oxaliplatin; changes less than 15% are not shown. BAX expression was significantly 
increased (71% compared to the control) for RAW in the HCT-116 cells, probably due to higher 




Figure 4.4B illustrates the percentages of protein expression in HCT-116 cells for some of the 
angiogenesis markers due to the treatment with RAW and PAW and the drug nintedanib, 
compared to the untreated cells. Interleukin-1 beta (IL-1-beta) (39% and 23%) and Tie-2 (65% 
and 52%) expression decreased significantly compared to the untreated cells in RAW and 
nintedanib. A study looking at markers in colorectal cancer patients with black raspberry extract 
treatment demonstrated reduction in micro vessel density as well as reduction in a pro-
inflammatory marker, IL-8, which correlated with reduction of cell proliferation (Kresty, 
Mallery, & Stoner, 2016). Expression also decreased for RAW and nintedanib for plasminogen 
(PLG) (47% and 52%) and angiopoietin 2 (ANGPT2) (31% and 27%). Platelet endothelial cell 
adhesion molecule 1 (PECAM-1) had a significant decrease in expression for RAW (61%), PAW 
(73%), and nintedanib (31%) compared to the control. In the diabetes-associated angiogenesis 
studies conducted by Kang et al. (2013), purple corn extract decreased PECAM-1, ANGPT2, and 
Tie-2 expression, which concur with our findings. Tie-2 is a receptor tyrosine kinase and 
ANGPT1 and ANGPT2 bind to it; in a tumor environment, ANGPT2 inhibits the Tie-2 signaling 
pathway, which destabilizes blood vessels, promoting VEGF-induced angiogenesis (Daly et al., 
2013). Matrix metalloproteinases (MMP) 1 and 9 decreased in RAW, PAW, and nintedanib, 
compared to the untreated cells. MMP-9 was statistically different for RAW, PAW, and 
nintedanib (77%, 75%, and 45%, respectively); for MMP-1 it was only for nintedanib (56%). A 
study looking at anti-metastatic effects of black rice, which is high in C3G, on oral cancer cells 
found that the black rice extract inhibited MMP-2, MMP-1, and MMP-9 expression (Fan et al., 
2015). Overall, RAW had a greater effect on the angiogenesis related markers compared to 
PAW. 




All estimated free energies of bindings of the corn ANC and nintedanib with the receptor and 
non-receptor tyrosine kinases were negative, indicating a spontaneous reaction. Table 4.3 and 
Table 4.4 present the estimated free energies of binding and the polar and hydrophobic amino 
acid interactions. Many similarities in the amino acid interactions can be seen amongst the ANC 
and nintedanib, which further demonstrates a capacity for ANC-rich extracts to inhibit markers 
along the growth factor receptor pathways. As expected, nintedanib had the most favorable 
estimated free energy, since it is a drug that inhibits tyrosine kinase receptor pathways 
(McCormack, 2015). Peonidin had the most favorable energy with the receptor tyrosine kinase 
(3VHE) at -7.76 kcal/mol. Peonidin, as well as P3G, Pr3G, shared one common polar amino acid 
residue interaction (GLU 885) and four hydrophobic interactions (VAL 899, LEU 1019, CYS 
1045, and ILE 1044) with nintedanib. The interaction between ligand and VEGFR2 at GLU 885 
is a key part of developing kinase-bound type II kinase inhibitors of VEGFR2 (Oguro et al., 
2010). Peonidin was the only ANC to have an interaction at the PHE 1047 residue of 3VHE. 
When designing VEGFR2 kinase inhibitors in a study by Oguro et al. (2010), this interaction 
was significant to consider, so this could explain why peonidin had the most favorable energy 
with 3VHE. 
C3G had the most favorable energy with the non-receptor tyrosine kinase (2XYN) at 7.86 
kcal/mol. PAW and PAWE have the highest peaks of C3G (Figure 4.1) which lends some 
explanation as to why they demonstrated greater capability to reduce the expression of Abl2, a 
non-receptor tyrosine kinase, compared to control by HT-29 western blots. The amino acid 
residue interactions that were common between C3G and nintedanib were polar at ASN 368, and 
hydrophobic interactions at VAL 302 and LEU 416. None of the other ANC had the same three 




residues such as ASP 427 and ALA 315. Figure 4.5 shows the protein-ligand interactions as well 
as the distance between amino acids of the protein and the ligand for peonidin and 3VHE and 
C3G and 2XYN. All the interaction distances were shorter than 5 Å, which is a standard distance 
to consider a bond likely to occur. Figure 4.6 presents the distances of interactions between 
2XYN and anthocyanin ligands for cyanidin, P3G, peonidin, Pr3G, pelargonidin, and nintedanib, 
as well as the anthocyanin in the catalytic site of 2XYN for cyanidin, P3G, peonidin, Pr3G, 
pelargonidin, and nintedanib. Figure 4.7 presents the distances of interactions between the 
receptor 3VHE and anthocyanin ligands for C3G, cyanidin, P3G, Pr3G, pelargonidin, and 
nintedanib, as well as the anthocyanin in the catalytic site of 3VHE for C3G, cyanidin, P3G, 
Pr3G, pelargonidin, and nintedanib. 
4.5 Conclusions 
This study showed that all ANC-rich purple and red corn extracts tested decreased colon cancer 
cell viability in a dose-dependent manner. RAW had the strongest inhibition potential. 
Comparing the three extracts of the purple corn, based on IC50 values in terms of mg C3G 
equivalent/mL, PW had the greatest potential, followed by PAW, and PAWE, signifying that 
water extraction is sufficient to generate effective extracts for inhibiting colon cancer cell 
proliferation. The three purple corn extracts significantly increased apoptotic cells compared to 
untreated cells and had more substantial effects on apoptotic markers, such as BAX, Cyt C, and 
survivin. RAW exhibited greater impact compared to PAW on angiogenic markers, especially 
Tie-2, ANGPT2, and PLG. All colored corn extracts significantly decreased VEGF expression, 
and a favorable free energy of binding was estimated for corn ANC with tyrosine kinases. These 




Figure 4.8 presents the apoptosis and angiogenesis markers within the pathways that the ANC-
rich corn extracts had significantly impacted throughout this study. This research contributes to 
the study of the potential of natural pigments, such as ANC, to act as functional foods with added 
health benefits. 
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FIGURES AND TABLES 
Table 4.1 Total monomeric anthocyanin concentration and HT-29 and HCT-116 concentrations 
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 PEAK IDENTITY RAW PAW PAWE PW 
1 Condensed forms 2.7 ±0.0d 22.1 ±0.4b 25.9 ±0.2a 16.4 ±0.4c 
2 C3G 7.0 ±0.1d 56.3 ±1.2b 63.4 ±1.2a 34.0 ±0.3c 
3 Pr3G ND 3.3 ±0.4a 3.8 ±0.1a 1.3 ±0.1b 
4 P3G 2.7 ±0.5c 6.7 ±0.4ab 8.3 ±1.6a 5.0 ±0.1b 
5 C3G-mal 14.5 ±0.4c 20.9 ±2.1b 25.0 ±1.7a 27.0 ±0.2a 
6 Pr3G-mal  0.9 ±0.2b 2.1 ±0.1a 2.1 ±0.2a 1.9 ±0.1a 
7 P3G-mal 8.9 ±0.4a 7.1 ±0.4b 7.1 ±0.2b 8.6 ±0.2a 
 
Figure 4.1 HPLC profiles of colored corn at 520 nm. A. Red corn acidified water extract 
(RAW), B. Purple corn acidified water extract (PAW), C. PAW with additional ethyl acetate 
purification (PAWE), D. Purple corn pericarp water extract (PW). E. Concentration of 
anthocyanins by HPLC at 520 nm. Concentration less than 0.05 mg/g extract was shown as ND 
(non-detectable). Letters represent significant differences between same type of anthocyanin (p < 
0.05). C3G: cyanidin-3-O-glucoside, Pr3G: pelargonidin-3-O-glucoside, P3G: peonidin-3-O-
glucoside, C3G-mal: cyanidin-3-O-(6”-malonyl-glucoside), Pr3G-mal: pelargonidin-3-O-(6”-





Figure 4.2 Colored corn extract and oxaliplatin-induced apoptosis after 24 h of treatment of HT-
29 cells. Percentages reflect the total apoptotic cells (pre-apoptotic and apoptotic: quadrants two 
and four combined) per treatment for A. Untreated cells (UNT), B. Red corn acidified water 
extract (RAW), C. Purple corn acidified water extract (PAW), D. PAW with additional ethyl 
acetate purification (PAWE), E. Purple corn pericarp water extract (PW) and F. Oxaliplatin 





Figure 4.3 Relative expressions of red corn acidified water extract (RAW), purple corn acidified water extract (PAW), PAW with 
additional ethyl acetate purification (PAWE), Purple corn pericarp water extract (PW), and oxaliplatin (OX) (nintedanib for vascular 
endothelial growth factor (VEGF) compared to the control and protein pictures in A. HCT-116 cells and B. HT-29 cells. Asterisks 
indicate significant difference between treatments and the untreated control, while letters indicate significant difference amongst the 
treatments (p<0.05). Abelson proto-oncogene 2, ABL2; B-cell leukaemia/lymphoma-2 associated X protein, BAX; B-cell 





Figure 4.4 A.Comparison of protein expression of apoptotic markers between red corn acidified water extract (RAW), purple corn 
acidified water extract (PAW), and oxaliplatin to the untreated control in pixels. B. Comparison of protein expression (%) of 
angiogenesis markers between RAW, PAW, and nintedanib and the untreated control in HCT-116 cells. Letters indicate statistical 




Table 4.2 Apoptosis marker details and percent change compared to untreated cells for red corn 
acidified water extract (RAW), purple corn acidified water extract (PAW) and oxaliplatin (OX). 
Marker/ 
Protein  








associated X protein 
Increases permeability of the 
mitochondrial membrane which 











Cytochrome complex Release from mitochondria 
activates caspase-3, promoting 









Cleaved Caspase-3 Active form cleaves proteins 
leading to cellular disassembly 










required protein A2 
Inhibits X-chromosome-linked 
inhibitor of apoptosis protein 
(XIAP), promoting caspase 











inducing ligand 1 death 
receptor 4 
Transmembrane receptor that 
induces apoptosis in tumor cells 
when TRAIL binds (Szliszka et 











inducing ligand 2 death 
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induces apoptosis in tumor cells 
when TRAIL binds (Szliszka et 







FADD Fas-Associated protein 
with death domain 
Recruiter of caspase 8 or 10 to 
activate Fas for apoptosis (Scott 
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receptor family that initiates a 
caspase cascade (Chakrabandhu 









Phosphorylated p53 at 
Ser 15 
DNA damage induces 
phosphorylation at s15 which 
leads to activation of BAX and 







Survivin Survivin  IAP that enhances cancer cell 
survival by inhibiting caspase 











Table 4.3 Estimated free energy of binding and comparisons for receptor tyrosine kinase, 3VHE, 
and non-receptor tyrosine kinase, 2XYN, interactions with colored corn anthocyanins and the 
positive control, nintedanib.  
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Table 4.4 Estimated free energy of binding and comparisons for interactions of receptor tyrosine 
kinase, 3VHE, and non-receptor tyrosine kinase, 2XYN, with coloured corn anthocyanins and 
the positive control, nintedanib.   
  Nintedanib Peonidin  Pelargonidin  Cyanidin 
Tyrosine 
Kinase 







-8.89 -8.50 -7.76 -6.93 -7.00 -6.87 -6.98 -6.24 
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Figure 4.5 The length between the protein tyrosine kinase and anthocyanin ligand for A. 
Peonidin to receptor tyrosine kinase (3VHE), B. Peonidin in the catalytic site of the tyrosine 
kinase to 3VHE, C. Cyanidin-3-O-glucoside (C3G) to non-receptor tyrosine kinase (2XYN), D. 





Figure 4.6 Distances of interactions between non-receptor tyrosine kinase (2XYN) and 
anthocyanin ligands, and the anthocyanin in the catalytic site of 2XYN, for Cyanidin A. and B., 
respectively; for Peonidin-3-O-glucoside (P3G) C. and D., respectively; for Peonidin E. and F., 
respectively; for Pelargonidin-3-O-glucoside (Pr3G) G. and H., respectively; for Pelargonidin I. 





Figure 4.7 Distances of interactions between receptor tyrosine kinase (3VHE) and anthocyanin 
ligands, and the anthocyanin in the catalytic site of 3VHE for Cyanidin A. and B., respectively; 
for Peonidin-3-O-glucoside (P3G) C. and D., respectively; for Peonidin E. and F., respectively; 
for Pelargonidin-3-O-glucoside (Pr3G) G. and H., respectively; for Pelargonidin I. and J., 





Figure 4.8 Pathways indicating which proteins involved are promoted or inhibited by the corn 
extracts (red corn acidified water extract, RAW; purple corn acidified water extract, PAW; PAW 
with additional ethyl acetate purification, PAWE; purple corn pericarp water extract, PW) based 





CHAPTER 5: COMPARISON OF THE EFFECT OF CHEMICAL COMPOSITION OF 
ANTHOCYANIN-RICH PLANT EXTRACTS ON COLON CANCER CELL 
PROLIFERATION AND THEIR POTENTIAL MECHANISM OF ACTION USING IN 
VITRO, IN SILICO, AND BIOCHEMICAL ASSAYS 
5.1 Abstract 
The objective was to compare the anti-proliferative effect of anthocyanin-rich plant extracts on 
human colon cancer cells and determine their mechanism of action. Eleven extracts were tested: 
red (RG) and purple grape, purple sweet potato, purple carrot, black and purple bean, black lentil 
(BL), black peanut, sorghum (SH), black rice, and blue wheat. HCT-116 and HT-29 inhibition 
correlated with total phenolics (r=0.87 and 0.77, respectively), delphinidin-3-O-glucoside 
concentration with HT-29 inhibition (r =0.69). The concentration of 50% inhibition (IC50) for 
BL, SH, RG on HT-29 and HCT-116 cell proliferation ranged 0.9–2.0 mg/mL. Extracts 
decreased expression of anti-apoptotic proteins (survivin, cIAP2, XIAP), induced apoptosis, and 
arrested cells in G1. Anthocyanins exhibited tyrosine kinase inhibitory potential in silico and 
biochemically; cyanidin-3-O-glucoside had one of the highest binding affinities with all kinases, 
especially ABL1 (−8.5 kcal/mol). Cyanidin-3-O-glucoside and delphinidin-3-O-glucoside 
inhibited EGFR (IC50= 0.10 and 2.37 μM, respectively). Cyanidin-3-O-glucoside was the most 
potent anthocyanin on kinase inhibition. 
 
  
This chapter is part of the publication: Mazewski, C., Liang, K., & de Mejia, E.G. (2018). 
Comparison of the effect of chemical composition of anthocyanin-rich plant extracts on 
colon cancer cell proliferation and their potential mechanism of action using in vitro, in 
silico, and biochemical assays. Food Chemistry, 242, 378-388. 





Anthocyanins (ANC) are plant-specific flavonoid compounds that accumulate in the vacuoles of 
plant cells and display colors of red, purple and blue found in leaves, petals, seeds and plant 
tissue (Fan et al., 2015). Thus, red, blue, and purple plants that are highly pigmented are typically 
rich in ANC. The six major anthocyanidins, the aglycone form of ANC, are 
cyanidin, peonidin, delphinidin, pelargonidin, petunidin, and malvidin which typically exist with 
their C3 position O-glycosylated; the most widespread ANC amongst fruits and vegetables being 
cyanidin 3-O-glucoside (C3G) (Fang, 2015). ANC produce phenolic acid metabolites that 
contribute to their antioxidative, anti-inflammatory, and anti-carcinogenic properties, among 
others (Charepalli et al., 2016). 
The potential for ANC to prevent and suppress colorectal cancer (CRC) proliferation has been a 
topic of recent studies (Anwar et al., 2016, Charepalli et al., 2016, Sharma et al., 2017). An 
association between diet and CRC incidence has been found with an increased risk of CRC 
related to a high intake of red and processed meats and a lowered risk due to an increased intake 
of vegetables, fruits, and whole grains (American Cancer Society. Cancer facts & figures, 2017). 
Despite a declining death rate, CRC is still the second leading cause of cancer-related deaths for 
men and third leading cause for women in the United States (American Cancer Society, 2017). 
The survival rate of CRC significantly decreases unless diagnosed before metastasis, with five-
year survival rates of 90.1% and 13.5% for localized and distant stages, respectively (National 
Institutes of Health. Cancer stat facts: colon, 2017). This drastic change in survival rate 
emphasizes the importance of early detection and advances in metastatic CRC treatments. 
The ability of bioactive compounds in foods, such as ANC, to suppress CRC growth and 




Apoptosis, or programmed cell death, induction is an important part of inhibiting cancer 
progression. A family of proteins named inhibitors of apoptosis proteins (IAP) regulates 
apoptosis by preventing caspase family activation, promoting pro-survival signaling pathways, 
and disrupting pro-apoptotic intermediates (Falkenhorst et al., 2016). Lee et al. 
(2009) demonstrated the ability of ANC from Vitis coignetiae Pulliat to inhibit the growth of 
human leukemia cells by interacting with IAP and other anti-apoptotic proteins. 
In addition to apoptotic protein modulation, the angiogenesis pathway, which is the growth of 
blood vessels to the tumor, is a major step towards metastasis that can be impacted by bioactive 
compounds. Tyrosine kinases play a key role in cell survival and angiogenesis in CRC, as well as 
other types of cancers, and there are drugs targeting tyrosine kinases that are either approved or 
in clinical trials for metastatic CRC treatment (Jeltsch, Leppänen, Saharinen, & Alitalo, 2013). 
Some of the tyrosine kinases that have been shown to play a part in CRC are Abelson proto-
oncogene 1 (ABL1), epidermal growth factor receptor (EGFR), tyrosine kinase with Ig and EGF 
homology domain 2 (TIE-2), and vascular endothelial growth factor receptor 2 (VEGFR2). 
ABL1 is a non-receptor tyrosine kinase involved in the promotion of cytoskeleton remodeling, 
motility, and proliferation (Raimondi, 2014). EGFR has been found to be overexpressed in CRC 
and participates in tumorigenesis and angiogenesis signaling (Ding, Li, Yang, Fan, & Wu, 2016). 
TIE-2 promotes blood vessel integrity and cell migration involved in angiogenesis (Fukuhara et 
al., 2008). Binding of VEGF to VEGFR2 promotes permeability, survival, proliferation, and 
migration in colon cancer cells (Tong et al., 2014). Research has shown a potential for ANC-rich 
extracts from bilberry and grape to modulate EGFR and VEGFR2 (Teller et al., 2009), for ANC-
rich purple corn extract to suppress TIE-2 (Kang, Lim, Lee, Yeo, & Kang, 2013), and quercetin, 




In this study, eleven different plant extracts, red and purple grape, black lentil, black bean, purple 
bean, black peanut, blue wheat, sorghum, black rice, purple carrot, and purple sweet potato, with 
varying phenolic concentrations were used to analyze their anti-proliferative effects on colon 
cancer cells. All plant extracts can be categorized into four groups: fruit, legumes, cereals, and 
vegetables. The hypothesis was that ANC-rich plant extracts would inhibit human colon cancer 
cell proliferation through inducing apoptosis and higher ANC and phenolic concentrations would 
correlate with greater colon cancer cell inhibition. The objective was to determine the chemical 
composition of the plant extracts and compare their anti-proliferative effect on HCT 116 and HT-
29 human colon cancer cells and to analyze their mechanism of action in vitro, in silico, and 
through biochemical assays. 
5.3 Materials and methods 
5.3.1 Materials 
Human normal colon cells, CCD-33Co, and human colon cancer cells, HT-29 and HCT 116, 
were purchased from the American Type Culture Collection (Manassas, Virginia). The 
purple sweet potato, purple carrot, and purple and red grape extracts were from San Joaquin 
Valley Concentrates in Fresno, CA. The extracts were further purified as described in 
Section 2.2.1.1. The black lentil, sorghum, blue wheat, black peanut, black and purple bean, and 
black rice extracts were from the Kraft Heinz Company (Chicago, IL). The preparation of these 
extracts is presented in Section 2.2.1.2. The CellTiter 96® AQueous One Solution Cell 
Proliferation Assay was purchased from Promega Corporation (Madison, WI). Eu-Anti-GST 
antibody, kinase tracer 199, kinase buffer A, (-)-epigallocatechin gallate (EGCG) > 95% purity, 
and epidermal growth factor receptor protein were bought from ThermoFisher (Waltham, MA). 




(P3G) > 95% were purchased from Chromadex (Irvine, CA). All other chemicals used in this 
study were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated. 
5.3.2 Chemical composition of the ANC extracts 
5.3.2.1 Extraction and semi-purification of ANC from plant extracts 
5.3.2.1.1 Semi-purification of purple sweet potato, purple carrot, and red and purple grape 
extracts 
The purple sweet potato, purple carrot, and red and purple grape extracts were diluted at a 1:10 
ratio (g dry extract: mL distilled water) and stirred at 4 °C for 24 h in the dark. Then, the mixture 
was centrifuged for 10 min and filtered through grade 2 filter paper. Twenty-five mL of extract 
was added to Amberlite resin FPX66 in ∼1:1 ratio of extract and resin volumes (Dow 
Chemical, Midland, MI; previously washed twice with distilled water) stirred for 2 h and 
the supernatant discarded. After, 25 mL of ethanol was added and stirred for 1 h; the supernatant 
was collected and evaporated in a rotary evaporator at 39 °C for approximately 20 min. Finally, 
1 mL of distilled water was added, and this was freeze-dried and then kept at -20 °C until use. 
The freeze-dried extracts kept at -20 °C were used within fifteen months, over which they 
maintained stability. 
5.3.2.1.2 Extractions from black lentil, sorghum, blue wheat, black peanut, black bean, purple 
bean, and black rice 
The seven plant extracts were obtained by extracting 1 kg of each type with 2 L of 2% v/v 
aqueous formic acid at 4 °C for 20–24 h in the dark. The extract was filtered through grade 2 
filter paper followed by 0.45 µm nylon membrane filters. The clarified extract was passed 




volumes) which was previously washed with distilled water. Then, the resin column was washed 
with distilled water until readings were taken with a conductivity meter equipped with a flow cell 
(Traceable®, ThermoScientific, Waltham, MA) suggesting that no significant amounts of 
unretained compounds were present. Absolute ethanol (USP grade) was introduced onto the 
column to remove ANC as well as other adsorbed phenolic compounds. The collection was 
started when color elution was observed and terminated when the eluate was colorless. Ethanol 
and water were removed under water aspirator vacuum using a rotary evaporator at bath 
temperatures of less than 40 °C in the dark. The remaining aqueous extract was freeze-dried, and 
the dried extract was stored at -20 °C until analysis. The freeze-dried extracts kept at -20 °C were 
used within fifteen months, over which they maintained stability. 
5.3.2.2 Measurement of total phenolic, monomeric ANC, and condensed tannin concentration 
5.3.2.2.1 Total phenolic concentration by Folin-Ciocalteu method 
The Folin-Ciocalteu method was mainly followed as described by Singleton, Orthofer, and 
Lamuela-Raventós (1999). Extracts were diluted to 0.5 mg/mL with deionized water. To a 96-
well plate, 50 µL of diluted extracts, standard (gallic acid, >97.5% purity), or blank (deionized 
water) were added. Next, 50 µL of 1 N Folin-Ciocalteu’s phenol reagent was added to each well. 
After 5 min incubation, 100 µL of 20% Na2CO3 was added, and the mixture was incubated for 
10 min at room temperature. The absorbance was read at 690 nm using a Synergy 2 multi-well 
plate reader (Biotek, Winooski, VT) and the results were expressed as mg gallic acid equivalent 
(GAE) per g of dry extract. 




Extracts were diluted using two buffers (pH 1.0, 0.25 M KCl buffer, and pH 4.5, 0.40 M sodium 
acetate buffer). Two hundred µL of diluted solutions at each pH were transferred to a 96-well 
plate, and the absorbance read at 520 nm and 700 nm using a Synergy 2 multi-well plate reader. 
The total monomeric ANC concentration was calculated as C3G equivalents per L as described 
below: 
Total monomeric ANC (mg/L) = (A ∗ MW ∗ D ∗ 1000) / (ε ∗ PL) 0.45 
where: A = (Absorbance at 520 nm – Absorbance at 700 nm) at pH1.0 – (Absorbance at 520 nm 
– Absorbance at 700 nm) at pH4.5; MW = 449.2 g/mol for C3G; D = dilution factor; 
PL = constant path length 1 cm; ε = 26900 L/mol-cm which is the molar extinction coefficient 
for C3G, 1000 conversion factor from g to mg and 0.45 as the conversion factor from the 
established plate reader method. Results were expressed as mg C3G equivalent (C3GE) per g of 
dry extract. 
5.3.2.2.3 Total condensed tannin concentration by vanillin-HCl method 
Extracts were diluted in 100% methanol to 1 mg/mL concentration and diluted as needed (two or 
four times). Diluted extracts were transferred in 50 µL amounts to a 96-well plate in triplicate, 
and 200 µL of 1:1 (8% HCl in methanol: 1% vanillin in methanol) were added to each well. As a 
blank to account for the color interference of the extracts in the absorbance reading, 50 µL of 
extracts were added to the plate in triplicate, and 200 µL of 4% HCl in methanol was added. The 
absorbance was read at 500 nm using a Synergy 2 multi-well plate reader. Catechin was used to 
form a standard curve and report results as mg catechin equivalent (CE) per g dry extract. 




HPLC analysis at 520 and 280 nm of the plant extracts was performed in duplicate using a 
Hitachi HPLC System (Hitachi High Technologies America, Inc., Schaumburg, IL) equipped 
with a multi- wavelength detector, L-7100 pump, following a previously reported protocol (West 
& Mauer, 2013) with some modifications. The injection volume was 20 µL, and the flow rate 
was 1 mL/min. The gradient used was from A. 2% formic acid in water and B. 0% acetonitrile to 
40% acetonitrile in a linear fashion using a Grace Prevail C18 (5 µm, 250 × 4.6 mm, Columbia, 
MD) for 30 min. ANC peaks were identified at 520 nm based on the same retention time as 
available standards (West & Mauer, 2013). The concentration of each ANC was determined 
using a calibration curve with 5 points in the range of 50–2000 ng/mL of C3G standard. P3G, 
pelargonidin-3-O-glucoside (Pr3G), D3G, cyanidin-3-O-(6″-malonyl-glucoside, peonidin-3-O-
(6″-malonyl-glucoside), and pelargonidin-3-O-(6″-malonyl-glucoside) standards were utilized in 
identifying peaks. The calibration curve was obtained by plotting the area of C3G peak versus its 
concentration (r
2
 > 0.99). Profiles of plant extracts at 280 nm were also obtained and utilized for 
analysis of phenolics in conjunction with the mass spectrometry analysis. 
5.3.2.4 Mass spectrometry 
MS/MS analysis was performed on the three extracts that were the most potent on the two cancer 
cell lines (black lentil, sorghum, and red grape). A Waters quadrupole time-of-flight (Q-Tof) 
Ultima equipped with an electrospray ionization (ESI) interface was utilized and controlled by 
MassLynx V4.1 software (Waters Corp., Milford, MA). Sunfire® C18 column 
(150 mm × 2.10 mm, 3.5 μm, Waters Corp., Milford, MA) was utilized for separation. The 
mobile phase was a linear gradient of 0.1% v/v formic acid (A) and acetonitrile (B) starting at 
0% (B) and increasing to 40% (B) over 30 min, the flow rate was 400 mL/min, and the column 




acquired in positive mode within the mass to charge ratio (m/z) range 50–950 at cone voltages 
35 V. Mass spectrometric data for ANC and phenolics were acquired in positive mode and 
monitored at 520 nm and 280 nm, respectively. ANC and phenolics were identified based on use 
of pure standards, the accurate mass measurements, tandem MS fragmentation, and/or published 
literature, when needed. 
5.3.2.5 Color measurements with Tintometer 
Color analysis was completed to provide additional criteria to discriminate between the eleven 
plant extracts. The parameters of hue angle, chroma, and saturation also gave better insight into 
the capabilities of the extracts to act as natural pigments in a food system. Understanding the 
correlations between color parameters and colon cancer cell inhibition can contribute to the 
benefit of using natural pigments. Deionized water was added to the eleven extracts to get a 
concentration of 1 mg/mL. Extracts were vortexed and added to cuvettes in duplicate. A 
Tintometer PFX990 (Lovibond, Amesbury, United Kingdom) was used to obtain L∗, a∗, and 
b∗ readings for each extract with observer/illuminant: 10° and D65 and path length of 1 cm. 
Values were converted to R, G, and B numbers to create color squares 
using http://colormine.org/convert/rgb-to-lab and Microsoft PowerPoint software. In addition, 
hue angle, chroma, and saturation were calculated based on the L∗, a∗, and b∗ values: 
Hue angle = tan-1(b∗/a∗)  
Chroma = (a∗2+b∗2)  
Saturation = Chroma/L∗ 
5.3.3 In vitro studies 




All three cell lines, HT-29, HCT 116, and CCD-33Co were cultured in Minimum Essential 
Medium Eagle with 10% FBS, 1% penicillin/streptomycin and 1% sodium pyruvate at 37 °C in 
5% CO2 and 95% air. HCT 116 cells exhibit microsatellite instability characteristics of early 
stage colon cancer cells, whereas HT-29 cells are microsatellite stable cells that have been 
associated with advanced stage colon cancer (Charepalli et al., 2016) allowing observation of 
effects at different representative stages of colorectal cancer. CCD-33Co cells are normal colon 
cells which provided the capability to assess cytotoxicity effects of the extracts. 
5.3.3.2 HT-29, HCT 116, and CCD-33Co cell proliferation 
The CellTiter 96® AQueous One Solution Cell Proliferation Assay was used to determine the 
most potent of the plant extracts, the IC50 values for the top three extracts on the HT-29 and HCT 
116 cells, and to determine potential cytotoxicity of the extracts on the CCD-33Co cells. The 
assay consists of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2 H-tetrazolium (MTS), and an electron coupling reagent (phenazine methosulfate). For each cell 
line tested, a 96-well plate was seeded with 1x10
5
cells per well and the volume of each well was 
adjusted to 200 µL with added medium. After 24 h, the plant extracts were added at 2.5 mg/mL 
to HT-29 cells and 1.0 mg/mL to HCT 116 cells, based on IC50 values of ANC-rich 
red corn obtained from a previous study (Mazewski, Liang, & de Mejia, 2017); the red corn 
extract in this previous study had been extracted in a similar manner and was tested on both cell 
lines so it was predicted that these concentrations of plant extracts would be in a similar range of 
potency for each cell line. They were then incubated for 24 h for comparing inhibition potential. 
The top three plant extracts were added in various concentrations (0.25–10 mg/mL), as well 
as oxaliplatin (5–50 µM) and the plates were incubated for 24 h in determining IC50 values. 




concentrations from 10 to 100 μM. The wells were washed one time with 100 µL of PBS to get 
rid of any remaining color (purple or red) from the ANC-rich plant extracts that may have 
interfered with absorbance readings. Then 100 µL of media was added to each well followed by 
20 µL of the CellTiter solution. After 1 h of incubation, the plate absorbance was read at 515 nm 
using an ELX808IU Ultra Microplate Reader (BioTek, Winooski, VT). Using the absorbance 
readings, the percent of cells inhibited was calculated by comparing untreated cells to treated 
cells. Prism 4 software (GraphPad Software, La Jolla, CA) was used to calculate IC50 values for 
the three most potent extracts and oxaliplatin for the HT-29 and HCT 116 cells. 
5.3.3.3 Evaluation of apoptosis and cell cycle by flow cytometry 
For apoptosis measurement, HT-29 and HCT 116 cells were seeded at 3x10
5
 cells per well in a 
six-well plate and grown at 37 °C in 5% CO2 95% air for 24 h. They were treated with black 
lentil, sorghum, and red grape extracts and oxaliplatin for 24 h at the IC50 determined values 
(ranging from 0.9 – 2.0 mg/mL). The media was collected in 15 mL tubes for each well. Each 
well was then washed with 1 mL of PBS and then washed twice with 0.5 mL of trypsin. The 
plate was incubated for 5 min at 37 °C. Cells were collected in 1 mL of PBS and added to the 
media of the designated 15 mL tubes. Cells were resuspended in binding buffer at a density of 
1 × 10
6
 cells/mL after centrifugation. Annexin V-FITC was added at suggested ratio of 5 µL per 
500 µL suspension and propidium iodide at 10 µL per 500 µL. After 10 min, a BD LSR II Flow 
Cytometry Analyzer (BD Biosciences, San Jose, CA) was used to evaluate the state of 10,000 
cells. Duplicate readings of each well were taken, and two independent experiments were 
analyzed. 
For cell cycle measurement, HT-29 cells were seeded at 4 × 10
5
 cells per well in a six-well plate 




cells in binding buffer where instead they were resuspended in 300 µL PBS. Suspended cells 
were fixed by adding drop by drop 700 µL ice-cold ethanol and then stored overnight in 4 °C. 
Ethanol-suspended cells were vortexed and then centrifuged. Ethanol was thoroughly removed, 
and then cells were vortexed in 1 mL of PBS. Cells were centrifuged again to form a compact 
pellet, and PBS was removed. Propidium iodide and RNAase solution were diluted in PBS and 
then added to the cell pellet. After vortexing, they were incubated at room temperature for 2–3 h 
and then a BD LSR II Flow Cytometry Analyzer was used to evaluate the state of 10,000 cells. 
Duplicate readings of each well were taken, and two independent experiments were analyzed. 
5.3.3.4 Apoptosis protein array 
R&D System’s (Minneapolis, MN) Human Apoptosis Array was used to analyze the effect of 
black lentil, sorghum, and red grape extracts on expression of proteins of apoptosis., but HCT 
116 cells at a 1 × 10
6
 seeding density in a 25 cm
2
 flask were incubated for 24 h at 37 °C and 5% 
C02/ 95% air. Then, they were treated with the IC50 concentrations of the black lentil, sorghum, 
and red grape, and one was left untreated. After 24 h, cells were harvested. Manufacturer’s 
instructions were mainly followed, but a Gel Logic 4000 Pro imaging system (Carestream 
Health, Inc., Rochester, NY) was used to detect protein expression on the membranes. 
5.3.4 In silico studies 
DockingServer was utilized for molecular modeling of the common food ANC with colon cancer 
related tyrosine kinases (Bikadi & Hazai, 2009). The MMFF94 force field and Gasteiger partial 
charges were used in the modeling. Non-polar hydrogen atoms were merged and rotatable bonds 
defined. Docking calculations were carried out on tyrosine kinase protein structures which were 
imported from RCSB Protein Data Bank (Rutgers, The State University of New Jersey, and the 




4WKQ, TIE-2 – 2WQB, and VEGFR2 – 3VHE. Different ligands, C3G, Pr3G, P3G, D3G, 
malvidin-3-O-glucoside, petunidin-3-O-glucoside, and EGCG, and the synthetic 
inhibitors, gefitinib and nintedanib, were used; structures were imported from the PubChem 
Compound database (National Center for Biotechnology Information, Bethesda, MD). Essential 
hydrogen atoms, Kollman united atom type charges, and solvation parameters were added with 
the aid of AutoDock tools (Morris et al., 1998). AutoDock parameter set and distance-
dependent dielectric functions were used in the calculation of the van der Waals and 
the electrostatic terms, respectively. Initial position, orientation, and torsions of the ligand 
molecules were set randomly. Docking results were derived from 100 different runs that were 
configured to terminate after a maximum of 250,000 energy evaluations. The population 
size was set up to 150. During the search, a translational step of 0.2 Å, and quaternion and 
torsion steps of 5 were applied. 
5.3.5 Biochemical analysis of tyrosine kinase EGFR inhibition by ANC 
To determine the validity of the docking analysis, pure ANC were tested in an EGFR 
biochemical assay. EGFR kinase binding assays were performed in white 384-well low volume, 
round bottom plates at room temperature following manufacturer’s instruction (ThermoFisher, 
Waltham, MA). C3G, D3G, and P3G were tested at concentrations of 0.01, 0.1, 1, and 10 µM. 
As a control, the pure ANC were tested without kinase to determine if the color at 10 µM had a 
significant effect on fluorescence, and if it did, that particular concentration for a particular ANC 
was not used in further analysis. A synthetic inhibitor, SB 202190, and EGCG were tested as 
positive controls at concentrations of 0.01, 0.1, 1, and 10 µM, and 100 µM for SB 202190 only. 
Five μl of diluted test compounds (or kinase buffer A for controls) were added to the wells 




transferase antibody. Immediately following the addition of the mixture, the reaction was 
completed by adding 5 μl of kinase tracer (substrate). The assay plates were incubated for 60 min 
at room temperature. The final concentration ratio for the kinase binding assay was 5:2:5 kinase 
to antibody to tracer. The plates were read using an Analyst HT Multimode Reader (Molecular 
Devices, Sunnyvale, CA) with time-resolved fluorescence settings with excitation at 340 nm and 
emission at 665 nm and 620 nm. For IC50 analysis, GraphPad Prism 4.0 was utilized. 
5.3.6 Statistical analysis 
Statistical analyses were conducted using one-way ANOVA to compare experimental to control 
values with JMP version 8.0. Comparisons between groups were performed using Tukey- 
Kramer test, and differences were considered significant at p < 0.05. Comparisons for the 
apoptosis array between the untreated control at 100% expression and extracts were performed 
using Student’s t-test, and differences were considered significant at p < 0.05. For IC50 analyses, 
GraphPad Prism 4.0 was utilized. At least two independent experiments run with at least 
duplicate data points were performed for every study. After collecting inhibition percentages of 
each extract from both cell lines, as well as, the chemical analyses for each extract, chemical 
criteria were compared with cell inhibition to determine potential correlations. Chemical 
criterion vs. percent inhibition was plotted and Pearson’s correlation coefficient (r) was 
determined for each comparison. A strong correlation was considered if r = ±0.600–1.000, 
moderate if r = ±0.400–0.599, and weak if r = ±0.000–0.399 (Evans, 1996). 
5.4 Results and discussion 




Table 5.1 shows the total phenolic, ANC, and condensed tannin concentrations for the 
eleven plant extracts. Black rice had the highest phenolic (382.3 mg GAE per g dry extract) and 
ANC concentration (287.5 mg C3GE per g dry extract). In a study on Chiang Mai black rice 
(Pengkumsri et al., 2015), total phenolics were calculated at 305.3 mg GAE per g dry extract and 
ANC at 487.3 mg C3GE per g extract. Purple bean had the highest condensed tannins (998.9 mg 
CE per g dry extract). 
HPLC profiles at 520 and 280 nm of the three most potent plant extracts at reducing colon cancer 
cell viability are shown in Figure 5.1. The rest of the plant extracts at 520 nm are displayed 
in Figure 5.2. The ANC profiles vary considerably amongst the plant extracts with some having 
one main peak (black lentil, black rice) and others with a broad range of ANC peaks (red grape, 
purple sweet potato). D3G was the most abundant of the ANC in the 11 extracts identified 
through HPLC based on standards available. D3G was especially high in red grape, black lentil, 
and black bean. Other studies have noted high amounts of delphinidin glycosides in grapes 
(Teller et al., 2009), black lentil (Giusti, Caprioli, Ricciutelli, Vittori, & Sagratini, 2016), and 
black bean (Mojica, Berhow, & de Mejia, 2017). Many phenolic compounds were found in black 
lentil, red grape, and sorghum based on mass spectrometry analysis. Black lentil had high 
delphinidin derivatives, as well as procyanidin B1. Sorghum, although low in ANC at 520 nm, 
showed high phenolic concentration, especially in procyanidin B1. Procyanidin B1 was also the 
major flavan-3-ol dimer identified in a study looking at red sorghum (Bröhan, Jerkovic, 
Wilmotte, & Collin, 2011). Red grape was mainly composed of ANC but also had quercetin 
derivatives. 
Color results, saturation, chroma, and hue angle, of the plant extracts dissolved in water are 




angle is the chromatic perceived color determined by the wavelength; all three parameters are 
used in determining potential to act as natural pigments in food systems (Cortez, Luna-Vital, 
Margulis, & Gonzalez de Mejia, 2017). Purple carrot had the highest saturation value followed 
by black rice and purple sweet potato. These three extracts also had the highest chroma values 
indicating that these extracts would have the greatest ability to act as a natural red pigment in a 
food system. Higher chroma and saturation and lower hue angle correlated with higher ANC 
concentration. Hue angles were below 90° for the eleven extracts with those closer to 90° 
indicating more of a yellowish hue and closer to 0° representing a red hue, closer towards purple 
and blue hues. In general, all the extracts were shades of red when dissolved in water, except 
sorghum. Black lentil had the lowest hue angle (2.79°) followed by red grape (7.24°) and black 
bean (7.57°). 
5.4.2 HT-29, HCT 116, and CCD-33Co cell proliferation inhibition by phenolic-rich plant 
extracts 
Black lentil, sorghum, and red grape had the highest inhibition percentages for HCT 116 cells at 
1 mg/mL (62.2%, 52.9%, and 35.2%, respectively) and HT-29 cells at 2.5 mg/mL (87.5%, 
84.3%, and 83.3%) when compared to the other plant extracts at the same concentration (Table 
5.1). It was important to analyze inhibition on both early (HCT 116) and advanced (HT-29) 
cancer cell lines to demonstrate the plant extract effectiveness in varying malignancy stages, as 
different characteristics and inhibition targets apply to different stages. It was also necessary to 
analyze normal colon cells, CCD-33Co, to confirm that there was no extract cytotoxicity. Black 
lentil was the most potent growth inhibitor for both cell lines and was the second highest in 
phenolic concentration (295.8 mg GAE per g dry extract). Sorghum was the second most potent 




concentration (225.7 mg GAE per g dry extract) and the second highest amount of condensed 
tannins (883.5 mg CE per g dry extract). Other phenolics, not just ANC, could be contributing to 
the cell inhibition potential of the extracts. A correlation was seen with both phenolic and 
condensed tannin concentration, this would explain why sorghum was very potent, despite not 
having high amounts of ANC. Although sorghum was not found to have ANC through the pH 
differential method and very small amounts from HPLC at 520 nm, there was a peak found with 
HPLC at 480 nm that is likely a 3-deoxy-anthocyanin, although this was still a low intensity peak 
in comparison to those at 280 nm. In the literature, 3-deoxyanthocyanins have been reported to 
be found in sorghum but different methods of extraction and different types of sorghum will alter 
the phenolic content (Ayala-Soto, Serna-Saldívar, Welti-Chanes, & Gutierrez-Uribe, 2015). Red 
grape had the third highest inhibition percentages in both cell lines and had high ANC (157.5 mg 
C3GE per g extract), as well as high phenolic concentration (266.2 mg GAE per g extract). Due 
to its high concentration of phenolics and ANC, black rice was expected to have high cell 
inhibition. However, it was only the fourth highest in HCT 116 cells and had low inhibition in 
HT-29 cells. As seen in Figure 5.2, black rice presented mainly one peak which was C3G. A 
correlation was observed between D3G and inhibition potential but not with C3G, so this could 
explain why black rice was not one of the most potent extracts. An ANC mixture containing 
ANC in a ratio to represent those present in V. coignetiae Pulliat with large amounts of D3G 
(23.9%) was effective at inhibiting HCT 116 cells (Shin et al., 2011). Black peanut and blue 
wheat had the lowest inhibition in both cell lines; these results were expected considering that 
they had a very low phenolic, condensed tannin, and ANC concentration. 
Since black lentil, sorghum, and red grape were the top three inhibitors of both cell lines, they 




and oxaliplatin, which was used as a control, had a dose-dependent relationship with increasing 
cell inhibition in both cancer cell lines. Oxaliplatin had the lowest IC50 for both cell lines, which 
was expected as it is a chemotherapy drug specifically used to treat colorectal cancer. Black 
lentil extract was most potent of the plant extracts in terms of IC50 for HCT 116 cells (0.9 mg dry 
weight/mL). Xu and Chang (2012) showed that lentils had a dose-dependent inhibition in 
colorectal adenocarcinoma cells with comparable IC50 values: SW 480 (1.91 mg/mL) and Caco-2 
(0.73 mg/mL). In HT-29 cells, black lentil extract had an IC50 of 1.4 mg dry weight/mL and 
sorghum of 1.7 mg dry weight/mL with no statistical difference between them. Many varieties of 
sorghum have been analyzed for anticancer properties; Hwanggeumchal sorghum extract was 
shown to suppress breast cancer tumor growth in mice (Park et al., 2012). Overall, IC50 values of 
the three extracts were lower for HCT 116 cells compared to HT-29 cells, which could be due to 
the higher resistance of the HT-29 cells related to their advanced stage. 
C3G, D3G, P3G, and Pr3G showed low (lower than IC30) to no inhibition at concentrations up to 
100 μM (data not shown). Although the crude extracts with a variety of ANC and phenolics were 
successful at inhibiting the colon cancer cells, pure ANC alone were unable to significantly 
inhibit the cells. A potential synergistic effect could be occurring with the ANC and other 
phenolic compounds present in the extracts. Similarly Zhang, Vareed, and Nair (2005) did not 
see inhibitory activity of HCT 116 cells with pure ANC tested; only aglycone malvidin and 
pelargonidin showed significant inhibition at concentrations higher than 150 μM. 
Cell proliferation inhibition of colon cancer cell lines, HT-29 and HCT 116, was significantly 
higher (p < 0.05) than inhibition of the normal colon cells, CCD-33Co, at high concentrations 
(2.5 and 10 mg/mL) (Table 5.1, and data not shown, respectively). The percentages of inhibition 




87.5%, for sorghum were 96.6% and 84.3%, and for red grape were 94.1% and 83.3%, 
respectively. In comparison, for CCD-33Co normal colon cells, the percentages of inhibition at 
2.5 mg/mL for black lentil, sorghum, and red grape were only 30.0%, 38.9%, and 36.5%, 
respectively. Black lentil, the most potent of the extracts on the cancer cell lines, at 10 mg/mL 
had only 9.7% inhibition of normal cells. A study evaluating the effect of red and white 
wine extracts on human peripheral blood mononuclear cells and human cervix and breast 
adenocarcinoma found greater cytotoxicity to the adenocarcinoma cells than to the unstimulated 
mononuclear cells; this finding indicated selectivity of the high polyphenolic extracts on the 
carcinoma cells (Matíc et al., 2010). This selectivity was also evident in the present study based 
on the significantly lower percentages of inhibition on the normal colon cells compared to both 
cancer cell lines. 
5.4.3 Effect of phenolic-rich plant extracts on apoptosis and cell cycle by flow cytometry 
Black lentil, sorghum, and red grape extracts significantly increased the percentage 
of apoptotic cells compared to the untreated HT-29 and HCT 116 cells (Figure 5.3). Black lentil 
had the largest percent of apoptotic cells (HT-29: 42.5% and HCT 116: 38.3%). In our previous 
study, it was seen that ANC-rich colored corn extracts significantly increased apoptotic cells 
compared to the untreated in HT-29 cells (Mazewski, Liang, & de Mejia, 2017). The plant 
extracts may be inhibiting colon cancer cell proliferation through promoting apoptosis. 
Black lentil, sorghum, and red grape increased the percentage of HT-29 cells in G1 phase 
compared to the untreated cells (Figure 5.4). The arrest of cells in G1 was significant for black 
lentil and sorghum. A study looking at the effect of blueberries, high in ANC, on human 
hepatocellular carcinoma cells also determined an increase in the percentage of G1 cells and 




of sorghum was also previously shown to arrest breast cancer cells in G1 (Park et al., 2012). 
Oxaliplatin, a chemotherapy drug that was used as a positive control, arrested cells in G2 
compared to the untreated cells. 
5.4.4 Effect of phenolic-rich plant extracts on expression of proteins related to apoptosis 
Sorghum and red grape reduced expression of BCL-2, HSP27, and livin as seen in Figure 5.3. 
Black lentil, sorghum, and red grape extracts decreased the expression of cIAP2, 
HSP70, survivin, XIAP, and IGFBPs. The inhibitor of apoptosis protein (IAP) family was 
affected: livin, survivin, XIAP, and cIAP2. These proteins inhibit the caspase cascade leading to 
apoptosis (Falkenhorst et al., 2016). A study evaluating the effects of ANC from Vitis coignetiae 
Pulliat on HCT 116 cells found that the ANC mixture downregulated IAPs and BCL-2 (Lee et 
al., 2009). In another study, delphinidin, which derivatives are high in the black lentil and red 
grape extracts, was shown to inhibit XIAP, cIAP2, and survivin in human prostate cancer cells 
(Ko et al., 2015). 
5.4.5 Correlation of chemical composition and inhibition of colon cancer cells 
Higher inhibition of both human colon cancer cell lines was seen with greater total phenolic 
concentration (HT-29: r = 0.87, p = 0.001; HCT 116: r = 0.77, p = 0.011) (Figure 5.5). Total 
phenolics positively correlated with DPPH radical scavenging, radical absorbance, and iron 
chelating capacities in a study looking at varieties of whole grain rice where red and purple brans 
had greater antioxidant capacities compared to the lighter brans (Min, Gu, McClung, Bergman, 
& Chen, 2012). Of the individual ANC that were present in the extracts, per HPLC analysis, the 
only one that had a strong correlation with HT-29 cell inhibition was D3G (r = 0.69). ANC from 




strong antioxidants in HT-29 cells (Jing et al., 2015). Also, a study analyzing pure 
anthocyanidins in colon cancer cells, found delphinidin had the lowest IC50 on both metastatic 
colon cancer cells tested when compared to cyanidin, malvidin, and pelargonidin (Cvorovic et 
al., 2010). There was a strong correlation with cell inhibition and condensed tannin 
(proanthocyanidin) concentration (HT-29: r = 0.77, p = 0.01, HCT 116: r = 0.75, p = 0.01). A 
study using procyanidin-rich fractions from grape and pine bark found that all extracts had a 
dose-dependent inhibition on HT-29 cells and were able to induce apoptosis and arrest cells 
in G2 phase (Lizarraga et al., 2007). Condensed tannins are within the polyphenol family so the 
existence of a correlation with higher cell inhibition and condensed tannin concentration 
contributes to the phenolic concentration correlation. Although there was a moderate correlation 
with ANC concentration and cell inhibition, it was not significant for either cell line. Therefore, 
the condensed tannin concentration may contribute more to colon cancer cell inhibition potential 
than ANC concentration. Higher inhibition was also correlated with lower hue angle with a 
strong correlation in HT-29 cells (HT-29: r = -0.81 p = 0.01, HCT 116: r = −0.58 p = 0.08). This 
indicated extracts with more of a reddish hue were more potent than those with more yellowish 
hue, except for sorghum. More blueish-red hues are associated with ANC so these results 
indicate that these compounds may have contributed to higher inhibition potential. Additional 
environmental factors, such as pH and temperature, and other phenolics, like condensed tannins, 
can have an effect on hue of the ANC-rich extracts (Cortez et al., 2017). 
5.4.6 Molecular docking of tyrosine kinases related to colon cancer with the most common ANC 
Estimated free energy of binding for each ANC, EGCG, nintedanib, and gefitinib with each of 
the four tyrosine kinases (ABL1, EGFR, TIE-2, and VEGFR2) is shown in Figure 5.6. All 




(used as a control), and the drugs tested. The drugs (gefitinib or nintedanib), which are selective 
tyrosine kinase inhibitors, always had the most effective free energy of binding. C3G was in the 
top two most negative free energy of binding for ANC for each of the four tyrosine kinases; D3G 
for three of the four (EGFR, TIE-2, and VEGFR2), and P3G for one of the four (ABL1). When 
comparing protein-ligand interactions between the drug and two ANC with each of the tyrosine 
kinases, there were many common hydrophobic interactions. Similarly, mainly hydrophobic 
interactions were seen in a study that looked at the EGFR domain with different flavonoids 
(Cassidy & Setzer, 2010). With VEGFR2, C3G, D3G, and nintedanib did have one common 
polar interaction, GLU885. The hydrophobic interactions that were the same for nintedanib and 
the ANC in VEGFR2 were VAL899, LEU 1019, and ILE1044. For ABL1, the common 
hydrophobic interactions for C3G, P3G, and gefitinib were LEU248 and 370 and VAL256. P3G 
also had ALA269 in common with gefitinib. For EGFR, the three common hydrophobic 
interactions among gefitinib, C3G, and D3G were LEU718 and 792 and VAL726. Also, 
ALA743 and LEU844 were common between gefitinib and C3G. In the Cassidy and Setzer 
study (2010), the flavonoid ligand binding site was reported to be mainly hydrophobic with 
residues of VAL702, LEU694, LEU820, ALA719, and GLY772. TIE-2 had one common 
hydrophobic interaction between gefitinib and C3G and D3G, LEU971. ILE830 and VAL838 
were common between gefitinib and C3G. Leucine and valine residues were observed as 
common interactions with all four of the tyrosine kinases. Figure 5.6 depicts two examples of 
the distance between a protein tyrosine kinase and an ANC ligand; for A. C3G in the catalytic 
site of ABL1 and B. D3G in the catalytic site of VEGFR2. C3G in ABl1 was chosen as an 




8.5 kcal/mol); D3G to VEGFR2 was the second lowest of the remaining tyrosine kinases (-
7.6 kcal/mol). 
5.4.7 Biochemical inhibition of EGFR by ANC 
The two pure ANC, C3G and D3G, and positive controls, EGCG and SB202190, showed a dose-
dependent inhibition of EGFR (Figure 5.7). Based on the docking analysis, C3G and D3G had 
the highest inhibition potential with the most negative free energy of binding for the natural 
compounds (-6.9 kcal/mol). However, C3G had a significantly lower IC50 (C3G: 0.10 µM; D3G: 
2.37 µM) based on biochemical assay. P3G was tested but did not have any effect on the EGFR 
inhibition. The docking analysis, ranking and effectiveness, differed somewhat with the 
biochemical assay as it was expected that D3G and C3G would be more similar in inhibition and 
both would be more potent than EGCG, while P3G was expected to at least have some 
inhibition. Although docking analysis is valuable in predicting inhibition, it is a simulation that 
provides potential interactions and the biochemical assay will more concretely show inhibition of 
tyrosine kinases by the natural compounds. Meiers et al. (2001) tested inhibition of 
anthocyanidins, cyanidin and delphinidin, as well as EGCG, on EGFR isolated from A431 
human vulva carcinoma cells, and it was seen that cyanidin and EGCG were the most potent; 
delphinidin still had a dose-dependent inhibition. In the present study, ANC were used, not 
anthocyanidins, but a similar potency trend to the Meiers et al. (2001) study was demonstrated. 
This is important because it shows that the sugar does not hinder or largely change the EGFR 
inhibition ability of the ANC, which is how it typically exists naturally in foods. 
Through this present study, it was discovered that phenolic-rich extracts could possibly reduce 
the proliferation through the modulation of the pathways of apoptosis and cell cycle in CRC 




angiogenesis through tyrosine kinase inhibition based on biochemical assays and in silico 
docking analysis. This study contributes to the mechanistic understanding of phenolics, including 
ANC, on CRC growth and progression; specifically, highlighting the importance of D3G 
concentration on anti-proliferation in vitro and C3G on tyrosine kinase inhibition in silico and 
biochemically. In addition, finding a strong correlation with total phenolic, condensed tannin, 
and D3G concentration and colon cancer cell inhibition is important as it provides chemical 
composition indicators of cancer cell inhibition potential.  Figure 5.8 summarizes the pathways 
analyzed in this study, highlighting where phenolic-rich extracts, or pure ANC, had an effect on 
proteins related to cell proliferation (such as survivin, HSP70, and BCL-2) and potentially 
angiogenesis (EGFR) based on quantitative results from the apoptosis protein array and EGFR 
biochemical assay. 
5.5 Conclusions 
Black lentil, sorghum, and red grape extracts exhibited the highest cell viability inhibition of 
both HT-29 and HCT 116 human colon cancer cells. All three plant extracts increased the 
percentage of apoptotic cells relative to untreated cells in HT-29 and HCT 116 cells. 
Downregulations of apoptotic proteins, such as cIAP2, livin, survivin, and XIAP, were seen in 
HCT 116 cells. Therefore, it is possible that these extracts are inhibiting the growth of the colon 
cancer cells by way of apoptosis induction. Also, sorghum and black lentil extracts significantly 
arrested HT-29 cells in G1 compared to untreated cells, so there may be influence by the 
phenolic-rich extracts on cell cycle progression. There were strong correlations between total 
phenolics and condensed tannins with percentage of inhibition of colon cancer cells in both 
human cell lines. This indicates that the overall category of phenolics is important to colon 




tannins, may contribute more to the inhibition potential than others, such as ANC. Although, 
there was not a strong correlation with inhibition and ANC, in HT-29 cells, there was a strong 
correlation between hue angle (negative) and concentration of D3G (positive) with the 
percentage of inhibition. The lower hue angle indicating more reddish color which is 
representative of ANC and D3G highlighted as a specific ANC that may contribute to the 
inhibition potential of the extracts. Predictive molecular docking with ANC found in the plant 
extracts demonstrated tyrosine kinase inhibition potential, especially by C3G and D3G. The most 
effective free energy of binding was predicted with C3G and ABl1. A correlation was observed 
between D3G concentration and cell inhibition potential but not with C3G; however, C3G was 
the most potent flavonoid on EGFR kinase inhibition when tested in a biochemical assay. Based 
on this study, it may be that different ANC interact with different pathways that affect 
progression of colon cancer. To our knowledge, this is the first report comparing the chemical 
composition of ANC-containing extracts from fruits, vegetables, legumes, and cereals and 
correlating their inhibition of both early and advanced stage human colon cancer cells. In 
addition, the inhibition potential of tyrosine kinases, which are key in colon cancer progression, 
was demonstrated by all six of the most abundant ANC in plants. 
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FIGURES AND TABLES 
Table 5.1 Chemical composition of and human colon cancer cell Inhibition by plant extracts. Total phenolic, anthocyanin (ANC), and 
condensed tannin concentrations and cell inhibition percentages for HT-29, HCT 116, and CCD-33Co cells at one concentration for all 
eleven plant extracts (only three extracts for CCD-33Co). Concentrations of 50% viability inhibition (IC50) for the three most potent 
extracts on colon cancer cell inhibition. In bold are the highest three concentrations for each chemical criterion and percentages of 





GAE/ g dry 
extract) 
Total ANC 
(mg C3GE/ g 
dry extract) 
Total condensed 
tannins (mg CE/ 
g dry extract) 
Percent 
inhibition of 




HT-29 at 2.5 
mg/mL 
Percent inhibition 
of CCD33Co at 
2.5 mg/mL 
IC50 HCT 





Black rice 382.3 ± 13.2
a
 287.5 ± 21.7
a
 76.3 ± 61.5
d
  29.1 ± 8.7
bcd
 16.9 ± 10.4
bc
 - - - 
Black lentil 295.8 ± 13.6
b
 57.6 ± 3.8
e
 760.8 ± 33.8
b
 62.2 ± 3.5
a
 87.5 ± 8.5
a
 30.0 ± 1.9
a
 0.9 ± 0.1
c
 1.4 ± 0.1
b
 
Purple grape 270.9 ± 4.0
c
 77.8 ± 3.5
d
 457.1 ± 78.3
c
 18.8 ± 14.4
cde











 119.9 ± 5.4
c
 7.5 ± 7.5
d
 10.1 ± 6.7
def





Red grape 266.2 ± 5.0
c
 157.5 ± 1.4
b
 167.2 ± 19.1
d
 35.2 ± 11.7
bc




 1.5 ± 0.1
a
 2.0 ± 0.2
a
 
Sorghum 225.7 ± 10.0
d
 0.0 ± 0.3
f
 883.5 ± 22.5
ab
 52.9 ± 19.0
ab
 84.3 ± 5.7
a
 38.9 ± 2.5
a
 1.0 ± 0.1
b
 1.7 ± 0.1
b
 
Black bean 187.0 ± 10.5
e
 81.5 ± 2.5
d
 385.7 ± 42.7
c
 0.7 ± 8.9
efg
 41.6 ± 8.1
b
 - - - 
Purple carrot 177.5 ± 1.9
ef
 57.7 ± 0.4
e
 45.9 ± 31.5
d
 11.9 ± 7.8
cdef
 -9.0 ± 13.4
cd
 - - - 
Purple bean 167.8 ± 2.3
f
 6.6 ± 0.1
f
 998.9 ± 61.6
a
 14.4 ± 8.3
cde
 26.6 ± 5.1
b
 - - - 
Black peanut 87.4 ± 2.9
g
 9.6 ± 0.0
f
 41.0 ± 15.7
d
 -10.0 ± 12.1
g
 -20.2 ± 23.4
d
 - - - 
Blue wheat 47.4 ± 1.5
h
 4.1 ± 0.4
f
 9.3 ± 9.3
d
 -13.3 ± 24.2
fg
 -25.5 ± 24.9
d
 - - - 








Letters represent significant differences among extracts per chemical criterion by Tukey test p < 0.05. GAE: gallic acid equivalent; C3GE: cyandin-3-O-glucoside equivalent; 





Figure 5.1 HPLC profiles of A. Black lentil extract at 520 nm, B. Black lentil at 280 nm, C. Sorghum extract at 520 nm, D. Sorghum 
extract at 280 nm, E. Red grape extract at 520 nm, and F. Red grape extract at 280 nm. Peak identifications are suggested based on 






Figure 5.2 HPLC profiles at 520 nm for A. black rice, B. blue wheat, C. black peanut, D. black bean, E. purple bean, F. purple carrot, 
G. purple sweet potato, and H. purple grape. Peak identification was based on standards available and identified based on retention 





Table 5.2 Plant extract color analysis. Color squares of the eleven plant extracts with their respective saturation, chroma, and hue 
angle measurement from tintometer readings. 
 





Figure 5.3 A. Flow cytometry apoptosis representative images after 24 h of each of the extract treatments on HT-29 cells. B. For HT-
29 and HCT 116 cells, percent of total apoptotic cells (pre-apoptotic and apoptotic from quadrants two and four combined) per 
treatment: untreated cells (UNT), black lentil (BL), sorghum (SH), red grape (RG), and oxaliplatin (OX). Letters indicate statistical 
difference among treatments through Tukey test (p < 0.05). C. Comparison of apoptotic protein expression (%) among BL, SH, and 
RG and the untreated control in HCT 116 cells. Letters indicate statistical difference among treatments through Tukey test (p < 0.05); 






Figure 5.4 Flow cytometry cell cycle analysis after 24 h of treatment of HT-29 cells. Images represent an example of the response of 
each treatment on HT-29 cells. Percentages in each cell cycle phase (G1, S, and G2) are represented in the bar chart for untreated cells 
(UNT), black lentil (BL), sorghum (SH), red grape (RG), and oxaliplatin (OX). Statistical difference among treatments is represented 





Figure 5.5 Correlation charts with total phenolics, condensed tannins, hue angle, and concentration of delphinidin-3-O-glucoside vs 
HT-29 inhibition. R values for both HT-29 and HCT 116 inhibition vs each chemical criterion are shown. ANC: anthocyanin; GAE: 





Figure 5.6 Molecular docking analysis of four tyrosine kinases with the six most common anthocyanins 
and tyrosine kinase inhibitor drugs and epigallocatechin gallate as controls. Estimated free energy of 
binding is given for all ligands. Hydrophobic interactions are given for the three most effective ligands for 
each tyrosine kinase. Bolded amino acid residues are those that are in common between the drug and 
anthocyanin. Images of the distance between protein tyrosine kinase and anthocyanin ligand for A. 
Cyanidin-3-O-glucoside in the catalytic site of Abelson proto-oncogene 1 (ABL1) and B. Delphinidin-3-





Fig. 5.6 cont. C3G, cyanidin-3-O-glucoside; D3G, delphinidin-3-O-glucoside; EGCG, (-)-
epigallocatechin gallate; EGFR, epidermal growth factor receptor; M3G, malvidin-3-O-glucoside; P3G, 
peonidin-3-O-glucoside; Pr3G, pelargonidin-3-O-glucoside; Pt3G, petunidin-3-O-glucoside; tyrosine 







Pure compound IC50 (µM) 
Cyanidin-3-O-glucoside 0.10 ± 0.05
a
 
Epigallocatechin gallate 0.71 ± 0.38
a
 
SB 202190 2.34 ± 0.20
b
 




Figure 5.7 Kinetic analysis of cyanidin-3-O-glucoside and delphinidin-3-O-glucoside, and 
positive controls, epigallocatechin gallate and SB 202190. Inhibition curves and the 
concentrations of 50% inhibition (IC50) are shown for each compound. Statistical difference 





Figure 5.8 Highlighted aspects of apoptosis, cell survival, and angiogenesis pathways indicating which proteins involved were 
inhibited in this study by the plant extracts or pure anthocyanins as seen with biochemical assays (in silico predictions not shown). 
Red proteins are tyrosine kinases or their ligands, blue are pro-survival proteins, green are pro-apoptotic proteins, and grey objects 
represent pathway outcomes. Solid lines indicate direct effects and dotted indicate indirect effects and that additional steps occur in 
between. Arrows are promoters and bar-headed lines are inhibitors. SH, sorghum; RG, red grape; BL, black lentil; C3G, cyanidin-3-O-
glucoside; D3G, delphinidin-3-O-glucoside; VEGF, vascular endothelial growth factor; VEGFR2, vascular endothelial growth factor 
receptor 2; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; ANGPT 1/2, angiopoietin 1 and 2; TIE-2, 
tyrosine kinase with Ig and EGF homology domain 2; BCL-2, B-cell leukemia/lymphoma-2; BAX, B-cell leukemia/lymphoma-2 
associated X protein; Cyt C, cytochrome C; IAP, inhibitor of apoptosis; XIAP, X chromosome-linked inhibitor of apoptosis; cIAP2, 
cellular inhibitor of apoptosis 2; PI3K, phosphatidylinositol-3-kinase; AKT, protein kinase B; HSP 70 and 27, heat shock protein 70 




CHAPTER 6: ANTHOCYANINS, DELPHINIDIN-3-O-GLUCOSIDE AND CYANIDIN-3-
O-GLUCOSIDE, INHIBIT IMMUNE CHECKPOINTS IN HUMAN COLORECTAL 
CANCER CELLS IN VITRO AND IN SILICO 
6.1 Abstract  
The objective was to assess the anti-progression and stimulatory immune response among 
anthocyanins and their metabolites on human colorectal cancer cells in vitro and in silico.   
Pure phenolics including delphinidin-3-O-glucoside and its metabolites, delphinidin (DC) and 
gallic acid (GA), were tested alone or in combination, on HCT 116 and HT-29 human colorectal 
cancer cells (100-600 µg/mL). HCT 116 and HT-29 50% inhibition concentrations (µg/mL) were 
396±23 and 329±17 for D3G; 242±16 and >600 for DC; and 154±5 and 81±5 for GA, 
respectively. Using molecular docking, cyanidin-3-O-glucoside (C3G) showed the highest 
potential to inhibit immune checkpoints: programmed cell death protein-1 (PD-1) (-6.8 kcal/mol) 
and programmed death-ligand-1 (PD-L1) (-9.6 kcal/mol). C3G, D3G, DC, GA, and D3G-rich 
extracts decreased PD-L1 protein expression in HCT 116 cells. C3G, D3G, and DC decreased 
PD-L1 fluorescence intensity by 39%, 30%, and 27%, respectively. Anthocyanins decreased PD-
1 expression in peripheral blood mononuclear cells in monoculture by 41% and 55%, and co-
culture with HCT-116 and HT-29 cells by 39% and 26% (C3G) and 50% and 51% (D3G), 
respectively. D3G and C3G, abundant in plant foods, showed potential for binding with and 
inhibiting immune checkpoints, PD-1 and PD-L1, which can activate immune response in the 
tumor microenvironment and induce cancer cell death.   
 
This chapter is part of the submitted manuscript to Scientific Reports: Mazewski, C., 
Kim, S., & de Mejia, E.G. (2019).Anthocyanins, delphinidin-3-O-glucoside and 
cyandidin-3-O-glucoside, inhibit immune checkpoints in human colorectal cancer cells in 





In the United States, colorectal cancer deaths in 2018 were estimated at 50,630 (National 
Institutes of Health, 2019). Currently, regional and distant stages represent 35% and 21% of the 
total colorectal cancer cases, and five-year survival rates are 71.1% and 13.8%, respectively, 
emphasizing the impact of metastasis on survival (National Institutes of Health, 2019). Three 
categories of drug therapies are used for metastatic colorectal cancer treatment: chemotherapy, 
targeted therapy, and immunotherapy. Chemotherapy drugs target highly proliferating cells while 
approved targeted therapies aim to inhibit proteins in the angiogenesis pathway, such as vascular 
endothelial growth factor (VEGF) (PDQ Adult Treatment Editorial Board, 2002). More recently, 
VEGF has been shown, in addition to its proangiogenic effects, to hinder immune function in the 
tumor microenvironment by impacting infiltration of T cells (Chen & Mellman, 2017; Y.-L. Li, 
Zhao, & Ren, 2016).   
Immunotherapy drugs are the newest addition to combat colorectal cancer. In 2017, the first two 
immunotherapies (nivolumab and pembrolizumab) that target programmed cell death protein 1 
(PD-1) were approved by the FDA for colorectal cancer with microsatellite instability-high or 
deficient mismatch repair solid tumors (Lynch & Murphy, 2016). Microsatellites are short 
repeated sequences in the genome, and microsatellite instability indicates a disruption in the 
mismatch repair system and greatly increased mutations (Boland & Goel, 2010). PD-1 is  part of 
a group of immune checkpoints, which are negative regulators of the immune system and are 
targeted in immunotherapy to help activate T cell response against tumors (Lynch & Murphy, 
2016). Other immune checkpoints, including programmed death-ligand 1 (PD-L1), the ligand for 
PD-1, and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), are also being targeted for 




overexpressed in tumor cells, contributing to the tumor cells’ ability to avoid immune 
destruction; when it binds to PD-1 on T cells, they are deactivated and unable to destroy the 
cancer cells (Passardi et al., 2017). In July of 2018, a combination treatment of nivolumab and 
ipilimumab, a CTLA-4 inhibitor, was approved by the FDA (National Cancer Institute, 2018). 
More successful therapies and the use of combination therapies are needed to enhance the highly 
complex mechanisms of the immune system in the tumor microenvironment (Chen & Mellman, 
2017; Mckee, Macleod, Kappler, & Marrack, 2010). 
A diet high in non-starchy vegetables, fruits, and whole grains is recommended for decreasing 
the risk of developing colorectal cancer (American Institute for Cancer Research, 2018). 
Anthocyanins (ANC) are phenolic compounds and natural pigments that provide blue, purple, or 
red color to fruits, vegetables, cereals, and legumes. ANC have been shown to have anti-
carcinogenic properties including an impact on autophagy regulation in tumor development 
(Moosavi et al., 2018; Choe et al., 2012; Mazewski & De Mejia, 2018; Wang & Stoner, 2008). 
ANC metabolites, including phenolic acids, have been shown to reach the colon during in vivo 
studies on bioavailability (Fernandes, Faria, Calhau, de Freitas, & Mateus, 2014). Assessment of 
ANC and immune response related to carcinogenesis has not been well examined. ANC from 
black rice promoted an immune response by increasing T cell and macrophage populations in a 
leukemia in vivo model (Fan et al., 2017). In vitro and in silico analyses of compounds present in 
ANC-rich extracts can provide more information on their mechanisms of action as it applies to 
the immune response in the tumor microenvironment.  
Our previous studies with colorectal cancer and ANC-rich extracts have shown the potential for 
such extracts to inhibit colorectal cancer cell growth in vitro, with effects on markers of 




However, in the present study we focused on pure ANC and their metabolites and extensively 
evaluate their effects on immune checkpoints. The objective of this research was to compare the 
anti-progression and stimulatory immune effects among ANC and their metabolites on human 
colorectal cancer cell lines, HCT-116 and HT-29.  We employed a co-culture set-up in addition 
to the monoculture analyses to test ANC in a more representative model of the tumor 
microenvironment. Our findings support the potential for ANC to inhibit immune-suppressing 
markers, providing a basis for additional studies on the impact of other plant phenolics on 
immune response.  
6.3 Materials and methods 
6.3.1 Materials 
Human colorectal cancer cells, HCT 116 and HT-29, were purchased from the American Type 
Culture Collection (Manassas, Virginia) and human peripheral blood mononuclear cells (PBMC) 
from BioIVT (Hicksville, New York). The CellTiter 96
®
 AQueous One Solution Cell 
Proliferation Assay was purchased from Promega Corporation (Madison, WI) and the Pierce 
LDH Cytotoxicity Assay Kit from ThermoFisher Scientific (Waltham, MA). D3G, cyanidin-3-
O-glucoside (C3G), malvidin-3- O-glucoside (M3G), delphinidin chloride (DC), procyanidin B1 
(PB1), naringenin-7-O-glucoside, eriodictyol-7-O-glucoside, and quercetin-3- glucuronide 
(Q3G) all with > 95% purity were purchased from ExtraSynthese (France). Red grape extract 
(RGE) was obtained from San Joaquin Valley Concentrates (Fresno, CA) and the black lentil 
extract (BLE) from the Kraft Heinz Company (Chicago, IL); both extracts were further purified 
as described in our previous publication ( Mazewski et al., 2018). Primary antibodies 
programmed cell death ligand-1 (1C10) (sc-293425), VEGF (F-5) (sc-365578), and GAPDH (sc-




Biotechnology (Santa Cruz, CA). Secondary antibody, anti-mouse IgG horseradish peroxidase 
conjugated, was obtained from GE Healthcare (Buckinghamshire, UK). Anti-PD-L1 antibody 
[EPR19759] (ab213524) was purchased from Abcam (Cambridge, UK). Atezolizumab and 
pembrolizumab were bought from BioVision, Inc. (Milpitas, CA). DC™ protein assay materials 
were obtained from Bio-Rad (Hercules, CA). All other chemicals used in this study were 
purchased from Sigma- Aldrich (St. Louis, MO) unless otherwise stated. 
6.3.2 Cell culture 
HCT 116 and HT-29 cells were cultured in Minimum Essential Medium Eagle and PBMC in 
Roswell Park Memorial Institute (RPMI) medium both with 10% FBS, 1% 
penicillin/streptomycin, and 1% sodium pyruvate at 37 ˚C in 5% CO2 and 95% air. When HCT 
116 cells were co-cultured with PBMC they were grown in RPMI medium. As microsatellite 
stability is important in the treatment of colorectal cancer, one cell line with a microsatellite 
instable phenotype (HCT 116) and another cell line with chromosomal instability (HT-29) were 
selected to allow for comparison of immune response effects (Ahmed et al., 2013).  
6.3.3 HCT 116 and HT-29 cell viability with phenolics  
The CellTiter 96® AQueous One Solution Cell Proliferation Assay was used to determine the 
most potent of the pure phenolics and the concentration of 50% inhibition (IC50 ) values for the 
ANC and metabolites on the HCT 116 cells based on the method described in our previous 
publication ( Mazewski et al., 2017). Pure phenolics alone or in combinations were added up to 
600 µg/mL and incubated for 24 h. Ratios (percentages) for the phenolic combinations were 
based on the three main phenolics discovered in three extracts previously found to be potent at 
colorectal cancer cell inhibition: D3G, M3G, and Q3G (57:33:10) representing red grape; PB1, 




O-glucoside (40:34:26) for sorghum (Mazewski et al., 2018). Because cyanidin is the most 
ubiquitous anthocyanidin in fruits and vegetables and C3G was present in at least small amounts 
in all of the extracts tested in our previous study, it was tested individually, as well (Khoo, 
Azlan, Tang, & Lim, 2017). Some of the phenolics tested in the combinations are not water-
soluble (Q3G, eriodictyol 7-O-glucoside, naringenin 7-O-glucoside) and had to be dissolved in 
DMSO, so they were not tested individually. A maximum of 0.5% DMSO was used on the cells, 
and an untreated control at the same percentage was always used for comparison. Additionally, 
two metabolites of D3G were tested: DC and gallic acid (GA). These were identified as 
metabolites based on the literature (Stalmach, Edwards, Wightman, & Crozier, 2013; Xie et al., 
2016).  
6.3.4 Interaction analysis of delphinidin-3-O-glucoside and anthocyanin-rich extracts with 
oxaliplatin 
Oxaliplatin is a commonly used chemotherapy drug for colorectal cancer, so it is important to 
learn about potential chemical interactions. Isobolograms were utilized to analyze the effect of 
ANC-rich extracts, BLE and RGE, and D3G on oxaliplatin inhibition. To determine if there was 
an antagonistic, additive, or synergistic effect, extracts were tested in combination with 
oxaliplatin. IC50 values were utilized: BLE (1.2 mg/mL), RGE (1.4 mg/mL), D3G (395.8 
μg/mL), and oxaliplatin (13.5 μg/mL). Extract (or D3G) were combined with oxaliplatin in a 1:1 
ratio of the IC50 concentrations as the highest concentration and step-wise dilutions were tested 
to determine the IC50 of the combination. Then, using the expected and observed IC50, the type of 
effect the extracts and D3G had on oxaliplatin inhibition effectiveness was determined based on 
the calculated V values (Timbrell, 2008).  




HPLC analysis at 520 and 280 nm of the pure ANC (D3G, C3G, and M3G) was performed in 
duplicate with pure compounds before application to the cells and in the media following 24 h 
treatment on HCT 116 cells. A Hitachi HPLC System (Hitachi High Technologies America, Inc., 
Schaumburg, IL) equipped with a multi-wavelength detector L-7100 pump was utilized with a 
Prevail C18 column (5 µm, 250 × 4.6 mm, Columbia, MD) (Li, Somavat, Singh, Chatham, & de 
Mejia, 2017). 
A Hunter Lab LabScan II (Hunter Associates Laboratory, Inc., Reston, VA) was used to analyze 
color parameters: L*, a*, and b using CIELAB 10˚/D65 for D3G, C3G, and M3G in the media 
before and after being applied to HCT 116 cells for 24 h in the incubator at 37˚C and 5% CO2. 
This was to confirm the visual color changes seen and offer quantitative data for each ANC 
treatment. The initial color was compared to the final color of the media that was collected 24 h 
after treatment on the cells. Calculations were made as described previously (Mojica, Berhow, & 
de Mejia, 2017).  
6.3.6 Evaluation of apoptosis induction by delphinidin-3-O-glucoside and its metabolites using 
flow cytometry 
Since the pure compounds tested were more effective on HCT 116 cells, apoptosis induction was 
determined for these cells. For apoptosis measurement, HCT 116 cells were seeded at 3x10
5
 cells 
per well in a six-well plate as described before (Mazewski et al., 2017). After 24 h, they were 
treated with D3G, DC, GA, red grape combination (RGC; D3G, M3G, and Q3G (57:33:10), and 
oxaliplatin for 24 h at the IC50 determined values (ranging from 13.5-395.8 µg/mL). A BD LSR 
II Flow Cytometry Analyzer (BD Biosciences, San Jose, CA) was used to evaluate the state of 





6.3.7 Immune response analysis 
6.3.7.1 Co-culture with PBMC and HCT 116 cells 
Day one PBMC were seeded in a 24-well plate at 0.5-1x10
6 
cells per mL untreated or with 
treatments for 48 h: C3G or D3G at 100 μM or pembrolizumab at 1 μg/mL. The concentration of 
100 μM was used after a pretest (data not shown) showed it had the highest induced cancer cell 
inhibition even with higher concentrations tested in pretreatment with the PBMC. HCT 116 cells 
were seeded at 1x10
4
 cells per well in a 96 well plate on day two. Day three PBMC from each 
treatment or untreated cells were centrifuged at 200 g for 15 min. Regular media was added to 
bring to 1x10
6 
cells per mL so that when adding 200 μL to each 96 well of HCT 116 cells, there 
would be a 10:1 PBMC to HCT 116 cell ratio. After 24 h, viability was determined using a 
Pierce LDH Cytotoxicity Assay Kit. A visual summary of the method is shown in Figure 6.1. 
6.3.7.2 Effect of pure phenolics and D3G-rich plant extracts on VEGF and PD-L1 protein 
expression 
Western blots for VEGF and PD-L1 were run using a protocol based on that used by Dia and 
Gonzalez de Mejia (2011). The PD-L1 antibody is a mouse monoclonal IgG2b raised against 
amino acids 18-238 which represents the partial length of human PD-L1. Briefly, HCT 116 and 
HT-29 cells were seeded in a six-well plate at 3x10
5
 cells per well for 24 h. Then, cells were 
either left untreated or treated with pure phenolics or the D3G-rich plant extracts (BLE or RGE) 
at their IC50. After another 24 h, cell lysates were obtained to be used in the SDS-PAGE 
electrophoresis.  
6.3.7.3 PD-L1 analysis through ELISA  
Human PD-L1 ELISA kit (Abcam ab214565) was used to analyze the effect of the phenolics and 




rabbit monoclonal with an immunogen of a recombinant full-length protein of human PD-L1 
containing the extracellular domain (Phe19-Thr239). The manufacturer’s instructions were 
followed. Briefly, HCT 116 and HT-29 cells were seeded in a six-well plate at 4x10
5
 cells per 
well for 24 h. Then, cells were left untreated or treated with pure phenolics (D3G, DC, GA, and 
RGC) or plant extracts (BLE and RGE) at their IC50 values. C3G was tested at the same 
concentration as D3G since it did not have high enough inhibition to have an IC50 value. 
Atezolizumab, a PD-L1 inhibitor drug, was used as a positive control at 1 μg/mL as suggested by 
the manufacturer; ELISA was the only method in which atezolizumab was recommended to be 
used because of the non-denatured conditions. After another 24 h, cell lysates were obtained by 
following the Abcam protocol for adherent cells. PD-L1 calculations for samples were based on 
the standard curve and translated to pg of PD-L1 per μg of protein based on their protein 
concentration.  
6.3.7.4 PD-1 analysis through ELISA in peripheral blood mononuclear cells 
Human PD-1 ELISA kit (Invitrogen BMS2214) was used to analyze the effect of C3G and D3G 
on PD-1 in PBMC in a monoculture and co-culture with HCT 116 cells. PBMC were seeded in a 
24-well plate 0.5-2x10
6 
cells per mL for 24 h either untreated or treated with C3G or D3G (100 
μM). Pembrolizumab, a PD-1 inhibitor drug, was used as a positive control at 1 μg/mL as 
suggested by the manufacturer. After 48 h, the cell culture supernatant was collected post-
centrifugation (200 g for 15 min). The media was then centrifuged at 14,000 rpm for 10 min at 
4°C and supernatant was collected. To analyze in co-culture with HCT 116 and HT-29 cells, at 
the step where media was collected post-centrifugation, media was also added to the cell pellet to 
be added at a 10:1 ratio of PBMC to colorectal cancer cells in a 96-well plate. After 24 h of co-




The DC™ protein assay was used to determine the concentration of protein for all supernatants. 
For the ELISA, the manufacturer’s instructions were followed. PD-1 calculations for samples 
were based on the standard curve and translated to pg of PD-1 per μg of protein.  
6.3.7.5 PD-L1 analysis through confocal microscopy  
Due to higher expression of PD-L1 in HCT 116 cells, further analysis with confocal microscopy 
was tested in these cells. The PD-L1 antibody was a rabbit monoclonal with an immunogen of a 
synthetic peptide within amino acids 250 to the C-terminus of human PD-L1. HCT 116 cells 
were seeded on 8-well immunofluorescence and high-end microscopy slide at 1.5x10
4
 cells per 
well. After 24 h, pure compounds were added, with one untreated well; for D3G and DC, the 
IC50 concentrations were used, and C3G was used at the same concentration as D3G. Following 
24 h, cells were washed with PBS and fixed in 4% paraformaldehyde for 30 min. They were 
permeated with 0.5% Triton X100 after PBS washes for 15 min. Then they were incubated in 
cold methanol for 15 min at -20°C and then for 30 min in PBS at room temperature. After 30 
min in ITsignal FX, the primary PD-L1 antibody was added at a 1:50 dilution and left overnight 
at 37°C. The next day, cells were washed and incubated for 3 h in the secondary antibody at a 
1:200 dilution. Cells were washed and drained before adding Prolong Gold. After 24 h in the 
dark, slides were kept at 4°C until analyzed using a Zeiss LSM 880 laser-scanning confocal 
microscope at the Carl R. Woese Institute for Genomic Biology at the University of Illinois.  At 
least three sections of a well and at least five cells within each section were used to quantify the 
expression of PD-L1. 
6.3.7.6 In silico studies of phenolics and immune response related proteins 
In silico analysis was utilized to screen the potential for phenolic compounds to inhibit immune 




(5FV1) were obtained from Protein Data Bank. Phenolic structures were downloaded from the 
PubChem Compound database (National Center for Biotechnology Information, Bethesda, MD): 
C3G (CID: 44256715), PB1 (CID: 11250133), D3G (CID: 443650), M3G (CID: 44257034), DC 
(CID: 68245), and GA (CID: 370).  Water molecules and ligands that accompanied the protein 
structures were removed in BIOVIA Discover Studio Client 2016. The protein structures were 
then uploaded to AutoDock Tool where partial Gasteiger charges were automatically 
implemented and the search space was configured to be a cube with sides measuring 20 
angstroms centered on the protein binding sites for each drug and respective ligand. Two sites 
were tested for each protein with each phenolic ligand: PD-1 at the nivolumab and PD-L1 
binding sites; PD-L1 at the atezolizumab and 8J8 small molecule inhibitor site; and VEGF at the 
VEGFR1 and VEGFR2 binding sites. The search space for the PD-1/PD-L1 binding site was 
centered to be near VAL64, ILE124, and LEU128 on PD-1.(Zak et al., 2015) VEGF binding 
sites to its receptors were estimated to be near ASP63, GLU64, and GLU67 for VEGFR1, and 
near ARG82, LYS84, and HIS86 for VEGFR2.(Walsh & Grant, 1997) A related small molecule 
inhibitor of each protein was used as a comparison. The small molecule 8YZ accompanied by 
5NIU was used for PD-1 and PD-L1 sites. For the 8J8 site on PD-L1, the 8J8 molecule that 
accompanied the 5N2D structure was selected. The control chosen for VEGF at VEGFR1 was 
vatalanib, obtained from PubChem (CID: 151194). Using MarvinSketch, a structure of PTC-858, 
a reported VEGF inhibitor, was replicated from ChemSpider (CID: 4501829).(Cao et al., 2016) 
Protein structures were transferred to AutoDock Tools as rigid molecules. Each phenolic and 
small molecule inhibitor was also uploaded to AutoDock Tools as a ligand and their number of 
flexible bonds was reduced to half their maximum torsions. After these alterations, all molecules 




AutoDock Vina was analyzed in BIOVIA Discovery Studio 2016 Client to determine the nature 
of each docking interaction and 3D configuration. 
6.3.8 Statistical analysis 
Statistical analyses were conducted using one-way ANOVA to compare experimental to control 
values with JMP version 8.0. Comparisons between groups for viability and apoptosis were 
performed using the Tukey- Kramer test; differences were considered significant at p < 0.05. For 
western blots and confocal microscopy, comparisons between the untreated control and 
treatments were performed using Student’s test; differences were considered significant at p < 
0.05. At least two independent experiments run with at least duplicate data points were 
performed for every study.  
6.4 Results 
6.4.1 HCT 116 and HT-29 cell viability inhibition by delphinidin-3-O-glucoside and its 
metabolites 
Of the three ANC (D3G, C3G, and M3G) and PB1 tested on HCT 116 cells, only D3G showed a 
dose-response inhibitory effect with an IC50 at 395.8 μg/mL. Figure 6.2 shows the inhibition 
curves, IC50’s, and inhibition at 400 μg/mL of the pure phenolics for comparison. Both of the 
D3G metabolites tested, DC and GA, inhibited HCT 116 cells with IC50 of 242.4 and 154.2 
μg/mL for DC and GA, respectively (Figure 6.2A-C). For the phenolic combinations (Figure 
6.2D-E), pure compounds from red grape had the highest potency with an IC50 at 394.3 μg/mL, 
not statistically different from D3G alone at 395.8 μg/mL (p > 0.05). Since the RGC was the 
most potent, it was also tested on HT-29 cells and had an IC50 of 589.9 μg/mL, statistically 
higher (p < 0.05) than that for HCT 116 cells. D3G and GA had IC50 for HT-29 cells of 329.1 




The IC50 for D3G on HT-29 cells was not statistically different from its IC50 for HCT 116 cells 
(p > 0.05).  
6.4.2 Black lentil and red grape extracts had an additive effect on oxaliplatin inhibition of HCT 
116 cells, but delphinidin-3-O-glucoside had a slightly antagonistic effect  
Figure 6.3 shows that both BLE and RGE had an additive effect with oxaliplatin. The V values 
were 0.84 and 0.90 for BLE and RGE respectively, putting them in the additive range (0.7-1.3) 
(Timbrell, 2008). However, D3G had a V value of 0.61, which just put it in the antagonistic 
range (V < 0.7).  
6.4.3 Transformation of anthocyanins that inhibited cell viability after incubation with HCT 116 
cells 
When performing the cell viability tests with ANC, notable color changes in the culture media 
occurred after 24 h of treatment on HCT 116 cells as shown in Figure 6.4. D3G had a more 
drastic color change (Figure 6.4A), while C3G and M3G (Figure 6.4B and C) had dulling of 
the color, but the media appeared to better retain its hue angle. Figure 6.4 shows that D3G is no 
longer present (at 520 nm) in media, after the 24 h treatment on the cells. However, for C3G and 
M3G the major peak remains after 24 h treatment, although at lower peak intensity. Colorimeter 
tests in Table 6.1 show a similar decrease in saturation, dulling of the color, for all three ANC 
but a larger change in L*, a*, and b* parameters for D3G.  
6.4.4 Delphinidin-3-O-glucoside and its metabolites induced apoptosis in HCT 116 cells 
Figure 6.5 shows the results of apoptosis induction by D3G, its metabolites (DC and GA), and 
the pure compound combination RGC, in comparison to untreated cells. There was a significant 




apoptotic cells (41.5%), followed by DC (27.9%) and D3G (25.8%). The increase of apoptotic 
cells caused by RGC was not statistically higher than the untreated DMSO control (p > 0.05).  
6.4.5 Cyanidin-3-O-glucoside treatment of peripheral blood mononuclear cells prior to co-
culture with HT-29 cells increased LDH activity 
Compared to the untreated HCT 116 monoculture, LDH activity increased for each co-culture of 
PBMC with HCT 116 cells by 53.3% for the untreated, 47.0% for the D3G pretreated, 49.5% for 
the C3G pretreated, and 74.5% for the pembrolizumab pretreated (p < 0.05). There was no 
statistical difference between the untreated PBMC and the pre-incubation of PBMC with C3G, 
D3G, or pembrolizumab. However, compared to the untreated HT-29 monoculture, LDH activity 
increased for each co-culture of PBMC with HT-29 cells by 51.1% for the untreated, 61.0% for 
the D3G pretreated, 93.8% for the C3G pretreated, and 118.0% for the pembrolizumab pretreated 
(p < 0.05). 
6.4.6 Delphinidin-3-O-glucoside, its metabolites, and D3G-rich plant extracts decreased 
expression of VEGF and PD-L1  
Figure 6.6 shows the western blot results for D3G, DC, GA, RGC, RGE, and BLE with VEGF 
for both HCT 116 and HT-29 cells. In HCT 116 cells (Figure 6.6A), all treatments decreased 
VEGF expression significantly compared to the untreated cells except BLE, with D3G 
decreasing the protein expression 57.2%. In HCT 116 cells, all treatments decreased the 
expression of PD-L1 compared to the untreated control, with RGC reducing the protein 
expression by 68.7%. C3G did not significantly decrease the PD-L1 expression with 20.7% 
inhibition compared to the untreated control (p > 0.05) (data not shown in the figure).  In HT-29 
cells (Figure 6.6B), all treatments reduced VEGF expression compared to the control, with RGE 




expression was too low in HT-29 cells to evaluate the effect of the treatments through western 
blots since well-developed bands could not be elucidated.  
6.4.7 Cyanidin-3-O-glucoside was the only non-pharmaceutical treatment to inhibit PD-L1 
expression through ELISA analysis 
In both HCT 116 and HT-29 cells, there were no significant inhibitions of PD-L1 by any of the 
D3G related pure compounds or extracts. However, C3G significantly inhibited PD-L1 in HCT 
116 cells at 39.5% (p < 0.05). Atezolizumab had high inhibition of PD-L1 in both cell lines: 
85.9% for HCT 116 and 79.1% for HT-29 cells compared to the untreated control cells. It was 
also shown that the expression of PD-L1 was much higher in pg per µg of total protein in HCT 
116 cells vs. HT-29 cells with 3.7 times the amount of PD-L1 protein in HCT 116 cells. Results 
are shown for D3G, C3G, and atezolizumab in Figure 6.6C. 
6.4.8 Cyanidin-3-O-glucoside and delphinidin-3-O-glucoside inhibit PD-1 through ELISA 
analysis in both monoculture and co-culture 
C3G and D3G decreased PD-1 expression in peripheral blood mononuclear cells in a 
monoculture by 41.0% and 54.8%, and in a co-culture with HCT 116 and HT-29 cells by 38.7% 
and 25.6%, and 49.5% and 51.0%, respectively, compared to the untreated control (p < 0.05) as 
show in Figure 6.6C.   
6.4.9 Delphinidin-3-O-glucoside, cyanidin-3-O-glucoside, and delphinidin chloride decreased 
fluorescence intensity and membrane localization of PD-L1 in HCT 116 cells 
Figure 6.7 shows examples of microscopy pictures from untreated HCT 116 cells and C3G, 
D3G, and DC treated cells revealing more intense fluorescence of PD-L1 in the untreated cells. 




respectively (p < 0.05). The pictures show the higher intensity of the PD-L1in the membrane for 
the untreated HCT 116 cells.  
6.4.10 Delphinidin-3-O-glucoside and cyanidin-3-O-glucoside show potential to inhibit VEGF 
and immune checkpoints in silico 
All tested phenolics (D3G, C3G, DC, M3G, GA, and PB1) were predicted to bind to immune 
checkpoints (PD-1 and PD-L1) and VEGF (Figure 6.8). For the drug binding sites of PD-1 and 
PD-L1, C3G and D3G (-5.9 kcal/mol) had the highest binding affinity. For PD-1 at the binding 
site of PD-L1, C3G and PB1 had a binding affinity of -6.8 and -6.1 kcal/mol, respectively. For 
PD-L1 at a small molecule inhibitor site, C3G and DC had the most negative predicted free 
energy of binding with -9.6 and -8.4 kcal/mol, respectively. For VEGF, C3G, PB1, and D3G had 
the highest binding affinity for both the VEGFR1 and VEGFR2 binding sites. Common 
interactions between C3G and the small molecule inhibitor for PD-L1 were a polar interaction 
with SER93 and a hydrophobic interaction with LEU50. D3G shared a polar interaction with 
GLN99 with the small molecule inhibitor for PD-1. The immune checkpoint CTLA4 was also 
modeled with the phenolics at the site of the drug ipilimumab (data not shown). D3G and C3G 
also had highest binding affinity of the phenolics, with -5.6 and -5.3 kcal/mol, respectively; GA 
had the lowest at -3.6 kcal/mol. The two-dimensional modeling pictures of the ANC ligands in 
the immune checkpoint proteins and VEGF are shown in Figure 6.8 and the three-dimensional 
pictures in Figure 6.9. There were several similar amino acid interactions not only among the 
phenolics but also among the phenolics and the small molecule inhibitor used as a comparison 
for each protein. These interactions are shown in Tables 6.2, 6.3, and 6.4 for PD-1, PD-L1, and 





Recent in vitro and in vivo studies have reported the inhibitory effects of ANC-rich extracts from 
a wide range of sources on proliferation and progression of colon cancer cells. However, little 
has been shown on ANC-rich extracts on the immune response in the tumor microenvironment 
(Choi et al., 2017; Fernández, García, Monte, Villar, & Lombó, 2018; Kubow et al., 2017; 
Venancio et al., 2017). Additionally, a lesser number of studies have analyzed the ability of pure 
ANC to inhibit colorectal cancer progression in vitro (Anwar et al., 2016; Jing et al., 2015). We 
discovered that the only ANC tested that was effective at colorectal cancer cell inhibition in HCT 
116 cells was D3G. Another study found that M3G was not effective, but metabolites, GA, 3-O-
methylgallic acid, and 2,4,6-trihydroxybenzaldehyde were successful inhibiting HCT 116 cells, 
as well as other colorectal cancer cells (Forester, Choy, Waterhouse, & Oteiza, 2014). In our 
study, we found that GA had a dose-dependent inhibition in both cell lines, HCT 116 and HT-29. 
It was expected that combining ANC and phenolics in ratios representative of phenolic-rich 
extracts would result in synergistic effects on the inhibition of HCT 116 cells. However, this was 
not seen in either cell line as determined by the RGC not being statistically better than D3G in 
HCT 116 cells; in HT-29 cells, D3G was significantly more effective than RGC. A study testing 
berry anthocyanidins (aglycones of ANC) on lung cancer cell inhibition found delphinidin as the 
only anthocyanidins that did not have a significantly higher inhibition with a mixture of 
phenolics compared to single anthocyanidin (Kausar et al., 2012). In the animal portion of the 
study, the mixture and delphinidin both exerted antitumor activity that was not statistically 
different. Delphinidin was the only anthocyanidin that was effective inhibiting the two lung 
cancer cell lines tested alone, similar to the trend in our study where D3G was the only effective 





It was demonstrated that the ANC-rich extracts did not negatively affect the ability of oxaliplatin 
to decrease colorectal cancer viability; however, D3G did have a slightly antagonistic effect. In a 
study looking at the effects of the phenolic compound quercetin on cisplatin (also in the 
platinum-containing family of drugs) in ovarian cancer models, it was concluded that quercetin 
had an antagonistic effect on cisplatin at low concentrations (N. Li et al., 2014). However, 
quercetin and its related glycoside, rutin, have been reported to decrease peripheral neuropathy, a 
common side effect of oxaliplatin treatment in mice that received biweekly injections of 
oxaliplatin (Azevedo et al., 2013).  
Significant color changes and lack of HPLC peak retention coincided with greater efficacy of 
D3G to inhibit HCT 116 viability in comparison to C3G and M3G. These observations led us to 
believe that cell uptake and transformation of D3G was occurring in the HCT 116 cells. 
Comparing the structure of C3G versus D3G, the difference is that D3G has an additional 
hydroxyl group on its B-ring. More hydroxyl groups have been connected to less stable pigment 
but also to higher antioxidant capacity which could explain a more considerable color change 
and cancer reduction of cell viability of D3G versus C3G (Hernández-Herrero & Frutos, 2011).   
We found that D3G, DC, and GA induced apoptosis significantly, providing further mechanistic 
knowledge. A study that analyzed grape and strawberry ANC-rich extracts found that the 
extracts and one of the metabolites induced apoptosis (López de las Hazas, Mosele, Macià, 
Ludwig, & Motilva, 2017). Additionally, a java plum extract containing glucosides of 
delphinidin was shown to increase apoptosis in HCT 116 cells (Charepalli et al., 2016). These 
studies provide evidence that ANC-rich extracts can stimulate apoptosis, including those that 
have D3G or its derivatives as a main component of the ANC profile. Here, we looked at 




as its metabolites, DC and GA.  Analysis continued in relation to angiogenesis and immune 
response by determining VEGF expression effects. In both HCT-116 and HT-29 cells, VEGF 
expression decreased due to D3G, DC, GA, and D3G-rich treatments (RGC, BLE, and RGE). 
VEGF has been shown to increase expression of PD-1 on T cells the tumor microenvironment 
(Chinai et al., 2015). A study discovered that pomegranate juice extract that contained 3-
glucosides and 3,5-diglucosides of delphinidin, cyanidin, and pelargonidin was successful at 
reducing VEGF expression in HT-29 cells (Banerjee, Kim, Talcott, & Mertens-Talcott, 2013). 
Additionally, delphinidin was capable of decreasing VEGF mRNA levels and protein expression 
in research with lung cancer cells (Kim et al., 2017). These studies corroborate our findings on 
DC and the ANC-rich extracts. Here, we also demonstrate that D3G, the glycoside of 
delphinidin, and GA, a phenolic acid metabolite of D3G and delphinidin, are effective 
suppressing VEGF. In the in silico analysis, we found that C3G, PB1, and D3G had the most 
potential to inhibit VEGF at the VEGFR1 and VEGFR2 sites of the protein, but ANC and 
metabolites may have more of an affinity at the VEGFR1 site. Previously, we demonstrated that 
D3G and C3G had a high binding affinity with VEGFR2 (Mazewski et al., 2018). Also, research 
on ellagic acid, a phenolic compound abundant in plant foods, showed anti-angiogenic potential 
through docking analysis by revealing strong bonds at the ATP site of the VEGFR2 kinase 
domain (N. Wang et al., 2012). We build on the in silico angiogenesis and immune response 
analysis to show that these ANC also have a potential to inhibit VEGF, a ligand of VEGFR1 and 
VEGFR2.  
Immunotherapy techniques have been identified as pivotal strategies to implement in 
combination with other therapies, to combat cancer progression and resistance (Greaves, 2018). 




expression compared to the untreated HCT 116 cells. Based on the docking results, C3G was 
shown to have the highest potential of all the pure compounds to inhibit PD-L1. C3G was able to 
inhibit PD-L1 expression in the ELISA where D3G and its metabolites did not. Despite higher 
expression of PD-L1 in HCT 116 cells and the microsatellite stability differences (HCT 116 
instable and HT-29 stable), atezolizumab was successful at inhibiting the expression in both cell 
lines. D3G, C3G, and DC were capable of reducing the fluorescence intensity of PD-L1, 
especially in the membrane, which is where PD-L1 exerts its inhibitory immune response. D3G, 
its related metabolites and extracts, and C3G inhibited PD-L1, which could decrease the binding 
of PD-L1 to PD-1 resulting in activation of T cells in the tumor microenvironment. D3G and 
C3G also inhibited PD-1 expression not only in PBMC cells in a monoculture but as 
pretreatments in a co-culture model with both HCT 116 and HT-29 cells; this showed their 
potential to block both immune suppressive proteins. Additionally, C3G pre-treated PBMC 
increased cytotoxicity of HT-29 cells in a co-culture. An in vivo hepatocellular cancer study with 
Lonicera caerulea ‘Beilei’ fruit showed this ANC-rich extract was able to alter the 
immunoregulatory activity (Zhou et al., 2018). ANC-rich black raspberries were researched in an 
in vivo esophageal cancer model and were reported to positively modulate cytokine and immune 
cell response, focusing on the innate immune response (Peiffer et al., 2016). These studies 
showed a potential of ANC-rich extracts to promote an immune response in other cancers. A 
recent in vivo study using Aronia berry demonstrated the ability of ANC-rich extracts to hinder 
colitis progression through T cell modulation (Pei et al., 2018). Here, we add to the potential 
mechanisms of how ANC and ANC-rich extracts may affect the immune response, specifically 




In summary, this study showed that D3G and its metabolites, DC and GA, inhibited HCT 116 
and HT-29 human colon cancer cell viability in a dose-dependent manner and induced apoptosis. 
D3G treatment on HCT 116 cells, produced significant changes in chromatographic profile and 
color parameters in cell media correlating with its inhibition ability. In silico screening showed 
potential for ANC and their metabolites to inhibit immune checkpoints and VEGF, with C3G 
indicating overall more favorable binding energies. Despite C3G not reducing the viability of 
either colorectal cancer cell line directly, PBMC pre-treated with C3G increased cytotoxicity of 
HT-29 cells, and C3G inhibited PD-L1 in vitro. D3G, its metabolites, and D3G-rich treatments 
(RGC, BLE, and RGE) decreased the expression of PD-L1 and VEGF proteins. C3G and D3G 
inhibited PD-1 expression in both a monoculture of PBMC, as well as through pre-incubation of 
PBMC in a co-culture with HCT 116 and HT-29 cells. A summary of the pure phenolic effects 
seen in this study are shown in Figure 6.10. The results of this research demonstrated the 
potential of ANC to promote immune destruction of colorectal cancer cells by inhibiting 
negative regulators, immune checkpoints, of the adaptive response in both colorectal cancer cells 
and immune cells. To our knowledge, this research shows, for the first time, the potential for 
pure ANC and their metabolites to inhibit immune checkpoints. This contributes to the 
understanding of the anti-carcinogenic potential of ANC-rich foods, opening further exploration 
of their stimulatory effects on the immune response. 
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FIGURES AND TABLES 
 
Figure 6.1 Summary of the method used for co-culture of peripheral blood mononuclear cells (PBMC) and colorectal cancer cells for 
viability and supernatant collection for programmed cell death protein 1 (PD-1) ELISA analysis. HCT 116 cells are shown as an 
example of colorectal cancer cells in the figure; the same procedure was used for HT-29 cells.  UNT, untreated; C3G, cyanidin-3-O-




Figure 6.2 Inhibition 
curves. A. Pure 
anthocyanins on HCT 
116 cells. B. Pure 
phenolics on HCT 116 
cells. C. The 
concentration of 50% 
viability inhibition 
(IC50) of the pure 
anthocyanins and 
phenolics on HCT 116 
cells and their percent 
inhibition compared at 
400 μg/mL. D. 
Inhibition curves of 
the pure phenolic 
combinations on HCT 
116 cells. E. The IC50 
values of the pure 
phenolic combinations 
on HCT 116 cells. F. 
Inhibition curves of 
the pure phenolics and 
red grape combination 
on HT-29 cells. G. 
The IC50 values of the 
pure phenolics and red 
grape combination on 
HT-29 cells. Letters 
indicate statistical 
difference between 
phenolics per category 
as determined by the 
Tukey test (p < 0.05). 
At least two 
independent 
experiments were run 
with triplicate data 
points. *Inhibition for 
delphinidin chloride at 
600 μg/mL was 
43.9%. GA, gallic 
acid; DC, delphinidin chloride; D3G, delphinidin-3-O-glucoside; PB1, procyanidin B1; C3G, 
cyanidin-3-O-glucoside; M3G, malvidin-3-O-glucoside; RG, red grape; BL, black lentil; SH, 





Figure 6.3 Isobolograms of anthocyanin-rich extracts or delphinidin-3-O-glucoside and 
oxaliplatin with their V values and the type of effect based on the V value ranges. A. Red grape. 
B. Black lentil. C. Delphinidin-3-O-glucoside. D3G, delphinidin-3-O-glucoside. Two 





Figure 6.4 High-performance liquid chromatography profiles and picture of a well from a 96-
well plate of phenolics in media at 520 and 280 nm initially and after incubation with HCT 116 
human colon cancer cells at 37 ˚C in 5% CO2 and 95% air. A. Delphinidin-3-O-glucoside (D3G). 
B. Cyanidin3-O-glucoside (C3G). C. Malvidin3-O-glucoside (M3G). Two independent 




Table 6.1 Comparison of color parameters of anthocyanins in the media initially and after 
incubation with HCT 116 cells for 24 h at 37˚C.  
  
L* a* b* Hue Angle Chroma Saturation ΔE  Color 
Cyanidin-3-O-
Glucoside 
Initial 1.3 ± 0.1 9.8 ± 0.6 0.9 ± 0.7 5.1 ± 4.5 9.8 ± 0.6 7.6 ± 0.1  
 
 After 24 h 10.9 ± 1.3 23.7 ± 1.8 13.3 ± 1.3 29.2 ± 1.3 27.1 ± 1.8 2.5 ± 1.3  
 




Initial 0.3 ± 0.0 1.8 ± 0.2 0.3 ± 0.1 10.4 ± 5.2 1.8 ± 0.2 6.5 ± 0.8  
 
 After 24 h 28.6 ± 2.5 19.7 ± 0.3 40.0 ± 1.3 63.7 ± 1.0 44.6 ± 1.1 1.6 ± 0.1  
 




Initial 0.3 ± 0.0 1.9 ± 0.0 0.4 ± 0.0 13.2 ± 0.1 1.9 ± 0.0 7.5 ± 0.1  
 
 After 24 h 8.7 ± 2.1 3.7 ± 1.4 7.9 ± 0.7 64.9 ± 8.0 8.7 ± 0.8 1.0 ± 0.2  
 
 Δ 8.4 1.8 7.4 51.8 6.8 -6.5 11.4 
 






Figure 6.5 Flow cytometry plots and percentages of total apoptotic HCT 116 human colon 
cancer cells. A. Untreated. B. Delphinidin-3-O-glucoside. C. Delphinidin chloride. D. Gallic 
acid. E. Percent of apoptotic cells for all tested treatments. The results are expressed as mean ± 
standard error. Letters indicate statistical difference between treatments as determined by Tukey 
test p < 0.05. At least two independent experiments with duplicate data points were performed. 
UNT, untreated; UNT D, untreated DMSO; D3G, delphinidin-3-O-glucoside; DC, delphinidin 





Figure 6.6 Comparison of 
percent of protein 
expression relative to the 
untreated (UNT) control 
normalized to GAPDH for 
vascular endothelial 
growth factor (VEGF) and 
programmed death-ligand 
1 (PD-L1) for delphinidin-
3-O-glucoside (D3G), 
delphinidin chloride (DC), 
red grape combination 
(RGC), red grape extract 
(RGE), and black lentil 
extract (BLE) and the 
associated protein band 
examples for A. HCT 116 
human colon cancer cells. 
B. HT-29 human colon 
cancer cells (VEGF only). 
RGC was compared to 
untreated DMSO (UNTD); 
both had 0.3% DMSO. 
The results are expressed 
as mean ± standard error. 
Letters indicate statistical 
difference between 
treatments and the 
untreated control (100%) 
as determined by 
Student’s T-test (p < 
0.05). At least two 
independent experiments 
were run. C. ELISA 
results for PD-L1 and 
programmed cell death 
protein 1 (PD-1) in terms 
of percent inhibition 
compared to the untreated 
control in monoculture or 
co-culture. The results are 
expressed as mean ± 
standard error. Asterisks 
indicates statistical difference from the untreated control as determined by Student’s T-test (p < 
0.05). GAPDH, glyceraldehyde 3-phosphate; MW, molecular weight; C3G, cyandin-3-O-glucoside; 




Figure 6.7 Effect 
of anthocyanins 
and delphindin 


















(D3G). D. DC. E. 
The relative 
fluorescence 
intensity of PD-L1 
for treatments of 
C3G, D3G, and 




expressed as mean 









Student’s T-test (p 
< 0.05). Two 
independent 
experiments were run. At least three sections of a well and at least five cells within each section 






including distances of 
interactions between 
an immune checkpoint 
or vascular endothelial 
growth factor (VEGF) 
protein and a phenolic 
ligand for A. 
Procyanidin B1(PB1) 
and programmed cell 
death protein 1 (PD-1). 
B. Delphinidin-3-O-
glucoside (D3G) and 
programmed death-
ligand 1(PD-L1). C. 
Cyanidin-3-O-
glucoside (C3G) and 
VEGF. D. Free energy 
of binding for two 
sites on PD-1, PD-L1, 
or VEGF with 




gallic acid, and a small 
molecule inhibitor. 
The top two or three 
phenolics with the 
highest binding 
affinities are bolded. 
*The small molecule 
8YZ was used for PD-
1 and PD-L1 sites 
except for the 8J8 site. 
For the 8J8 site on PD-
L1, the actual 8J8 
molecule was selected. 
Vatalanib was utilized 
for VEGF at VEGFR1 
and PTC-858 for 
VEGFR2. Lengths 








and binding free 




cell death protein 1 
(PD-1) at the 
programmed death-
ligand 1 (PD-L1) 
binding site. B. 
Delphinidin-3-O-
glucoside (D3G) 
and PD-1 at the 
nivolumab binding 
site. C. Delphinidin 
(DC) and 
programmed death-
ligand 1 (PD-L1) at 




and PD-L1 at the 
Atezolizumab 
binding site. E. 
Procyanidin B1 
(PB1) and vascular 
endothelial growth 
factor (VEGF) at 
the VEGFR2 
binding site. F. 
Gallic acid (GA) 






Table 6.2 Estimated free energy of binding and interactions between amino acids of the phenolic ligand (or small molecule inhibitor) 












PHE56, SER57, SER62, 
PHE63 
THR59, SER60, GLU61, PHE82, PRO83, 
GLN99, ARG104, PHE106  
ASN58, GLY103 




Nivolumab -6.6 SER57, PHE63 
PHE56, ASN58, GLU61, SER62, VAL64, 
PHE82, PRO83, PHE106 
GLN99 
 
PD-L1 -6.1 LYS78, GLY124, GLU136 
VAL64, ASN66, THR76, LEU122, ALA125, 
LEU128 




PHE56, SER57, PHE63, 
GLN99, GLY103 




ASN66, LYS78, LEU122, GLY124, 
ALA132, ILE134 
ILE126 TYR68, THR76 
Malvidin-3-
O-glucoside 
Nivolumab -5.6 GLU61 
PHE56, SER57, ASN58, SER60, SER62, 
PHE63, PHE82, GLN99, GLY103, 
ARG104, PHE106  
  
PD-L1 -5.5 ASN66, THR76, LYS78 





Nivolumab -5.4 PHE56, SER57, PHE63 










ASN33, SER57, SER60, 
SER127, GLN133 
PHE56, ASN58, THR59, LYS135 
  





Nivolumab -7.0 SER57 
ASN58, GLU61, SER62, VAL64, PHE82, 















Table 6.3 Estimated free energy of binding and interactions between amino acids of the phenolic ligand (or small molecule inhibitor) 




















-9.6 TYR56, ARG125 
ALA18, PHE19, ILE54, ASP61, ASN63, 
GLN66, VAL68, VAL76, MET115, 
LYS124 




Atezolizumab -5.4 ARG82, THR102 
SER79, SER80, GLN83, ASP103, 
GLN107 




-2.6 ASP61, ASN63, TYR123 
THR20, TYR56, LYS62, GLN66, LYS75, 
HIS78, SER79, ASP122 








PHE19, THR20, TYR56, 
ASP61, LYS124, ARG125 
ALA18, GLU58, LYS62, ASN63, 
TYR123 








-6.8 THR20, GLN66, LYS124 
PHE19, VAL21, TYR56, GLU58, LYS62, 










ILE54*, TYR56*, GLN66, ILE116*, 








-6.7 ILE54, MET115* 
VAL55, TYR56, MET115*, ILE116, 
ALA121*, ASP122*, TYR123 
MET115*, ALA121* SER117 
8YZ (small 
molecule inhibitor) 
Atezolizumab -5.9 GLN83 
LYS62, SER80, THR102, ASP103, 
GLN107 
ARG82, ARG84, LYS105 
 





ILE54*, VAL68, VAL76, ILE116*, 








Bolded interactions are those that are the same between the phenolics and the small molecule inhibitor; Underlined interactions are those that are the same between phenolics 




Table 6.4 Estimated free energy of binding and interactions between amino acids of the phenolic ligand (or small molecule inhibitor) 













PHE47, SER50, ASN62, 
ASP63, LEU66 
ASP34, LYS48, CYS60, CYS61, GLU67, 
LYS107 
PHE36, ILE46, GLU64 
 
VEGFR2 -6.4 SER50, GLU64 
PHE47, PRO49, ASN62, ASP63, PRO85, 
HIS86, GLN89 
ILE46, LYS48, ILE83 
 
Procyanidin B1 
VEGFR1 -7.5 GLY59, GLU64, CYS68 
CYS26, ASP34, PHE36, ILE46, PHE47, 
SER50, ASN62, ASP63, LEU66, GLU67 
CYS60, CYS61, GLU64, 
LYS107  
VEGFR2 -8.0 ASN62, ASP63 PHE47, PRO49, SER50, GLY65, GLN89 
ILE46, LYS48, GLU64, 
ILE83, PRO85  
Delphinidin-3-O-
glucoside 
VEGFR1 -7.5 SER50, CYS68 
ASP34, PHE36, ILE46, LYS48, GLY59, 
ASN62, ASP63, LEU66, GLU67, ILE83 
CYS60 CYS61 
VEGFR2 -6.2 PHE47, GLN89 
PRO49, SER50, ASN62, ASP63, GLU64, 
PRO85 




VEGFR1 -7.2 ASP34, ASP63 
PHE47, LYS48, SER50, CYS51, CYS60, 
CYS61, ASN62, LEU66, GLU67, LYS107 
PHE36, ILE46, GLU64 
 
VEGFR2 -6.1 ASN62, GLN89 PHE47, PRO49, SER50, ASP63, GLU64 ILE46, LYS48, ILE83 PRO85 
Delphinidin chloride 
VEGFR1 -6.9 SER50, ASP63 
ASP34, PHE36, LYS48, CYS60, LEU66, 
CYS68, ILE83 
ILE46, CYS61, ASP63, 
GLU64 
GLU67 
VEGFR2 -5.9 SER50, ASN62 
PHE47, PRO49, ASP63, GLU64, PRO85, 
GLN89 
ILE46, LYS48, ILE83 SER50 
Gallic acid 
VEGFR1 -5.1 
GLY59, CYS61, ASN62, 
ASP63, LYS107 
CYS26, SER50, CYS60, GLU64, LEU66, 
GLU67, CYS68   
VEGFR2 -4.2 SER50, ASN62 PHE47, PRO49, ASP63, GLU64, ILE83 ILE46, LYS48 SER50 
Vatalanib VEGFR1 -7.6 SER50, ASP63 
ASP34, PHE36, LYS48, GLY59, CYS60, 
CYS61, ASN62, CYS68, ILE83 
ILE46, GLU64 PHE47 
PTC-858 (small 
molecule inhibitor) 
VEGFR2 -5.8 ASN62 PHE47, LYS48, SER50, ASP63, GLN89 ILE46, ASN62, ILE83 GLU64 





Figure 6.10 Summary of the effects of anthocyanins and metabolites on the immune response markers tested. Inhibition (bar-headed 
lines) or promotion (arrows) shown if effects were seen through western blots, ELISA, confocal microscopy, and/or in silico analysis. 
C3G, cyanidin-3-O-glucoside; D3G, delphinidin-3-O-glucoside; DC, delphinidin chloride; GA, gallic acid; MHC, major 
histocompatibility complex; PD-1, programmed cell death protein 1; PD-L1, programmed death-ligand 1; TCR, T cell receptor; 




CHAPTER 7 - BLACK LENTIL WATER EXTRACT ATTENUATED COLITIS-
ASSOCIATED COLON CARCINOGENESIS THROUGH MODULATION OF 
CYTOKINES MEDIATING THE COMMUNICATION BETWEEN IMMUNE CELLS IN 
A MOUSE MODEL 
7.1 Abstract 
The objective was to compare the efficacy of a black lentil water extract (BL) and a delphinidin 
3-O-(2-O-β-d-glucopyranosyl-α-l-arabinopyranoside(D3G)-enriched lentil extract to prevent 
tumor development and inflammatory processes and impact immune response in an 
azoxymethane (AOM)/ dextran sodium sulfate (DSS) model. C57BL/6 mice (7.5 weeks old) 
were randomly separated into four groups: healthy control (n=6), AOM/DSS control (n=14), 
AOM/DSS+BL (n=12), and AOM/DSS+ D3G (n=12). The mice were given treatments for 11 
weeks, either placebo, BL: 600 mg/kg body weight, or D3G: 41 mg/kg body weight (equivalent 
to D3G concentration in BL) using a voluntary jelly administration every morning. 
AOM/DSS+BL group had a lower disease activity index, throughout and at the end (2.4) 
compared to AOM/DSS (6.3) (p<0.05); this trend was reflected in the mucosal damage scores 
(2.5 vs 4.3, respectively, p<0.05). Mice in the AOM/DSS+BL group had an average of 7.8 
neoplasms while the AOM/DSS control had 12.8 (p<0.05). AOM/DSS+BL group had a lower 
relative spleen weight 5 mg/g and colon weight to length 59 mg/cm compared to 10 mg/g and 82 
mg/cm for the AOM/DSS control, respectively (p<0.05). Interleukin-6 protein expression was 
downregulated in colon mucosa (-44.5%), plasma (-72.6%) and gene expression in colon polyp 
(FC: -4.0) in the AOM/DSS+BL compared to the AOM/DSS. Although the AOM/DSS+D3G did 
not have significant macroscopic changes compared to the AOM/DSS, gene expression in the 




genes modified (Secreted phosphoprotein 1 and chemokine ligands 2, 5, and 10). BL treatment 
showed both anti-carcinogenic and anti-inflammatory properties while the D3G-enriched 
treatment modulated inflammatory genes.    
7.2 Introduction 
In the United States, the lifetime risk of being diagnosed with colorectal cancer is 4.2% with a 
higher incidence in men (45.2 new cases per 100,000 people) than women (34.5 new cases per 
100,000 people) (National Institutes of Health, 2019). Inflammation has long been associated 
with colorectal cancer, and those suffering from inflammatory bowel disease have an increased 
risk of developing colon cancer. Over 20% of people with inflammatory bowel diseases like 
Crohn’s disease or ulcerative colitis will develop colitis-associated cancer within 30 years 
(Terzić, Grivennikov, Karin, & Karin, 2010). There are molecular changes that occur in the 
progression of colitis-associated colon cancer similar to those in sporadic colon cancer but with 
the additional promotion by pro-inflammatory cytokines on related signaling (Terzić et al., 
2010). Animal models that closely mimic the mechanisms of human colitis-associated colon 
cancer, such as the azoxymethane (AOM)/dextran sodium sulfate (DSS) carcinogenesis model in 
mice, are valuable in providing preclinical insights on impacted molecular markers (Snider et al., 
2016).  
The complex inflammation and immunity crosstalk is important in the progression of colorectal 
cancer. A high systemic immune-inflammation index is associated with poor prognosis for 
patients with metastatic colorectal cancer (Xie et al., 2018). Some cytokines are better 
understood and have clear pro-inflammatory properties, such as interleukin (IL)-6; high levels of 
IL-6 in colon tissues and the blood are indicative of tumor development and are a prognostic 




cytokines have dual roles and can both contribute to the colorectal cancer progression as well as 
promoting immune response, such as granulocyte-macrophage-colony-stimulating factor (GM-
CSF) or IL-9 (Mager et al., 2016). Immune checkpoints, including programmed death ligand 1 
(PD-L1), are negative regulators of the immune system, and evidence has shown that various 
cytokines can upregulate them. Interferon (IFN)-γ, IL-2,  IL-4, IL-6, IL-7, IL-15, and GM-CSF 
have demonstrated promotion of the expression of PD-L1 on tumor cells (Chinai et al., 2015; Kil 
et al., 2017; Mimura et al., 2018). With the upregulation of immune checkpoints, there is 
increased T cell inactivation and less immune destruction of cancer cells (Chinai et al., 2015). 
Anti-inflammatory properties are associated with healthy foods. Plant foods can exert health 
benefits due to their vitamins and minerals but also typically contain bioactive compounds like 
polyphenols. Polyphenols from various sources have been shown to provide anti-inflammatory 
as well as anti-carcinogenic effects in colorectal cancer, impacting initiation and progression 
(Alam, Almoyad, & Huq, 2018). Anthocyanins, natural red, blue, and purple pigments, fall 
within the flavonoid category of polyphenols and have also shown preventive and anti-
progression effects in vitro and in vivo (Mazewski & De Mejia, 2018). The majority of colorectal 
cancer-related studies with anthocyanins have utilized various sources of fruit, where vegetables, 
cereals, and legumes are less studied (Mazewski & De Mejia, 2018). High legume consumption 
has been associated with lower colorectal cancer risk in cohort studies (Zhu, Sun, Qi, Zhong, & 
Miao, 2015). Lentils have been previously shown to have health benefits but the black beluga 
variety is an understudied legume, despite its rich source of phenolics including anthocyanins 
(Ganesan & Xu, 2017). In our previous study, we identified a black lentil extract as the most 
potent of eleven phenolic-rich sources on inhibiting colon cancer cell proliferation (Mazewski, 




a delphinidin glycoside: delphinidin 3-O-(2-O-β-d-glucopyranosyl-α-l-arabinopyranoside) (D3G) 
(Gary R. Takeoka, Lan T. Dao, Hirotoshi Tamura, & Harden, 2005).   
The objective of this research was to compare the efficacy of a well-characterized black lentil 
water extract (BL) and a D3G-enriched lentil extract to prevent tumor development and 
inflammatory processes and impact immune response in an AOM/DSS C57BL/6 mouse model. 
We hypothesized that the BL treatment would be most effective at reducing inflammation and 
carcinogenesis due to the more complex profile and variety of phenolic compounds.  
7.3 Materials and methods 
7.3.1 Materials 
Organic black beluga lentils (Lens culinaris L.) were purchased from Mulberry Lane Farm 
(Loda, Illinois). AOM was obtained from Sigma Aldrich (St. Louis, MO) and colitis grade DSS 
(36-50,000 M.Wt.) from MP Biomedicals (Solon, OH). AIN9-3M diet was bought from Envigo 
(Huntingdon, United Kingdom). HemoCue America Beckman Coulter Hemoccult SENSA Fecal 
Occult Blood System was purchased from Fisher Scientific (Hampton, NH).  Sucralose 
(Essential Everday) and unflavored gelatin (Knox) were obtained from County Market, 
Champaign, IL.  
7.3.2 Methods 
7.3.2.1 Black lentil water extraction 
Black lentils were soaked for 16 h in distilled de-ionized water at a 1:2 w/v ratio at room 
temperature in the dark. The liquid was then filtered through a 0.22 μm filter and then frozen at -
80˚C for at least one day. The frozen material was then freeze-dried for at least 3 days.  




Lentils were ground into a fine powder with a coffee mill and passed through a 60 mesh filter to 
collect the fine ground fraction. Batches of 250 g of ground lentils were extracted with 1% HCl 
in methanol with stirring overnight at 24°C. The liquid was decanted and filtered through a 
Whatman 54 filter paper. The remaining solid material was extracted with only methanol a 
second time with stirring overnight and decanted and filtered. The extracts were pooled, and 
approximately 400 mL of water was added and allowed to evaporate over 72 h in the hood 
rotoevaporated at 45°C to remove the methanol. The concentrated extract was filtered to remove 
any remaining solid material. 
A Buchi (Newcastle, DE) Sepacore flash chromatography system with dual C-605 pump 
modules, C-615 pump manager, C-660 fraction collector, C-635 UV photometer, with 
SepacoreRecord 1.2 chromatography software was used for collecting D3G-rich fractions. A 40 
x 150 mm flash cartridge column with approximately 90 g of preparative C18 reverse phase end 
capped bulk packing material (Silicycle SiliSep BUC18 (17%) 60 Angstroms, 40-63 μm, 
Silicycle, Quebec, Canada) was used for the preparative separation. After samples (50-100 mL) 
were loaded on the column, the column was developed with a binary gradient to 40% methanol 
over 10 min, then to 100% methanol over an additional 5 min. For anthocyanins, the effluent was 
monitored at 520 nm and 50 mL fractions were collected in the fraction collector by the software 
program. Fractions were concentrated by as explained above. The fractions containing the D3G 
were pooled and freeze dried over 2-5 days to dryness. 
7.3.2.3 HPLC analysis 
Samples were run on a stand-alone Shimadzu 10A HPLC system (SCL-10A system controller, 
two LC-10A pumps, CTO-10A column oven, and SIL-10A autoinjector) to determine D3G 




running under the HP Chemstation software version A.02.05. The column used was an Inertsil 
ODS-3 reverse phase C-18 column (5 µM, 250 x 4.6 mm, with a Metaguard column, from 
Varian). For anthocyanin analysis, the initial conditions were 2% acetonitrile and 0.5% acetic 
acid in water, at a flow rate of 1 ml per min. The effluent was monitored at 520 nm on the PDA. 
After injection, the column was held at the initial conditions for 2 min and then developed to 
100% acetonitrile in a linear gradient over 60 min. Standard curves based on nanomoles injected 
were prepared from a pure standard of delphinidin-3-O-glucoside purchased from Chromadex 
(Irvine, CA). Extinction coefficients were calculated as explained previously (Mojica, Berhow, 
& Gonzalez de Mejia, 2017).  
7.3.2.4 LC-ESI-MS analysis of anthocyanins and black lentil extract 
The procedure used by Mojica, Berhow, and de Mejia was followed with minor modifications 
(Mojica et al., 2017). For anthocyanin analysis, the initial solvent system was 10% methanol 
versus water with 0.1% formic acid at a flow rate of 0.25 mL per min. After injection, the 
column was held at the initial conditions for 2 min then developed with a linear gradient to 100% 
methanol and 0.1% formic acid over 50 min. The MS was run with the ESI probe in the positive 
mode. The maximal mass resolution is set at 30,000, the spray voltage is set at 3.0 kV, the tube 
lens was set at 100 V. The software was set to collect mass data between 100-2000 AMUs.  
Black lentil extract was examined with the Q-Exactive MS system (Thermo, Bremen, Germany) 
in the Metabolomics Laboratory of Roy J. Carver Biotechnology Center at the University of 
Illinois at Urbana-Champaign as explained previously to determine other phenolics in the extract 
(Q. Zhang, 2019).  




Forty-four male C57BL/6 mice were received at 7.5 weeks old (born August 24, 2018) from 
Envigo. Mice were caged in individual caging systems and acclimated for three days upon 
arrival. They were housed in an environment with a 12 h light/dark cycle and a room kept at 
24°C. The AIN-93M purified diet, given ad libitum, contained 12.4% protein, 68.3% 
carbohydrate, and 4.1% fat by weight with 3.6 kcal/g. 
A summary of the study design is shown in Figure 7.1. Briefly, after the three day acclimation 
period, the mice were trained to eat the jelly treatments using the placebo gelatins with 7% 
gelatin sweetened with 10% sucralose for taste. The use of a voluntary oral jelly administration 
was chosen because it avoids the potential errors and harm that can be induced through daily 
gavage of small animals but reduces variability in intake in the method of just adding the 
treatments in the diet or water (Zhang & Zhang, 2011). In week two, the mice were randomly 
separated into four groups: 1. healthy control (n=6), 2. AOM/DSS control (n=14), 3. AOM/DSS 
+ BL: 600 mg/kg body weight of BL (n=12), and 4. AOM/DSS + D3G: 41 mg/kg body weight 
of D3G-enriched extract (n=12). Week two is when groups three and four started receiving their 
respective extract jelly treatments and placebo jellies were continued for groups one and two. 
The dose for the D3G-enriched extract was based on the percent of D3G of the total phenolics in 
the BL (~7%) to compare the same amount of D3G alone to the BL extract that contains a 
mixture of phenolics with the D3G.   
At the beginning of week three, the mice in groups two-four received an AOM injection 
intraperitoneally at 10 mg/kg body weight, while the mice in group one received a saline 
injection to keep stress and handling consistent with the groups receiving an AOM injection. 
Both the saline and AOM solutions were filtered through 0.22 μm cellulose acetate filters to 




one week. This was followed by two weeks of regular water. The second cycle of DSS was at 
1% for one week, and the third was 1% for four days, both followed by two weeks of regular 
water. DSS was reduced to 1% for cycles two and three due to more severe colitis symptoms 
seen after the 2% administration in cycle one as to decrease the risk of losing animals.  
For the euthanasia, mice were deeply anesthetized using isoflurane and blood was taken through 
cardiac puncture as a terminal procedure. The blood was collected in EDTA-coated tubes, mixed, 
and left on ice for 10 min. Samples were then centrifuged at 4°C for 10 min at 10,000 rpm. 
Plasma was collected and stored at -80°C until use.  
Immediately after euthanasia, the colon, liver, and spleen were harvested and weighed. Both 
proximal and distal portions of the colon were stored in formalin for histology analysis. Colons 
were analyzed for neoplasms and the weight and length were recorded. Colon non-polyp and 
polyp tissues were cut and weighed between 20-30mg and stored in RNAlater (Thermo Fisher 
Scientific, Waltham, MA), for gene expression analysis. A portion of the colon was designated 
for mucosa obtainment.  
The methods were performed in accordance with the protocol approved by the Institutional 
Animal Care and Use Committee at the University of Illinois at Urbana-Champaign (protocol # 
18189).   
7.3.2.6 Disease activity index 
At least once per week, the body weight was measured, and the disease activity index (DAI) was 
determined based on body weight, stool consistency, and whether blood was present in the feces. 
Fecal occult blood was determined through a Hemoccult test kit. The DAI was calculated on a 
scale of 0-12, with 0-4 for each of the three categories as follows: Weight loss criteria: 0 = gain 




(Snider et al., 2016). Weight change was based on the last data point taken. Stool consistency: 0 
= normal, 2 = soft stool, 4 = diarrhea. Fecal blood: 0= no blood, 2 = blood identified through 
hemoccult test, 4 = gross perianal bleeding (Snider et al., 2016). 
7.3.2.7 Colonic mucosal damage analysis 
Colons were stored in 10% neutral buffered formalin and both portions (from the proximal and 
distal section) were then embedded in paraffin using a Leica EG1150 C cold plate and Leica 
EG1150 H heated paraffin dispensing module after dehydration and treatment overnight with a 
Leica ASP300 Tissue Processor. Slices of 5 µm thickness were cut using a Leica RM2255 rotary 
microtome. Two to three slices were placed on microscope slides. All tissue processing 
equipment was used at the Institute of Genomic Biology at the University of Illinois at Urbana-
Champaign. Hemotoxylin and eosin staining were performed on colon slides at the Veterinary 
Medicine Histology Lab at the University of Illinois at Urbana-Champaign. A NanoZoomer 
Digital Pathology System C96000-12 (Hamamatsu, Hamamatsu, Japan) was used to take 
pictures of the slides with a 40x lens and 225 nm/pixel. NDP view software version 2.7.39 was 
utilized to analyze pictures. Six colon replicates per group were evaluated for mucosal damage 
scores blindly by two researchers using a modified scoring system based on those previously 
described:: 0 – no damage, normal, 1 – infiltration of granulocytes, inflammation, 2 – minor 
mucosal ulceration, 3 - <3 sites of mucosal ulcerations, low-grade dysplasia 4 - <25% of mucosal 
ulceration, high-grade dysplasia, and 5 - > 25% mucosal ulceration, adenocarcinoma (Yu et al., 
2014; Riddell et al., 1983). 
7.3.2.8 Markers of inflammation analysis in the colon mucosa and plasma 
Colons were opened on the longitude, and a portion was scraped using a glass slide to obtain the 




Polytron™ PT 10-35 GT Homogenizer in 300 µL of cell lysis buffer provided from the abcam 
(Cambridge, UK) Mouse Inflammation Antibody Array Kit (ab133999) with added protease 
inhibitor cocktail. The array had 40 inflammation-related markers. After 30 min on a shaker at 
4ºC, the tissue lysates were centrifuged at 13,000 rpm for 20 min at 4ºC. The supernatant was 
collected, and the protein was measured with a DC protein assay. Mice tissue lysates from the 
AOM/DSS control and AOM/DSS + BL groups were pooled into two groups each of 250 µg of 
protein. For the protein array, manufacturer’s instructions were followed. Plasma was pooled for 
the positive control group and BL group and two replicates were run. Mouse Th1/Th2/Th17 
Cytokines Multi-Analyte ELISArray Kit (336161) from Qiagen (Hilden, Germany) was used to 
analyze twelve cytokines: IL2, IL4, IL5, IL6, IL10, IL12, IL13, IL17A, IL23, IFNγ, TNFα, and 
TGFβ1.   
7.3.2.9 Gene analysis in polyp and non-polyp colon tissue 
Since few neoplasms were found in the proximal zone, and most of the polyps were located in 
the distal region, a portion of tissue was obtained from the proximal (non-polyp) and distal 
(polyp) zones; the healthy control group only had non-polyp tissue. Therefore, the gene 
expression analysis contained seven experimental units: colon tissue from the healthy control, 
and proximal (polyp) and distal (non-polyp) tissue from the AOM/DSS control, AOM/DSS + 
BL, and AOM/DSS + D3G groups. The tissue was stabilized in RNAlater Stabilization Solution 
(Thermo Fisher Scientific) and used within four days of storage. Tissue was ground using a 
Polytron™ PT 10-35 GT Homogenizer, and total RNA was extracted using the RNeasy mini kit 
(Qiagen) following the manufacturer’s instructions. RNA quantification was determined using a 
NanoDrop 1000 microvolume spectrophotometer (Thermo Scientific), and integrity was assessed 




synthesized using the SuperScript® III First-Strand Synthesis System for RT-PCR kit 
(Invitrogen, Carlsbad, CA) and then all of the targeted genes were pre-amplified in a single-cycle 
PCR reaction for each sample by combining 1.25 µL cDNA with the pooled primers and 
TaqMan Pre-Amp Mastermix (Fluidigm BioMark™) following conditions outlined in the 
manufacturer’s protocol. Finally, quantitative PCR was performed for each primer pair on each 
sample on a 96.96 Integrated Fluidics Circuit (IFC) using the EvaGreen detection assay on a 
Biomark HD system following standard Fluidigm protocols at the University of Illinois at 
Urbana-Champaign Functional Genomics Unit of the Roy J. Carver Biotechnology Center. 
Primers were purchased from Qiagen (Mouse Cancer Inflammation & Immunity Crosstalk RT² 
Profiler PCR Array). Data were analyzed using Fluidigm Real-Time PCR Analysis v4.0.1 
(Fluidigm) and graphed using Prism v7.0 (GraphPad Software). The expression for each sample 
was normalized to the geometric mean of the expressions of the three housekeeping genes 
(Gapdh, Rplp0, Hprt1). Samples with cycle thresholds greater than 28 were excluded from the 
analysis. In order to run a hierarchical clustering analysis, we grouped the analyzed genes based 
on their main biological function. Seven functions were identified: immune and inflammatory 
responses, signal transduction, chemokines, chemokine and interleukin receptors, interleukins, 
growth factors and receptors, and apoptosis. 
7.3.2.10 Functional enrichment analysis 
Similarities and differences in the genes affected by the treatments were analyzed by GeneVenn 
(Pirooznia, Nagarajan, & Deng, 2007). The genes were annotated and biological processes were 
analyzed using DAVID v6.7 (Huang, Sherman, & Lempicki, 2009a, 2009b). As an alternative 
approach to identifying the biological processes and functions that were modulated by BL and 




Core analysis parameters were set-up as follows: Network analysis: direct and indirect 
relationship; Molecules per network: 35; Network per analysis: 25; Data sources: all; confidence: 
experimentally observed; Species: mouse; and Tissues and cell lines: all. Additionally, 
Downstream Effect Analysis was performed using IPA, which identifies biological functions that 
are expected to be increased/decreased given the observed gene expression changed in a data-set 
uploaded to the software; in order to reduce the chance that random data will generate significant 
predictions, an absolute z-score of ≥2 was considered significant, thus, in this case, a function is 
decreased if the z-score ≤ 2, and increased if the z-score ≥ 2. The cut-off used for reporting 
significant changes in gene expression was p < 0.05. 
7.3.2.11 Statistics 
Statistical comparisons were determined using one-way ANOVA tests. For parametric data, 
Tukey-Kramer analysis was used through JMP v. 8.0 with differences considered significant at p 
< 0.05. Nonparametric data were analyzed using the Kruskal-Wallis test in GraphPad Prism v. 
7.04 with differences considered significant at p < 0.05. 
7.4 Results 
7.4.1 Black lentil extract has D3G as its main anthocyanin and a high phenolic concentration 
Mass spectrometry analysis identified the D3G peak in BL. The BL water extract had total 
anthocyanin concentration of 20.4 ± 0.6 µg D3G equivalent /mg dry weight extract and total 
polyphenol concentration of 268.4 ± 4.1 µg gallic acid equivalent/ mg dry weight extract. 
Additionally, quercetin derivatives, procyanidin dimers and trimers, catechins, and phenolic 
acids were identified in the extract. This information is summarized in Figure 7.2.   




Overall average weight gain for the healthy control and AOM/DSS + BL groups was 27.0% and 
26.3%, respectively, which were not statistically different and were higher than the AOM/DSS + 
D3G and AOM/DSS control groups with 5.5% and 5.2%, respectively (p < 0.05) (Figure 7.3A). 
The DAI for the AOM/DSS + BL group was consistently lower than the positive control. During 
the last week, the AOM/DSS + BL group had a lower DAI of 2.4 compared to 6.3 for the 
AOM/DSS control (p < 0.05); the AOM/DSS + D3G group had a DAI of 4.0 which was not 
statistically lower than the AOM/DSS control (p> 0.05) (Figure 7.3B). 
7.4.3 Black lentil treatment reduced the number of total and large neoplasms 
The mice in the AOM/DSS + BL group had fewer neoplasms (7.8 ± 1.0) than the AOM/DSS 
control (12.8 ± 0.9) (p<0.05) (Figure 7.3C). The healthy group had no neoplasms, as expected. 
The AOM/DSS + BL group had fewer large neoplasms (2.4 ± 0.7) than the AOM/DSS control 
(5.2 ± 0.5) groups (p < 0.05) (Figure 7.3D).  The average size of the largest neoplasm was also 
smaller (mm) for the AOM/DSS + BL group (3.3 ± 0.3) versus the AOM/DSS control group (5.3 
± 0.3) (p < 0.05) (Figure 7.3E). 
7.4.4 Black lentil treated mice had lower relative colon and spleen weight 
The colon weight to length ratio of the AOM/DSS + BL group was 59.2 ± 5.4 mg/cm which was 
lower than the AOM/DSS control at 82.1 ± 6.0 mg/cm and the AOM/DSS + D3G group at 82.6 
± 5.9 mg/cm (p<0.05) (Figure 7.3F). A representative picture of a colon from each group is 
shown in Figure 7.3G. The healthy control (2.5 ± 0.3 mg/g) and AOM/DSS + BL group had a 
lower relative spleen weight of 5.4 ± 0.7 mg/g compared to 9.6 ± 1.2 and 10.0 ± 1.3 of the 
AOM/DSS control and AOM/DSS + D3G groups, respectively (p < 0.05) (Figure 7.3H). An 
example from each group of the spleen pictures is shown in Figure 7.3I. There was no 




7.4.5 Black lentil treatment reduced colonic mucosal damage 
The AOM/DSS + BL group had less mucosal damage than the AOM/DSS control with histology 
scores of 2.5 ± 0.2 and 4.3 ± 0.2, respectively (p < 0.05). The AOM/DSS + D3G group had a 
score of 3.4 ± 0.2 which was not statistically lower than the AOM/DSS control (p > 0.05). 
Overall, the BL treated group had fewer abscess crypts and less loss of goblet cells. 
Representative pictures of the stained colons and the histology scores are shown in Figure 7.4.   
7.4.6 Black lentil treatment decreased expression of pro-inflammatory cytokines in the colon 
mucosa and plasma 
The AOM/DSS + BL group modulated 26 of the 40 target proteins of the inflammation array 
(Figure 7.5A) and four of the twelve in the plasma ELISArray compared to the AOM/DSS 
control (Figure 7.5B, C). IL-6 expression was reduced in both the mucosa (44.5%) and in the 
plasma (72.6%) (p < 0.05). There was a 100% reduction of IL-23 in the plasma in the AOM/DSS 
+ BL group. Some chemokines, such as monokine induced by gamma interferon (MIG) (94.3%) 
and macrophage inflammatory protein-1alpha (MIP-1α) (90.2%) had significant reductions in the 
mucosa of the BL group compared to the positive control. Table 7.1 summarizes the proteins 
most modulated in the mucosa and plasma.   
7.4.7 Black lentil and D3G treatments modulated inflammatory genes compared to the disease 
control 
To have a better understanding of the effect of BL and D3G preventing the colitis-associated 
colon carcinogenesis on mice, first, we compared the differential gene expression of the healthy 
control vs. the AOM/DSS polyp group. Out of 96 probes, a total of 32 genes were statistically (p 
< 0.05) affected by AOM/DSS treatment, with fold-changes ranging from 2.0 (IFNγ) to 60.7 




treatments is shown in Figure 7.6A. A functional annotation analysis showed that the 32 genes 
corresponded to cytokine-cytokine receptor interaction (FDR = 1.79
-35
) and IL-17 signaling 
(FDR = 6.5
-19
) pathways, among others (Table 7.2). Comparing with the AOM/DSS control, the 
treatment with BL and D3G resulted in a significant (p < 0.05) modulation of 18, and eight 
genes, respectively. Out of the 18 genes modulated by BL compared to AOM/DSS polyp, nine of 
them correspond to the genes that were affected by AOM/DSS vs. healthy control (Figure 7.6B); 
meanwhile, D3G modulated five genes (Figure 7.6C). This subset of genes (Cxcl10, Cxcl5, IL-
6, nitric oxide synthase (Nos)2, IL-2, activation-induced cytidine deaminase (Aicda), chemokine 
receptor (Cxcr)1, colony stimulating factor (Csf) 3, and Cxcr2) (Figure 7.6D) was associated to 
the cytokine-cytokine receptor interaction (FDR = 6.01
-11
), IL-17 signaling (FDR = 1.2
-6
), and 
intestinal immune network (FDR = 1.12
-5
) pathways, among others (Figure 7.6E). The two most 
down-regulated genes by BL were IL-6 (FC: -4.0), and Cd274 (PD-L1) (FC: -2.9). Additionally, 
the biological process associated to the genes affected by BL and D3G included immune 
response (FDR = 8.52
-8
), cellular response to cytokine stimulus (FDR = 4.9
-7
), among others 
(Figure 7.6F). Looking at specific genes, in Table 7.2 it can be observed the top ten up- and 
down-regulated genes in each group compared to the polyp tissue from the AOM/DSS control. 
When comparing the healthy control with the non-polyp tissue of the AOM/DSS control, it was 
observed that the inflammatory status was lower since the fold-change range was -10.5 to 1.7 for 
inflammation-related genes. In that sense, comparing the healthy control with the non-polyp 
tissue of the groups treated with black lentil and D3G, eight and four genes were statistically 





The average gene expression of the different experimental units (colon tissue from the healthy 
control, and proximal (polyp) and distal (non-polyp) tissue from the AOM/DSS control, 
AOM/DSS + BL, and AOM/DSS + D3G groups) is shown in Figure 7.7. Cluster analyses of the 
gene expression showed that the experimental units were satisfactorily segregated into groups 
according to their expression profile across the different biological functions. The polyp 
(AOM/DSS, AOM/DSS + BL polyp, AOM/DSS + D3G polyp) tissue regrouped on the left, and 
the non-polyp (healthy control, AOM/DSS non-polyp, AOM/DSS + BL non-polyp, AOM/DSS + 
D3G non-polyp) tissue experimental units regrouped on the right (Figure 7.7A-G). Although 
overall, no substantial effects were observed for D3G throughout the study in AOM/DSS-treated 
mice, a strong association was found between AOM/DSS + D3G non-polyp and healthy control. 
The lower z-score clustering values (data not shown) were found in the apoptosis and growth 
factors and receptors gene groups, suggesting no major modulation of these set of genes by the 
BL or D3G treatments. 
According to an upstream analysis, BL and D3G can potentially modulate markers related to 
colorectal cancer progression. Figure 7.8 summarizes the significant (-2 < Z > 2, and p < 0.05) 
prediction of activation or inhibition of genes associated with the specific differential expression 
profile caused by BL and D3G. The gene modulation pattern caused by BL resulted in a 
significant predicted inhibition of inflammation-related markers such as NF-κB complex (p = 
8.2
-19
), IL-18 (p = 3.0
-19
), IL-1β (p = 1.4
-14
) and TNF (p = 7.5
-18
), and also inhibition of cancer-
progression related molecules such as AKT (p = 5.0
-17
) and JUN (p = 4.7
-8
) (Figure 7.8A). The 
differential gene expression caused by BL promoted a predicted activation of immune response-
related molecules such as IL-10 (p = 1.5
-24
), FOXP3 (p = 1.5
-12
), and TNFAIP3 (p = 1.1
-12
) and 
also some pro-apoptotic markers such as BCL6 (p = 2.9
-12
) and TP53 (p = 1.5
-9




Regarding the effects of D3G, it was observed that due to the differential gene expression 
profile, a significant inhibition was predicted for molecules related to immune response such as 
IL-18 (p = 2.1
-9
), IL-1 (p = 4.1
-10
), IL-1β (p = 6.1
-6
), CD28 (p = 6.3
-8
), and STAT3 (p = 7.5
-11
) 
(Figure 7.8C). Moreover, the differential gene expression pattern caused by D3G, promoted a 
significant activation prediction of IL-10 (p = 6.1
-10
) and RXRA (p = 2.3
-6
) (Figure 7.8D). 
Additionally, for both BL and D3G, the highest scored canonical pathway was the role of 
cytokines in mediating communication between immune cells. Furthermore, IPA’s diseases and 
functions predictive score indicated that based on the gene modulation by BL and D3G, the 
highest scored reduced functions were the migration of tumor cell lines, activation of 
macrophages, inflammatory response, and cell proliferation of tumor lines, among others.   
7.5 Discussion 
Due to the valuable insight provided by the AOM/DSS model on potential effects of treatments 
on human colitis-associated colon carcinogenesis, it has been used to explore the impact of 
phenolic-rich extracts on inflammation and colorectal cancer (L. Chen et al., 2018; Cuellar-
Nuñez et al., 2018; Lippert et al., 2017). Here, we used this model to analyze a novel phenolic-
rich extract and to compare its effects with an extract enriched in its major anthocyanin, D3G. 
Additionally, this investigation analyzed the immune response, determining the immune 
pathways affected by the BL and D3G-enriched treatments. 
Throughout the study, the AOM/DSS + BL group was exhibiting lesser severity of symptoms of 
colitis compared to the other disease-induced groups. There were no mice in the BL group that 
had severe colitis symptoms leading to early euthanasia where one mouse in the AOM/DSS + 
D3G group and two mice in the AOM/DSS control group were euthanized early due to 




mice from losing significant weight during DSS treatments. Similarly, it was demonstrated that 
mice with 4.5% whole Aronia berry supplemented diet, maintained their weight and had a lower 
colitis symptom score compared to the DSS induced control (Martin, Smyth, Liu, & Bolling, 
2018). The AOM/DSS + BL group had lower DAI throughout the study, especially in the last 
few weeks, compared to the AOM/DSS control; the AOM/DSS + D3G group only had a lower 
DAI than the AOM/DSS control at the final measurement. Diets supplemented with 2.5% and 
5% moringa leaves, rich in a variety of phenolic compounds, were found to decrease DAI in 
AOM/DSS-treated mice (Cuellar-Nuñez et al., 2018). Another study, looking at a polyphenol-
rich supplement of curcumin, green tea, and selenium, found a reduced DAI in DSS treated mice; 
additionally, the study saw histological benefits in a 2,4,6-trinitrobenzenesulfonic acid-treated rat 
model and showed improvement for humans with ulcerative colitis (Shapira et al., 2018).    
Macroscopic measures were seen to be positively modulated post-euthanasia in the AOM/DSS + 
BL group compared to the AOM/DSS control and AOM/DSS + D3G group, with fewer and 
smaller neoplasms and a lower mucosal damage score. The statistical trend seen in the DAI was 
reflected in the mucosal damage scores. A resveratrol grape seed extract combination also 
showed tumor reduction in an AOM treated mouse model (Reddivari et al., 2016). Another study 
with phenolic-rich oleaster leaf-infused water reduced tumor size in a nude mice colon cancer 
model (Zeriouh et al., 2017). Additionally, the AOM/DSS + BL group had lower relative colon 
and spleen weight indicating lower inflammation. In a colitis model, colon inflammation was 
attenuated with treatment of persimmon phenolic extract as shown by a lesser decrease in colon 
length compared to the disease control (Direito et al., 2017). In a breast cancer model, a similar 
concentration of a delphinidin-3-glycoside, delphinidin-3-glucoside, was used in mice (40 mg/kg 




our study, the D3G group, at the concentration used, showed no benefit in the reduction of 
neoplasm count or size in the colon. Another study, looking at effects of isolated delphinidin and 
an anthocyanidin mixture from bilberry saw a reduction in lung tumor volume for both 
treatments; however, in this research, the administration was through intraperitoneal injection, 
and the delphinidin concentration was three times that of the mixture (Kausar et al., 2012). 
Potentially, the D3G-enriched treatment would be more effective through an alternative 
administration or at a higher concentration than we used in this study.     
BL modulated many markers of inflammation, especially decreasing IL-6 expression compared 
to the AOM/DSS control across methods. In an ulcerative colitis mouse model, S. grandiflora 
leaves which are high in polyphenols reduced IL-6 (Gupta, Motiwala, Mahajan, & Sabre, 2018).  
A study using the AOM/DSS model found an enriched diet with a combination of 
phytochemicals reduced IL-6 mRNA expression (Girardi et al., 2018). AOM/DSS + BL and 
D3G groups showed potential to modify other cytokines, including IL-1β and IL-10. Freeze-
dried black raspberries also elicited modulations to these two cytokines in an esophageal cancer 
model in rats (Peiffer et al., 2016). A decrease in VEGF gene expression was seen in the BL 
group compared to the AOM/DSS control. In a lung cancer model, VEGF was reduced in tumor 
tissue in mice treated intraperitoneally with delphinidin (Pal et al., 2013). Immune checkpoints, 
PD-L1 and PD-1, were downregulated in the polyp and non-polyp tissue of the BL treated mice, 
respectively; cytokines that have been demonstrated to upregulate PD-L1 and PD-1 expression, 
including IL-2, 6, and 7, were also shown to be decreased in colon mucosa of the BL treated 
mice compared to the AOM/DSS control. According to the upstream gene analysis, BL treatment 




response. In a hepatocellular cancer model, Lonicera caerulea ‘Beilei’ fruit also elicited 
immunoregulatory effects (Zhou et al., 2018).  
Additionally, the differential gene expression caused by BL treatment promoted a significant 
prediction of activation of tumor suppressor p53 and inhibition of the antiapoptotic marker 
NFκB, demonstrating pro-apoptotic potential in the polyp tissue. In the same model, licorice 
flavonoids were shown to reduce the activation of NF-κB and increase p-P53 expression (Huo, 
Liu, Gao, Li, & Cao, 2016). Predicted inhibition of both NF-κB and STAT3 could be linked to 
reduced PD-L1 expression, as these transcriptional factors have been shown to upregulate PD-L1 
expression in solid tumors, with cytokines such as IL-6 and IFNγ increasing PD-L1 expression 
through the STAT3 pathway (Zerdes, Matikas, Bergh, Rassidakis, & Foukkakis). Based on the 
protein (colon mucosa and plasma) and gene expression (colon polyp and non-polyp tissue) 
changes seen in this study, a proposed pathway of impact induced by the black lentil is shown in 
Figure 7.9.  
Although D3G was not potent at preventing the colorectal carcinogenesis, the non-polyp tissue 
of mice treated with D3G had only four genes differentially compared to the healthy control and 
had the strongest clustering score with the healthy control throughout the gene expression 
analysis. This evidence suggests that D3G had a potent effect preventing an inflammatory status 
in the non-polyp tissue. The chemopreventive effect of certain anthocyanins has been reported, 
as well as their anti-inflammatory effect (Diaconeasa, Frond, Ştirbu, Rugina, & Socaciu, 2018; 
Madka & Rao, 2013); therefore the ability of D3G to reduce inflammation but not the cancer 
initiation might be related to the concentration used in this study. 
In summary, the BL treated mice demonstrated benefits compared to the AOM/DSS control mice 




(Figure 10). Weight stabilization during periods of DSS treatment and low DAI values during 
the study showed the protection of the BL treatment against the colitis symptoms and colorectal 
cancer progression. BL treatment lowered the amount and size of the neoplasms and size of the 
spleens. Further analyzing the molecular mechanisms, BL treatment demonstrated anti-
inflammatory effects. Markedly, IL-6 was reduced by BL in all methods tested. PD-L1 had the 
second highest fold change in the colon polyp tissue of the AOM/DSS + BL group compared to 
the AOM/DSS control polyp tissue. Based on the protein and gene changes, it appeared to be a 
possible alteration of the immune checkpoint cytokine pathway by the BL treatment. The D3G 
treatment was unable to elicit a protective response macroscopically; potentially, a higher 
concentration or alternative administration could lead to a more effective response of this D3G-
enriched extract. Additionally, the variety of phenolics, including proanthocyanidins, flavonols, 
and phenolic acids, among others, in the BL extract were thought to contribute to the anti-
carcinogenic impacts. However, anti-inflammatory benefits were induced by the D3G-enriched 
extract as demonstrated in the gene expression modulation which showed the positive impact of 
the D3G component on reducing inflammation. To our knowledge, this is the first in vivo study 
with black lentils pertaining to inflammation or colorectal cancer. This study demonstrates the 
ability of phenolic-rich extracts to modulate cytokines involved in the communication between 
immune cells to induce anti-inflammatory and anti-carcinogenic effects.   
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FIGURES AND TABLES 
 
Figure 7.1 Overall study design for 7.5 week old C57BL/6 mice (n= 44). Ad libitum diet provided throughout and regular water 
unless indicated dextran sodium sulfate in water. All jellies contained 7% gelatin and 10% sucralose. *4 days only. AOM, 
azoxymethane; BL, black lentil; D3G, BW, body weight; delphinidin 3-O-(2-O-β-d-glucopyranosyl-α-l-arabinopyranoside; DSS, 







Figure 7.2 Black lentil composition results. A. High performance liquid chromatography profiles at 520nm and 280 nm. B. Table 
showing the total anthocyanin and polyphenol concentrations. C. Table with the list of specific polyphenols identified in the black 






Figure 7.3 Macroscopic data. A. Average body weight. B. Average disease activity index. C. 







Fig. 7.3 cont. F. Colon weight relative to the length. G. Examples of colon pictures from each 
group. H. Relative spleen weight. I. Examples of spleen pictures from each group. Letters 
indicate statistical difference between groups as determined by Tukey-Kramer (p < 0.05).  AOM, 
azoxymethane; BL, black lentil; D3G, delphinidin 3-O-(2-O-β-d-glucopyranosyl-α-l-






Figure 7.4 Hematoxylin and eosin staining of colons stored in 10% neutral buffered formalin. A. 
Healthy control. B. AOM/DSS control. C. AOM/DSS + Black lentil (BL). D. AOM/DSS + 
Delphinidin 3-O-(2-O-β-d-glucopyranosyl-α-l-arabinopyranoside (D3G). Black arrows indicate 







Fig. 7.4 cont. E. Average histology scores for each group. Scores were blindly determined by 
two researchers separately with six replicates per group. Letters indicate statistical difference 
among groups as determined by Kruskal-Wallis (p < 0.05). AOM, azoxymethane; DSS, dextran 





Figure 7.5 Inflammation protein modulation in colon mucosa and plasma. A. Results from the 
inflammation protein array analysis of the colon mucosa. All markers shown were statistically 
different between the AOM/DSS + black lentil (BL) and AOM/DSS control groups. B. 
Inflammation protein array analysis of the colon mucosa for LIX and MIP-1γ. C. Cytokine 
expression in plasma. Asterisks indicate statistical difference between the AOM/DSS control and 
AOM/DSS + BL groups as determined by Tukey-Kramer (p < 0.05). AOM, azoxymethane; colony 
stimulating factor, CSF; DSS, dextran sodium sulfate; interferon, IFN; interleukin, IL; LIX, chemokine ligand 5; MIG, monokine 
induced by gamma; MIP, macrophage inflammatory protein; stromal cell derived factor, SDF-1; T cell activation, TCA; Tissue 




Table 7.1 Inflammatory proteins significantly affected in the colon mucosa and the four 
significantly altered markers in the plasma by the AOM/DSS + black lentil (AD-BL) group 
compared to the AOM/DSS control (AD).  
Protein Abbreviation Basic function related to inflammation ∆ AD-BL vs AD 
Colon Mucosa    
Granulocyte-colony 
stimulating factor 
GCSF (CSF3) Cytokine that produces granulocytes (Turner, 





GM-CSF Can elicit protective properties on the colon 
mucosa but also can lead to colorectal 
carcinogenesis (G. Chen, Han, Shen, & Li, 
2014) 
100% 
Interleukin 7 IL-7 Cytokine with adaptive immunity properties 
shown to be high in sera and solid tumors of 





MIG (CXCL9) Chemokine upregulated by proinflammatory 
cytokines, involved in migration and metastasis 





MIP-1α Pro-inflammatory mediator (M.-J. Yang et al., 
2018) 
-90.2% 
Interleukin 1 beta IL-1β Pro-inflammatory cytokine, leads to 
abnormalities in the epithelial barrier (Lasry, 
Zinger, & Ben-Neriah, 2016) 
-76.1% 
Leptin Leptin Adipokine that controls fat stores, overexpressed 
in carcinoma tissues, promotes vascular 





MCSF (CSF1) Cytokine that activates production and 
activation of monocytes (Turner et al., 2014) 
-72.3% 
Interleukin 2 IL-2 Involved in the adaptive immunity response, 
both an immune suppressor and activator(Turner 
et al., 2014)  
-71.6% 
Interleukin 12 P70 IL-12 p70 Elevated levels in ulcerative colitis patients 
compared to tissues in non-inflammatory bowel 





MCP-1 (CCL2) Pro-inflammatory chemokine, activates 
differentiation to M2 macrophage, promotes 
vascular permeability and metastasis (L.-M. 
Chen et al., 2017) 
-66.6% 
Interleukin 10 IL-10 Anti-inflammatory cytokine, reduces pathogenic 
TH17 inflammatory response (Long, Lundsmith, 











Table 7.1 cont. 
Protein Abbreviation Basic function related to inflammation ∆ AD-BL vs AD 
Colon Mucosa    
    
Lymphotactin Lymphotactin 
(XCL-1) 
Chemokine with chemotactic functions 
(Turner et al., 2014) 
-59.3% 
Soluble tumor necrosis 
factor receptor-2 
sTNFRII Upregulation on intestinal epithelial cells in 
inflammatory conditions, TNF binding can 
result in proliferation of tumor cells (Mager et 
al., 2016) 
-58.2% 
Interleukin 6 IL-6 Pro-inflammatory cytokine, induced by NF-
кB, promotes colorectal cancer development 
(Lasry et al., 2016) 
-44.5%   
Plasma    
Interleukin 23 IL-23 Overexpressed in intestinal inflammation, 
induces other pro-inflammatory cytokines 
(Mager et al., 2016) 
-100%  
Interleukin 6 IL-6  -72.6%  
Interferon gamma IFNγ Pro-inflammatory cytokine, upregulated in 
early stages of colitis associated cancer and 
promotes PD-L1 expression (Mimura et al., 
2018; Terzić et al., 2010) 
-49.0% 








showing A. a 





Each row represents 
one of the 32 genes 
affected by 
AOM/DSS 
compared to the 
healthy control. The 
color scale shows 
the gene expression 
standard deviations 
from the mean. B. 
Venn diagram 
comparing the 
affected genes in the 
healthy control, BL, 
and D3G compared 
with the AOM/DSS 
polyp. C. Venn 
diagram comparing 
the affected genes in 
the non-polyp tissue 
by AOM/DSS, BL, 
and D3G compared 






Fig. 7.6 cont. D. List of genes with fold-change compared to AOM/DSS polyp among the healthy control, BL, and D3G and genes 
compared to healthy control among the AOM/DSS control, BL, and D3G groups corresponding to the Venn diagram intersections. E. 
Functional KEGG pathway enrichment analysis and F. Functional biological function Gene Ontology (GO) project enrichment 
analysis impacted by BL and D3G treatment compared to the AOM/DSS control. AOM, azoxymethane; BL, black lentil; D3G, 




Table 7.2 Top ten differentially expressed genes (p < 0.05, fold-change (FC) of each type of tissue 
compared to the polyp tissue of the AOM/DSS control. 
Healthy control AOM/DSS non-
polyp 
BL non-polyp BL polyp D3G non-polyp D3G polyp 
Gene FC Gene FC Gene FC Gene FC Gene FC Gene FC 
Il-15 2.8 Cxcl12 3.7 Tlr3 3.3 Ccl28 1.7 Cxcl12 2.6 - - 
Myd88 2.4 Egf 3.5 Egf 3.0 Irf1 1.7 Tlr3 2.5 - - 
Ccr10 2.1 Tlr3 3.1 Cxcl12 2.9 Tlr3 1.6 Egf 2.4 - - 
Ccl28 2.0 Ccl28 2.7 Ccl28 2.6 - - Il-15 2.3 - - 
Irf1 1.7 Il-15 2.1 Gbp2b 2.4 - - Ccl28 2.1 - - 
Tnfsf10 1.7 Ccr10 1.9 Il-15 2.4 - - Irf1 1.6 - - 
Ccl5 1.7 Fasl 1.8 Irf1 2.2 - - - - - - 
- - Irf1 1.7 Ccl5 2.0 Nos2 -1.7 - - - - 
- - Il-5 1.7 Cxcr3 1.9 Cxcl5 -1.8 - - - - 
- - Tlr7 1.6 Ifnγ 1.7 Cxcl10 -1.8 - - - - 
Il-17a -6.4 Cxcl1 -2.7 Cxcl1 -2.6 Il-4 -2.0 Csf3 -5.6 - - 
Il-1α -6.8 Ccl22 -2.9 Il-1α -3.0 Fasl -2.0 Cxcl1 -6.1 - - 
Tnf -7.7 Il-1β -3.5 Tnf -3.3 Vegfa -2.3 Il-1β -8.1 Il-5 -1.9 
Il-1β -13.1 Cxcr2 -3.6 Nos2 -3.4 Csf3 -2.3 Spp1 -8.3 Il-4 -1.9 
Il-23a -18.1 Tnf -4.5 Il-1β -4.8 Il-2 -2.5 Csf2 -8.6 Csf3 -1.9 
Nos2 -19.7 Cxcl2 -5.7 Spp1 -7.4 Il-13 -2.6 Cxcl2 -10.2 Cxcr1 -2.0 
Cxcr2 -19.9 Spp1 -6.7 Cxcl5 -7.6 Il-22 -2.7 Nos2 -11.8 Ccl20 -2.0 
Spp1 -22.7 Cxcl5 -6.9 Cxcr2 -8.1 Cxcr1 -2.7 Cxcl5 -13.0 Il-2 -2.1 
Cxcl5 -29.6 Il-23a -8.5 Cxcl2 -8.3 Cd274 -2.8 Il-23a -13.9 Cxcr2 -2.1 
Cxcl2 -60.7 Nos2 -8.9 Il-23a -9.7 Il-6 -4.0 Cxcr2 -13.9 Il-22 -2.2 
            
Programmed death-ligand 1, Cd274; C-C motif chemokine, CCL; chemokine ligand, Cxcl; chemokine receptor, Cxcr; epidermal 
growth factor, EGF; fas ligand, Fasl; Interleukin, IL; Interferon regulatory factor 1, IRF1; Nitric oxide synthase 2, Nos2; secreted 










Fig. 7.7 cont. C. Chemokines D. Interleukins E. Chemokine and interleukin receptors F. Growth 
factors and receptor and G. Apoptosis. AOM, azoxymethane; BL, black lentil; D3G, delphinidin 3-O-(2-O-β-d-































in response to 
black lentil 
polyp compared 
to AOM/DSS polyp. Significant predicted C. inhibition and D. activation of associated markers based on the differentially expressed 
genes in response to D3G polyp compared to AOM/DSS polyp. E. The type of interaction is indicated by orange color (prediction of 





Figure 7.9 Proposed inflammation and immune response related pathway impacted by the black 
lentil extract in tumor cells based on modulation seen compared to the AOM/DSS positive 
control. A decrease in the pro-inflammatory cytokines is predicted to lead to a reduction in 
tumorigenesis, angiogenesis, and invasiveness induced by the STAT-3 and NFκB pathways. 
Markers that had a reduction in protein expression as seen in the plasma are marked with a blue 
triangle and in the colon mucosa are marked by a blue circle. Decreases in gene expression in the 





Figure 7.10 Integration of the effects induced by the black lentil extract and delphinidin 3-O-(2-
O-β-d-glucopyranosyl-α-l-arabinopyranoside (D3G)-enriched extract compared to the 
azoxymethane/ dextran sodium sulfate disease control. 
Chemokine ligand, CXCL; Interleukin, IL; Interferon, IFN; MIG, monokine induced by gamma; 
MIP, macrophage inflammatory protein; Programmed death-ligand 1, PD-L1; secreted 








CHAPTER 8: CONCLUSIONS 
 Red and purple colored corn extracts inhibited HCT 116 and HT-29 human colorectal cancer 
cell viability with concentrations of 50% inhibition (IC50) ranging from 1.1 to 6.3 mg/mL. The 
red corn had the lowest IC50 in both cell lines, showing the greatest inhibition potential. 
 Colored corn extracts increased apoptosis and reduced activity of angiogenesis. Purple corn 
extracts increased apoptotic cells, reduced anti-apoptotic markers (BCL-2 and survivin), and 
increased pro-apoptotic markers (BAX, cytochrome C, TRAILR2/D5). Purple and red corn 
extracts reduced VEGF expression. The red corn significantly reduced other important 
markers of angiogenesis like the tyrosine kinase TIE-2. In silico analysis showed high affinity 
of corn anthocyanins to a non-receptor (ABL2) and receptor (VEGFR2) tyrosine kinase.  
 Out of eleven phenolic-rich cereal, legume, vegetable, and fruit extracts tested on HCT 116 
and HT-29 cells, black lentil, sorghum, and red grape extracts showed the highest inhibition 
of cell viability. Black lentil had the lowest IC50 for both cell lines (HCT 116: 0.9 mg/mL, 
HT-29: 1.4 mg/mL).  
 Black lentil, sorghum, and red grape extracts induced apoptosis and black lentil and sorghum 
arrested cells in G1 phase of the cell cycle. Anthocyanins, cyanidin-3-O-glucoside (C3G) and 
delphinidin-3-O-glucoside exhibited tyrosine kinase inhibitory potential in silico and 
biochemically; C3G had one of the highest in silico binding affinities with all of the tested 
pro-angiogenic kinases (ABL1, VEGFR2, TIE-2, and EGFR).  
 Correlations between chemical composition and inhibition of colorectal cancer cells were 
seen. Inhibition of HCT 116 and HT-29 cell viability correlated with total phenolics (r = 0.87 




29 viability inhibition (r =0.69), and there was a strong inverse correlation with hue angle and 
HT-29 viability inhibition (r = -0.81). 
 D3G, its metabolites (delphinidin and gallic acid), and a combination of phenolics 
representing the composition of red grape phenolics had IC50 values ranging from 81-600 
µg/mL for reducing HCT 116 and HT-29 cell viability.   
 In silico analysis showed high binding affinity of phenolics to immune-suppressing 
checkpoint proteins, programmed death protein-1 (PD-1) and programmed death-ligand 1 
(PD-L1). C3G, D3G, and delphinidin demonstrated high inhibition potential of PD-L1 
activity in two of the three methods tested.  
 Anthocyanins, C3G and D3G, decreased PD-1 expression in peripheral blood mononuclear 
cells in monoculture by 41% and 55%, and co-culture with HCT-116 and HT-29 cells by 39% 
and 26% (C3G) and 50% and 51% (D3G), respectively.  
 Throughout an eleven-week azoxymethane/dextran sodium sulfate colitis-associated 
carcinogenesis mouse model, the black lentil group had lower disease activity index, with a 
final value of 2.4 compared to 6.3 for the positive control group (p < 0.05).  
 Mice in the black lentil group had a lower average of 7.8 neoplasms while the positive control 
had 12.8 (p < 0.05). Additionally, black lentil fed mice showed anti-inflammatory outcomes, 
with a lower relative spleen weight and colon weight to length at 5 mg/g and 59 mg/cm 
compared to 10 mg/g and 82 mg/cm of the disease control group, respectively (p<0.05). 
 The black lentil extract reduced pro-inflammatory markers in both plasma and colonic 
mucosa. Interleukin-6 protein expression was downregulated in colon mucosa (-44.5%), 
plasma (-72.6%) and gene expression in colon polyps tissue (FC: -4.0) in the black lentil 




 The D3G-enriched extract did not have significant macroscopic changes compared to the 
disease control, other than a decreased disease activity index at the final measurement, but 
gene expression in the non-polyp tissue compared to the healthy control tissue was very 
similar with only 4 genes modified (Secreted phosphoprotein 1 and CXCL2, CXCL5, and 
CXCL10), which demonstrated its anti-inflammatory effects.  
 Both black lentil and D3G-enriched extracts showed potential to modulate pathways realted to 
IL-17 signaling, cytokine-cytokin receptors interactions, and intestinal immue networks.  
 
 




CHAPTER 9: INTEGRATION AND FUTURE WORK 
As evidenced by the ten hallmarks of cancer, there are many processes and characteristics 
involved that lead to the formation and progression of cancer. In colorectal cancer, 
pharmaceutical approaches to fight the disease include chemotherapy, targeted therapy, and 
immunotherapy. Chemotherapy attempts to inhibit growth and induce cell death of over 
proliferating cells. The current approved targeted therapies for colorectal cancer target molecules 
in the angiogenesis pathway, attempting to prevent and destabilize the growth of blood vessels to 
the tumor. The newest category, immunotherapy, helps to counteract the abilities of tumor cells 
to avoid immune destruction. In this research, we wanted to analyze the ability of anthocyanins 
and anthocyanin-rich extracts to modulate the tumor cell activity in similar manners to these 
pharmaceutical approaches. The idea being that this dietary approach could work in complement 
to the pharmaceutical treatments since often, pharmaceutical treatments are given in combination 
to attack the cancer at many forefronts. The four aims of this research were focused on the 
pathways of apoptosis, angiogenesis, and immune response.   
In aim one, it was first necessary to answer the question of whether anthocyanin-rich 
extracts could inhibit colorectal cancer proliferation and if so, could they also impact tumor 
progression pathways. Once it was confirmed that the anthocyanin-rich extracts could reduce the 
viability of colorectal cancer cells, the pathways of apoptosis and angiogenesis could be explored 
in vitro and in silico. With success in seeing modulation of these pathways, in aim two it was 
necessary to understand how the chemical composition of anthocyanin-rich extracts could impact 
their viability inhibition potential and ability to target apoptotic and angiogenic proteins. Finding 
correlations of colorectal cancer cell viability inhibition with total phenolics as well as with the 




aim three. Therefore, in this third aim, the plan was to look at these progression pathways with 
pure phenolics to discover if they could elicit inhibitory effects on tumorigenesis and negative 
immune regulators alone or if a combination in extract form was needed. D3G and its 
metabolites were able to inhibit cell viability although at somewhat high concentrations. It was in 
this aim where the immune response analysis began, and we discovered that anthocyanins, D3G 
and cyanidin-3-O-glucoside, were capable of inhibiting immune suppressing checkpoints, 
programmed death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1). Since the black 
lentil extract was the most potent extract tested through aims one and two and D3G was the most 
potent pure anthocyanin in aim three, in aim four we tested these materials in an animal model. 
We utilized a colitis-associated carcinogenesis mouse model to look at molecular targets from the 
apoptosis, angiogenesis, and immune response pathways in addition to inflammatory proteins 
and macroscopic changes in the mice. The black lentil extract, but not the D3G-enriched lentil 
extract, reduced the growth of neoplasms and attenuated disease activity index throughout. Both 
extracts demonstrated anti-inflammatory effects through the gene expression modulation in the 
colon tissue. Additionally, the black lentil extract decreased gene expression related to apoptosis 
like TP53, angiogenesis, like vascular endothelial growth factor (VEGF), and the immune 
response, like PD-L1. The amount of black lentil used was an obtainable amount in humans and 
not a mega dose. It was estimated that the human (60 kg) equivalent dose would be 58 g black 
lentils/day, which would be equivalent to about 1.7 servings. The mice consumed 4 mg 
polyphenols/day from black lentils, equivalent to approximately 767 mg polyphenols/day for 
human consumption which falls well within the range of polyphenol intake in the United States. 
This research is important, in part, because of its impact on the food industry. Natural 




natural pigments. Adding to the knowledge on their bioactivity further promotes their usage as 
functional foods with potential added health benefits. Also, we provided more insight on the 
correlation of phenolic composition and health benefits, namely prevention of colorectal 
tumorigenesis. There are many potential future directions for this area of work. With the 
successful results seen with the pure anthocyanins in vitro and black lentil extract in vivo 
pertaining to immune checkpoints, further analysis of the immune response would be a viable 
avenue of discovery. Especially since immunotherapy is at the forefront of pharmaceutical 
therapy, further research on bioactive compounds and immune response are valuable. Black 
lentils are much-understudied materials. Our work with black lentils and colorectal cancer is the 
only research, to our knowledge, that has analyzed the anti-carcinogenic properties of this variety 
of lentils. Additional animal studies using different models, such as metastatic colorectal cancer 
models, with this phenolic-rich plant extract would be a possible future direction. Another 
important route would be to look further at the effect of processing on anthocyanin and phenolic 
composition in plant foods and how that may change their biological activity and health benefits.  
The overall outcome of this research was a further understanding of the mechanisms of 
action of anthocyanins and anthocyanin-rich extracts on colorectal cancer progression. We 
identified that anthocyanin-rich extracts, the anthocyanin D3G, and its metabolites, could inhibit 
colorectal cancer viability. Apoptosis modulation was seen in vitro with plant extracts and pure 
phenolics. Plant extracts also demonstrated inhibitory angiogenesis effects in silico, in vitro, and 
in vivo, especially with impacts on VEGF.  Anthocyanins inhibited immune-suppressing 
checkpoints in vitro and by black lentil in vivo. Inflammatory cytokines were modified by black 
lentil and D3G-enriched extracts in vivo, especially IL-6. Anthocyanins and anthocyanin-rich 





Figure 9.1 Integration of the results of the main extracts and pure compounds tested and main pathways analyzed over the four aims 
of research. Abelson proto-oncogene, ABL; B-cell leukemia/lymphoma-2 associated X protein, BAX; B-cell leukemia/lymphoma-2, 
BCL-2; cellular inhibitor of apoptosis 2, cIAP2; cytochrome C, Cyt C; interferon gamma, IFNγ; interleukin, IL; epidermal growth 
factor receptor, EGFR; matrix metalloproteinase, MMP; monocyte chemotactic protein, MCP; programmed cell death protein 1, PD-1; 
programmed death-ligand 1, PD-L1; vascular endothelial growth factor, VEGF; vascular endothelial growth factor receptor 2, 







8-OHdG 8- hydroxy20 -deoxyguanosine 
ABL Abelson proto-oncogene 
ABTS•+ 2,2-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) 
AC aberrant crypt 
ACF aberrant crypt foci 
AFP alpha-fetoprotein 
AKT protein kinase B 
ANC anthocyanin 
ANGPT 1/2 angiopoietin 1 and 2 
AOM azoxymethane 
APC adenomatous polyposis coli 
Bad BCL-2-associated death promoter 
BAX B-cell leukemia/lymphoma-2 associated X protein 
BCL-2 B-cell leukemia/lymphoma-2 
BL black lentil 
BRAF B-RAF (rapidly accelerated fibrosarcoma) 
BrdU 5-bromo-2′-deoxyuridine 
C3G cyanidin-3-O-glucoside 
C3GE cyanidin-3-O-glucoside equivalent 
C3G-mal cyanidin-3-O-(6″-malonyl-glucoside) 
CA carbohydrate antigen 
CBMN cytokinesis-block micronucleus 
CCSC colon cancer stem cells 
CDKN2A cyclin-dependent kinase inhibitor 2A 
CE catechin equivalent 
CEA carcinoembryonic antigen 
cIAP2 cellular inhibitor of apoptosis 2 
COX-2 cyclooxygenase 2 
cPLA2 cytosolic phospholipase A2 
CRC colorectal cancer 
CRP C-reactive protein 
CTNNB1 catenin (cadherin-associated protein) beta 1 
CXCL chemokine ligand 
CXCR chemokine receptor 
Cyt C cytochrome C 
D3G delphinidin-3-O-glucoside 
D3GE delphinidin-3-O-glucoside equivalent 
DAI disease activity index 
DC delphinidin chloride 
DCF dichlorofluorescin 





DNMT1 DNA methyltransferase 1 
DSS dextran sodium sulfate 
E7G eriodictyol-7-O-glucoside 
EGCG (-)-epigallocatechin gallate 
EGF epidermal growth factor 
EGFR epidermal growth factor receptor 
ELISA enzyme-linked immunosorbent assay 
EMT epithelial to mesenchymal transition 
EPIC European prospective investigation into cancer and nutrition 
ERK extracellular-signal-regulated kinase 
GA gallic acid 
GAE gallic acid equivalent 
GAPDH glyceraldehyde 3-phosphate dehydrogenase 
γ-GCLC gamma glutamate-cysteine ligase catalytic subunit 
GI gastrointestinal 
GM-CSF granulocyte-macrophage colony-stimulating factor 
GSHPx glutathione peroxidase enzyme 
GSR glutathione reductase 
HDAC Histone deacetylase 
HPLC high performance liquid chromatography 
HSP 70 and 27 heat shock protein 70 and 27 
IAP inhibitor of apoptosis 
IC50 concentration of 50% inhibition 
ICAM-1 intercellular adhesion molecule 1 
IFNγ interferon gamma 
IGF insulin-like growth factor 
IGFR insulin-like growth factor receptor 
IL interleukin 
iNOS inducible nitric oxide synthase 
KRAS Kirsten rat sarcoma 
LDH lactate dehydrogenase 
LIA line immunoassay 
LINE-1 Long Interspersed Element-1 
M3G malvidin-3-O-glucoside 
MBDCap-seq methyl- binding-domain–capture sequencing 
MCP monocyte chemotactic protein 
Min multiple intestinal neoplasia 
MMP matrix metalloproteinase 
MPO myeloperoxidase 
mTOR mechanistic target of rapamycin 
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
N7G naringenin-7-O-glucoside 
NF-κB nuclear factor kappa B 







PARP Poly ADP ribose polymerase 
PAW purple corn resin-purified acidified water extract 
PAWE purple corn resin-purified acidified water extract with additional ethyl 
acetate purification 
PAX6a paired box 6a 
PB1 procyanidin B1 
PBMC peripheral blood mononuclear cells 
PCNA proliferating cell nuclear antigen 
PCR polymerase chain reaction 
PD-1 programmed cell death protein 1 
PD-L1 programmed death-ligand 1 
PGE2 prostaglandin E2 
P13K phosphatidylinositol-3-kinase 




PW purple corn pericarp water extract 
Q3G quercetin-3-glucuronide 
RAW red corn resin-purified acidified water extract 
RG red grape 
RGC red grape combination 
ROS reactive oxygen species 
RT-qPCR reverse transcription quantitative polymerase chain reaction 
SH sorghum 
SMAD4 mothers against DPP homolog 4 
SOD superoxide dismutase 
Sp specificity protein 
Src Rous sarcoma oncogene cellular homolog 
SRFP secreted frizzled related protein 
TCA tricarboxylic acid 
TGF transforming growth factor 
TIE-2 tyrosine kinase with Ig and epidermal growth factor homology domain 2 
TNF-α tumor necrosis factor α 
TNM tumor, node, and metastasis 
TUNEL terminal deoxynucleotidyl transferase dUTP nick end-labeling 
UNT untreated 
VCAM-1 vascular cell adhesion molecule 1 
VEGF vascular endothelial growth factor 
VEGFR2 vascular endothelial growth factor receptor 2 
WIF1 Wnt inhibitory factor 1 
XIAP X chromosome-linked inhibitor of apoptosis 
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